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Abstract
Background
Deprescribing is an intervention used to help reduce the risks associated with
inappropriate polypharmacy, especially for older adults. However, rates of
polypharmacy use have continued to increase worldwide, including in Australia.
Limited research is available that considers deprescribing and the management of
polypharmacy from the perspective of both older adults and GPs. This is despite the
key role both play in decision making. This study investigated deprescribing as an
aspect of medication management. The role of older adult health literacy was explored
to determine if this was an important facilitator of shared decision making about
deprescribing.
Aim
The aim of this research was to explore the factors which influence the process of
deprescribing in primary care in Australia.
Objectives
1. How does the structure of the healthcare environment in primary care in Australia
facilitate or impede discussions about polypharmacy and deprescribing between older
adults and their GPs?
2. What is the relationship between perceptions of ageing and the likelihood of
discussions about polypharmacy and deprescribing?
3. What is the role of health literacy in managing polypharmacy and making decisions
about deprescribing?
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4. What, if any, is the relationship between attitudes to medication use, age cohort,
socio-economic status and the likelihood of discussions about polypharmacy and
deprescribing?
Methods
A sequential, explanatory mixed methods approach was employed adopting a
pragmatic theoretical stance. The views of GPs and autonomous, community living,
older adults using five or more medications, were included. An initial quantitative
phase was conducted using two observational cross-sectional surveys with GPs (n=85)
and the second with older adults (n=187). A new survey tool was developed to assess
GP practices and attitudes toward deprescribing, as no tool existed at the time. The
older adult survey included two previously validated tools: the Patients’ Attitudes
Towards Deprescribing tool (PATD) and the All Aspect of Health Literacy Scale
(AAHLS). A second qualitative phase using individual interviews was also conducted
with GPs (n=16) and older adults (n=25).
The data for both quantitative studies were analysed using descriptive statistics and
bivariate analysis of correlations and relationships between groups employing SPSS
version 24. Qualitative data was explored using thematic analysis assisted by
organising and coding the data in NVivo 12. Finally, the results from each study were
considered together in order to identify points at which findings complemented,
converged or diverged from each other.
Results
Structural and attitudinal factors were found to influence the process of deprescribing
in Australia. GPs were often prevented from playing to the strengths of their generalist
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role when co-ordinating medication management. This was the result of structural
factors such as short consultation times, poor communication between multiple
healthcare providers and unclear lines of responsibility for medication management
decisions. Continuity of care, provided by GPs, resulted in trust. The presence of trust
was important to ameliorate the effects of uncertainty associated with medication
management and deprescribing, in the context of multimorbidity. However, trust also
resulted in some older adults deferring medication decisions to their GP and giving
precedence to the decisions of specialists.
Participants explicitly noted the role of structural factors however the influence of
attitude was implied. Both older adults and GPs held negative attitudes toward age
and ageing. This disrupted shared decision making and normalised medication use in
the context of old age. A pragmatic attitude toward the use of medications meant GPs
and older adults were more concerned about finding a level of appropriate
polypharmacy and maintaining this over time, as opposed to deprescribing. Research
driven numerical goals for polypharmacy use carried little weight although there was a
general desire to use as few medications as possible, especially in those using 10 or
more.
High health literacy scores were associated with a willingness to consider
deprescribing. Older adult participants described specific health literacy practices
related to the daily management of their often complex and burdensome medications
regimens. However, health literacy capabilities played a limited role in deprescribing
decision making as older adult capabilities were generally not acknowledged or
applied in consultations.
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Conclusion
Implications for practice highlight opportunities to improve shared decision making.
The consistent use of comprehensive medication reviews is recommended to allow
older adults to share their daily experiences, goals and preferences regarding
polypharmacy use. The acknowledgement and use of older adult health literacy
capabilities would enable a collaborative approach to shared decision making.
Recognition of capabilities would also reduce the disempowerment experienced by
many because of the influence of negative stereotypes towards older people.
The influence of frailty appears to be important although numbers of frail individuals
in this study were small. Further research is needed to explore the impact of increasing
health literacy demands and reduced access to primary care at a time when
medication management needs are increasing.
The pragmatic approach, using a mixed methods design, allowed the production of
practical knowledge. It added a greater level of insight particularly the exploration of
health literacy level and practices and the barriers to health literacy use in
consultations.
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Chapter One Introduction

1. Introduction
This research investigated an important topic in medication management, namely
deprescribing. The factors which influence deprescribing of medications in primary
care were explored, in order to produce practical knowledge to inform clinical practice
and to provide a better understanding of the perspectives and needs of older adults.
Rather than privileging the views of either prescribers or polypharmacy users, this
study examined the experiences of older community living adults with polypharmacy
and the role of General Practitioners (GPs) as providers of care. This approach allowed
insights into the complexities faced by both parties and how these interact to shape
action toward deprescribing. GPs were chosen as a target group as they prescribe the
majority of medications in primary care (NPS MedicineWise, 2018). Community living
older adults with polypharmacy were targeted because they are the group most
impacted by polypharmacy use in the daily management of medications. Older adults
are the fastest growing group of medication users and polypharmacy use is recognised
as a significant public health concern (World Health Organization., 2019).
Deprescribing has been promoted as an intervention aimed at reducing polypharmacy
and inappropriate medication use (Reeve et al., 2015). Both healthcare professionals
and older adult medications users have expressed concern about the use of
polypharmacy (Moen et al., 2009, Moen et al., 2010). Similarly, both have also
expressed a willingness to consider deprescribing (Carrier et al., 2019, Reeve et al.,
2018). Despite this willingness and growing attention in the research literature, rates
1

of polypharmacy and inappropriate medicines use in older adults have continued to
increase (Reeve et al., 2017). Deprescribing as an intervention does not appear to be
having a noticeable effect on clinical practice and this presents a challenge to
understand why (Stryczek et al., 2020).
The study focused on a range of specific objectives which have previously received
little research attention. Earlier deprescribing research has sought to: clarify a
definition for deprescribing (Page et al., 2018a, Reeve et al., 2015); develop processes,
algorithms and guidelines to facilitate deprescribing in clinical practice (Reeve, 2020);
investigate the feasibility and outcomes of deprescribing (Bloomfield et al., 2020, Page
et al., 2016); explore and describe the barriers and facilitators to deprescribing
(Doherty et al., 2020); and understand the attitudes and practices of healthcare
practitioners and patients’ attitudes toward deprescribing (Linsky et al., 2015b, Linsky
et al., 2017, Reeve et al., 2013c). Based on this earlier research, the study began with
the assumption that the factors which influence deprescribing are diverse, complex
and interdependent. As such, objectives were developed including to further our
knowledge of the influence of the healthcare environment on deprescribing
discussions, to understand the influence of perceptions of ageing and to explore the
relationship between age cohort (‘younger’ older adult or ‘older’ older adult) socioeconomic status and attitudes toward medication use on deprescribing discussions.
Health literacy has been alluded to in the literature as a potential factor that may
influence deprescribing discussions, however, it has received no research attention
(Bokhof and Junius-Walker, 2016, Holmes and Todd, 2017, Todd et al., 2018).
Therefore, an additional objective was included to investigate the role of older adult
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health literacy in the management of polypharmacy and the consideration of
deprescribing. Health literacy refers to the ‘personal characteristics and social
resources needed for people to access, understand, appraise and use information and
services to make decisions about health’ (Dodson et al., 2014). Aspects of health
literacy have been shown elsewhere to influence involvement in medical decision
making (Brabers et al., 2017, Ousseine et al., 2019). Consequently, health literacy was
thought to be an important factor of influence on deprescribing, including in
investigation, participation in decision-making, acceptance and carrying out of
deprescribing processes.
Notably, most studies of deprescribing for older community living adults have been
conducted in other countries and their findings will be reviewed in detail in chapter 2.
Few have been conducted within Australia. This study determined what differences
and similarities might exist in the Australian context, when compared to the findings
of studies conducted elsewhere.
1.2. Research aim
The aim of this research was to explore the factors which influence deprescribing
medications from the perspective of both GPs and older community living adults with
polypharmacy, and investigate the role of health literacy in the decision making
process.
1.2.1 Specific research objectives
1. How does the structure of the healthcare environment in primary care in Australia
facilitate or impede discussions about polypharmacy and deprescribing between older
adults and their GP?
3

2. What is the relationship between perceptions of ageing and the likelihood of
discussions about polypharmacy and deprescribing?
3. What is the role of health literacy in managing polypharmacy and making decisions
about deprescribing?
4. What, if any, is the relationship between attitudes to medication use, age cohort,
socio-economic status and the likelihood of discussions about polypharmacy and
deprescribing?
1.3 Chapter overview
In this chapter, background information is presented, demonstrating the need for
further investigation of this area. A formative conceptual framework is introduced that
was used to guide the study design. The methods used are briefly explained. Finally,
the chapter concludes with an overview of the subsequent thesis chapters.

2. Background
This section sets the scene for this study. It begins by outlining the demographics of
ageing in Australia and the subsequent prevalence of multimorbidity. Australian GP
and primary care services are also described. The key concepts important to this thesis
are defined and discussed, including deprescribing, polypharmacy, attitudes toward
medication use, health literacy, shared decision-making and perceptions of ageing. A
conceptual framework indicating the relationships between factors which influence
deprescribing is described.
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2.1 Demographics of ageing in Australia
Like other developed countries, Australia’s population is ageing. One in seven
Australians were aged 65 years or older in 2017 (Australian Institute of Health and
Welfare, 2018b). Furthermore, predictions indicate that over the next 30 years, those
aged 65 years or older will increase from 15% of the population (3.8.million) as at June
2017, to 8.8 million (22% of the population) by 2057 (Australian Institute of Health
and Welfare, 2018b). Australia has the fifth highest life expectancy for males (80.4
years) and the eighth highest for females (84.6 years) across countries within the
Organisation for Economic Co-operation and Development (OECD) (Australian
Institute of Health and Welfare, 2018a).
In the context of this study and its focus on community living older adults, in 2016
Australian males aged 65 could expect to live another 19.6 years (nine of these would
be in good health). Women aged 65 could expect to live another 22.3 years (ten of
these would be in good health) (Australian Institute of Health and Welfare, 2017).
These statistics illustrate the extended time span of the period of older age in
Australia. They emphasise the importance of focusing research attention on this large
and growing population group to ensure that an increasing number of communityliving older Australians enjoy good health across their later years. However,
multimorbidity is also becoming the norm in old age (Marengoni et al., 2011). The gap
between healthy life years and life expectancy indicates that a level of disease and
disability is common in the last years of life (Robine and Cambois, 2013). Findings
from Australia’s National Health Survey, 2017–18, indicate that 80% of Australians
aged over 65 report having at least one chronic disease with 51% reporting two or
more conditions (Australian Institute of Health and Welfare, 2020). The clinical
5

management of these multimorbidities has contributed to the growing use of
polypharmacy in older Australians. This has led to complex medication management
demands on both prescribers and older adults themselves.
2.2 Polypharmacy use by older adults in Australia
The use of multiple medications by older adults in Australia is growing. An analysis of
dispensing data from the Pharmaceutical Benefits Scheme of those aged 70 years or
older, between 2006–2017, indicated an increase in the use of five or more prescribed
medications from 33.2% to 36.2% of the population (Page et al., 2019). This was a 9%
increase since 2006 but represents a 52% increase in the absolute number of older
adults affected by polypharmacy due to the rapid population growth of those aged 70
or older in Australia. The same study indicated that polypharmacy increases with age,
with higher rates in those aged 80–84 years (43.9%) and 85–89 years (46.0%) (Page et
al., 2019). An earlier nationwide, cross-sectional survey of Australians aged 50 years or
older indicated that 46.3% also used complementary medications (Morgan et al.,
2012).
This increase in multiple medication use is in line with global trends. For example, a
comparison of two population based studies of older adults aged 65 years or older in
England reported that the prevalence of the use of five or more medications, including
both prescribed and over the counter items, quadrupled from 12% during the period
1991 to 1994 to 49.6% during the period 2008 to 2011 (Gao et al., 2018). In the USA,
community dwelling older adults aged between 65–85 years were included in a
longitudinal study involving in-home direct medication inspection. The use of five or
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more prescribed medications increased from 30.6% in 2005–2006 to 35.8% in 2010–
2011 (Qato et al., 2016).
2.3 Primary care services in Australia
In order to identify challenges or facilitators of deprescribing, this research achieved
its objectives by exploring the medication management practices of GPs in primary
care and the practices carried out in the everyday lives of older adults. Key aspects of
medication management in the primary care setting in Australia are outlined below.
Medication management itself is a dynamic area that is being refined to incorporate
concepts such as the quality use of medicines, medicines optimisation and individually
tailored prescribing. In Australia, systems have been mapped in order to determine
ways to develop consumer-centred medication management for older adults. Current
systems are described as being complex, occurring across multiple settings and
practitioners (Page et al., 2018b). Whilst it is important to recognise this complexity,
this thesis will only focus on medication management carried out in the primary care
setting, by GPs and older adults.
2.2.1 General Practice services
The following quote describes General Practice service provision in Australia.
‘General Practice in Australia provides universal, unreferred access to whole
person medical care for individuals, families and communities. General
practice care means comprehensive, coordinated and continuing medical care
drawing on biomedical, psychological, social and environmental
understandings of health.’ (The Royal Australian College of General
Practitoners, 2021)
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In Australia 85% of the population visit a GP at least once each year, with an average
of 6.9 visits per head of population per year. The average consultation length is 14.9
minutes (Britt et al., 2016). The supply of medication, or writing of a prescription or
advising the use of an over the counter medication is the most common clinical
intervention provided by general practice doctors in Australia (NPS MedicineWise,
2018). Over an average 100 consultations GPs ordered 82 medications, supplying a
further nine and recommended 11 over-the-counter medications (Britt et al., 2016).
GPs are the group of health professionals most likely to be involved in ongoing
medication management for older adults living in the community. Most Australian
older adults prefer to consult only one GP because of a desire for continuity of care,
allowing trust to develop (Bonney, 2011). However, older adults are four times more
likely to consult a specialist than their younger counterparts (Australian Institute of
Health and Welfare, 2018b). GPs coordinate access to specialists, with a referral
required from a GP before specialist services can be consulted.
2.2.2 Primary care costs
Primary healthcare costs in Australia are subsidised under two key policy platforms:
Medicare, and the Pharmaceutical Benefits Scheme. However many Australians still
have significant health related out of pocket expenses (Australian Institute of Health
and Welfare, 2018c). Australians are free to choose their own GP. Medicare provides a
level of universal medical insurance funded by the Australian Federal Government. It
covers the entire cost of a consultation for 65% of patients who attend ‘bulk billing’
GPs (Australian Institute of Health and Welfare, 2018c). Non-bulk billing GPs charge
above the Medicare scheduled rate, leaving patients with some out-of-pocket
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expenses. Only 31.5% of specialists bulk billed their services, with a median out of
pocket cost per service of $64. Access to bulk billing GPs and specialists varies by
geographic area (Australian Institute of Health and Welfare, 2018c). Any extra out of
pocket costs for primary care GP or specialist services are not covered by private
health insurance. In addition to regular consultations, Australians from 75 years of age
are eligible for a free annual health assessment performed by their GP.
Despite subsidies for prescription medication in Australia via the Pharmaceutical
Benefits Scheme, costs remain a barrier to purchasing needed prescriptions in lower
socio-economic areas (Australian Institute of Health and Welfare, 2018a). Because of
this, medication related cost concerns were explored as a potential facilitator of
deprescribing in this study.
2.2.3 Home Medicines Reviews
In Australia, Home Medicines Reviews (HMRs) are available via accredited community
pharmacists who provide a comprehensive medication review in the home. A GP
referral is required for older adults to access this service. The cost is covered under
Medicare (Pharmaceutical Society of Australia, 2020). The HMR program is targeted
at older community living adults using polypharmacy and aims to reduce problems
that may arise as a result of inappropriate medicines use (Ahn et al., 2015). It is
designed to be a collaborative review between the patient, the pharmacist and the GP,
who must first request the review and is then provided a report. A recent review of the
program indicated low referral rates with less than 10% of those using polypharmacy
having accessed the service over a five year period (Du et al., 2019).
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3. Key Concepts
3.1 Deprescribing
Stopping medications has long been recognised as a final step in the prescribing
process (De Vries, 1994). Research attention on this step has increased over the last
two decades with the use of the term ‘deprescribing’ first used in the literature in 2003
(Woodward et al., 2003). However, in clinical practice, most importance is placed on
decisions around the commencement of new medication, adjustment of doses,
substitution of similar medications and repeat prescribing (Ostini et al., 2011).
Prescribers and medication users give less attention to considering the ongoing
appropriateness of long-term medication or the need to discontinue medications that
are no longer appropriate (Alldred, 2014).
For the purposes of this study the following definition of deprescribing was adopted:
‘Deprescribing is the process of withdrawal of an inappropriate medication,
supervised by a health care professional with the goal of managing
polypharmacy and improving outcomes’ (Reeve et al., 2015 p 1255).
This definition was derived from a systematic review of 37 definitions used in the
emerging deprescribing literature (Reeve et al., 2015). It precludes patient initiated
stopping of medications. It emphasises that deprescribing is a process with multiple
aims, these being to: withdraw inappropriate medication, manage polypharmacy and
improve outcomes. Outcomes are not defined as to whether these are clinical or
patient reported or both and polypharmacy use is implied as being problematic. The
definition has been critiqued for its lack of clarity as to what constitutes an
inappropriate medication (Holmes and Todd, 2017). Despite its limitations, this
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definition was used to guide this study, for the purpose of consistency and to allow
comparability of results with other studies.
Ideally, the process of deprescribing takes into account changes in the context of an
individual’s treatment goals, their current level of functioning, life expectancy, values
and preferences (Scott et al., 2015). A number of deprescribing processes, guides and
algorithms have been developed to assist healthcare providers to systematically
consider such contextual factors when deprescribing. However, few have been tested
in clinical practice (Thompson et al., 2019). Outside of research settings there is little
evidence of the use of these tools to guide deprescribing or of assessments to predict
patients’ attitudes toward deprescribing (Ailabouni and Reeve, 2019, Ronquillo et al.,
2018).
Despite the lack of use of deprescribing guides in clinical practice, their application in
research settings has been shown to be safe and the benefit of deprescribing
demonstrated, to some extent (Hilmer and Gnjidic, 2018). In a review by Page et al.
(2016) of deprescribing interventions, no significant reduction in mortality or
morbidity was found in randomised control trials of deprescribing. However, such
trials have mostly been small and have been designed with the intention of
demonstrating the feasibility of deprescribing rather than outcomes such as
reductions in mortality or morbidity. Non-randomised trials and randomised trials
that included interventions that were tailored to the specific medication regime of the
individual medication user did show a significant reduction in mortality, especially in
the age group 65–80 years (Page et al., 2016). This evidence suggests that continuing
research into deprescribing is worthwhile in order to improve health outcomes for
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older adults. However, the lack of clarity about actual deprescribing practices in
clinical settings suggests there are knowledge gaps which need to be addressed in
order to understand how best to realise the potential benefits of deprescribing (Sawan
et al., 2020).
3.2 Polypharmacy
Polypharmacy is the term used when multiple medications are prescribed. For
practical purposes in this study, polypharmacy was conceptualised numerically as the
use of five or more concurrent medications, used continuously. Numerical definitions
of polypharmacy as the use of five or more medications are the most commonly used,
as indicated by two recent systematic reviews (Masnoon et al., 2017, Sirois et al., 2019).
However, this definition is contested, with others proposed from research, clinical
practice or public health sources (Sirois et al., 2019). A small number of definitions,
mostly from a clinical practice perspective, explain polypharmacy descriptively for
example as ‘the use of multiple medications concurrently’ (Masnoon et al., 2017) or
seek to problematize polypharmacy suggesting the use of ‘more drugs than needed’
(Sirois et al., 2019). Masnoon et al. (2017) noted seven studies which qualified
polypharmacy using terms such as appropriate or inappropriate. These more nuanced
definitions emphasise the need to assess the potential risks and benefits of each
medication in order to determine its appropriateness or necessity. They acknowledge
that polypharmacy can be of overall benefit to an older adult with multiple
morbidities (Duerden et al., 2013, Hughes et al., 2014, Lee et al., 2020).
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3.2.1 Polypharmacy outcomes
The use of polypharmacy has been problematised in the deprescribing literature
because of the higher risk of preventable medication related adverse events in older
adults who are exposed to polypharmacy, compared to younger populations (Assiri et
al., 2018). A review of mainly observation studies has indicated an association between
the use of polypharmacy and poor clinical outcomes, including increased adverse drug
events, hospitalisation, falls, mortality and reduced cognition (Fried et al., 2014).
The mechanisms for these poor clinical outcomes related to polypharmacy use are
complex and may result from reduced compliance, cognitive impairment, increasing
frailty, drug–drug interactions, drug–disease interactions or changes in
pharmacodynamics and/or pharmacokinetics (Mangin et al., 2018). A study conducted
in the USA of community dwelling older adults found a quarter were at risk of at least
one drug–drug interaction and 16% had a potential drug–disease interaction and that
this risk increased with the number of medications prescribed (Hanlon et al., 2017).
Additionally, poor outcomes are more likely where the use of polypharmacy includes
particular high-risk classes of medications or high-risk combinations such as
anticholinergics and sedative hypnotics (Lee et al., 2020). Prescribers for older adults
with multiple morbidities are left with an inherent tension between ensuring that
symptoms are treated effectively and limiting iatrogenic disease associated with the
use of multiple medications. How prescribers manage this tension is further explored
in this thesis and discussed specifically in chapters 5 and 6.
In addition to poor clinical outcomes reported in previous studies, patients have also
noted poor outcomes as a result of polypharmacy use although patient reported
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outcomes have received little attention in the literature. Poor patient reported
outcomes have been demonstrated in relation to increased personal costs, side effects,
burden of medication management, poor compliance, misdiagnosis of cognitive
impairment and an increased risk of initiating a ‘prescribing cascade’ (the use of
further medications to treat an adverse reaction to another medication) (Linsky et al.,
2019, Scott et al., 2013, Todd et al., 2018). In order to achieve person-centred care,
these outcomes are as important as the clinical outcomes mentioned previously and
should be explored as part of a deprescribing process. Patient reported outcomes of
medication use underpin research interest into what has been termed ‘minimally
disruptive medicine’ and the ‘burden of treatment’ (Abu Dabrh et al., 2015, May et al.,
2014). Patients’ views are discussed in detail in chapter 8.
3.2.2 Guidance for polypharmacy management
Despite the potential for poor health outcomes associated with polypharmacy use,
there is relatively little appropriate guidance for GPs that accounts for the complexity
of managing medications in the context of multimorbidity in older age (Hoffmann et
al., 2018). Clinical treatment guidelines are promoted as fundamental to ensuring the
rational use of medicines (Holloway, 2011). However, these have usually been
developed on a single disease model. GPs report the use of such clinical guidelines in
older adults with multimorbidities as a contributor to polypharmacy (Moen et al.,
2010). Recent clinical guidelines specifically designed to assist GPs to manage
multimorbidity and polypharmacy have been developed, although their usefulness is
yet to be demonstrated (Muth et al., 2019).
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Clinical trials of medications rarely enrol older participants with multimorbidity (Le
Couteur et al., 2010). This is despite the fact that older adults are the largest
consumers of medicines (World Health Organization., 2019). Older adults also face
unique risks when using medications due to changes in their physical response to
medication (pharmacodynamics) and also how medications are absorbed, distributed,
metabolised and excreted (pharmacokinetics) (Mangoni and Jarmuzewska, 2020). As
a result, the claimed benefits and safety results from trials may not be generalisable to
this population (Greenhalgh et al., 2014, Mangoni and Jarmuzewska, 2020).
Furthermore, the effect of long-term use of medication is not measured in clinical
trials which typically only run for six months or less (Busfield, 2006). Despite a
growing body of research on the limitations of the current evidence base, there
continues to be a gap in the design of clinical trials and the transfer of knowledge from
research into clinical practice. GP attitudes to the suitability of the evidence available
to them to facilitate prescribing and, more specifically, deprescribing are explored in
chapters 5 and 6.
3.2.3 Patterns of polypharmacy use
Polypharmacy use is present in all healthcare settings, globally and has been found to
be patterned, being influenced by socio-economic factors (World Health
Organization., 2019). Just as patterns of poor health outcomes in older age are
associated with socio-economic disadvantage (Kollia et al., 2018) it is not surprising
that higher rates of polypharmacy use are similarly patterned (Richardson et al., 2014,
World Health Organization., 2019). A national survey in Sweden confirmed lower
educational attainment was associated with polypharmacy (Haider et al., 2008) and
similar results have been found in the USA (Kantor et al., 2015). Lower socio-economic
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status and associated access to means tested public funded healthcare in Ireland led to
higher polypharmacy rates (Richardson et al., 2014). The effect of socio-economic
status, as indicted by the location of the participants, was used within this study in
order to explore if this patterning is noticeable within the Australian context. This is
discussed further in chapters 5, 7 and 9.
Other observed patterns noted in the literature appear to be unrelated to expected
patterns of health outcomes. For example, differences have been noted between
physician prescribing patterns which then result in distinct patterns of polypharmacy
use across areas (Gigerenzer et al., 2011). This implies that there is not only a
patterning of polypharmacy use driven by socio-economic factors but also a patterning
driven by how polypharmacy is managed. GP practices were explored to investigate
differences in polypharmacy management (Chapter 5 and 6).
3.3 Attitudes toward medication use
Older adult attitudes toward medication use vary. In a qualitative synthesis of lay
experiences of medicine taking, Pound et al. (2005) observed widespread caution
regarding the use of medicines, especially those required to be used long-term.
Concerns were based on fears of potential adverse effects including side effects,
tolerance, dependence and addiction. Other research has emphasised lay perceptions
of the overall benefit of medication use to manage poor health outcomes, despite
acknowledging the experience of side effects (Fried et al., 2008). Additional concerns
included the potential for interactions between concurrent medications (Moen et al.,
2009). It is important to understand older adult attitudes toward medication use as
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these have been shown to influence lay medication management practices, including
whether medication concerns will be raised during consultations (Pound et al., 2005).
Prescribing medications has become closely associated with the role of medical
doctors, especially GPs, who do the bulk of all prescribing (Britten, 2008). In a
systematic review of research about two-way communication about medicines
between patients and healthcare professionals, doctors were more likely to discuss
medication benefits, rather than side effects, risks or precautions (Stevenson et al.,
2004). However, in the context of polypharmacy use in older adults, multiple studies
have illustrated GP uncertainty about the benefits versus the risks of prescribing
multiple medications (Anthierens et al., 2010, Fried et al., 2011, Moen et al., 2010,
Sinnott et al., 2015, Søndergaard et al., 2015). Both GP and older adult attitudes
toward medication use are explored in chapters 5, 6, 7 and 8.
3.4 Health literacy
Older age has been associated with low health literacy levels (Baker et al., 2000,
Bostock and Steptoe, 2012, Geboers et al., 2016, Kutner et al., 2006, Wolf et al., 2010)
and shown to contribute to poor knowledge and understanding about medications
(Mosher et al., 2012) and polypharmacy (Huxhagen, 2018). Commentary on patient
deprescribing preferences suggest that these may be influenced by the older person’s
ability to comprehend health information and/or to communicate their preferences
with their doctors (Holmes and Todd, 2017). However, one previous Danish survey of
older adults using polypharmacy found no association between attitudes toward
medication or deprescribing and self-reported health literacy skills (Schiøtz et al.,
2018).
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More recent conceptualisations of health literacy suggest that rather than it being a
static, measurable skill, health literacy is more usefully thought of as an asset that
develops and changes over time, is distributed throughout a community and shapes
context specific everyday practices (Edwards et al., 2012, Edwards et al., 2015). This
study investigated health literacy based on this broader conceptualisation. A review of
relevant health literacy literature is included in chapter 3.
It is known that opportunity to accumulate health literacy resources is influenced by
demographic characteristics such as age, gender, geographic isolation, disability,
cultural/linguistic background and socio-economic status (Australian Commission on
Safety and Quality in Health Care, 2014). This may result in a ‘double burden’ of risk
where population groups already at risk for poor health outcomes as a result of
disadvantage also face an additional burden of low health literacy, adding to their risk
profile. This is explored in chapter 7 comparing the socio-economic status of
participants and their health literacy.
3.5 Shared decision making
Shared decision making is an aspect of person-centred care (Håkansson Eklund et al.,
2019). Shared decision making is thought to be key to an active partnership between
prescribers and their patients where patients are able to express their own preferences
and treatment goals with the aim of reaching a shared or agreed upon decision
(Sandman and Munthe, 2010). Shared decision making is assumed as the foundation
of some deprescribing tools (Reeve et al., 2014). However, there is little evidence of
patient involvement in shared decision making about medicines (Couët et al., 2015,
Stevenson et al., 2000, Stevenson et al., 2004). Additionally, shared decision making

18

for older adults with multimorbidity is complex and may require trade-offs as
competing priorities and preferences are considered (Hoffmann et al., 2018). Mulley
and Wenberg (2011) question whether people are capable of participating in decision
making given that there is unavoidable uncertainty in medical decisions and each
individual has variable levels of health literacy and numeracy. This again emphasises
the importance of this thesis and its exploration of the interaction between health
literacy and involvement in polypharmacy and deprescribing decision making
processes.
3.6 Perceptions of ageing
The deprescribing literature to date has generally discussed older adult medication
users as though this age group are homogenous (Gillespie et al., 2018). Evidence based
understandings of ageing take the view that older adults are in fact the most
heterogeneous, or varied, of all population groups (Stegemann et al., 2010). The
majority of older adults continue to live in the community and are a diverse group that
contribute to society as mentors, consumers, members of the workforce, caregivers
and innovators, despite the challenges of the aging process (World Health
Organization, 2015). Chronological age is only loosely related to physiological
changes, with some ‘younger’ older adults burdened with disability as a result of poor
health while some ‘older’ older adults remain relatively free of the limitations resulting
from the burden of disease (Australian Institute of Health and Welfare, 2017). The
concept of old age is moving away from the definition of universal, progressive decline
(Higgs, 2013). This in itself is challenging the way social institutions such as healthcare
facilities treat older people, and how older adults themselves interact with these
systems (Higgs, 2013). How this might play out in the interactions and discourse
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between older adults and their GPs may also influence the likelihood that there is
active discussion of deprescribing options. This is explored in chapter 6 and 8.

4. Conceptual framework
A formative conceptual framework, ‘Deprescribing in primary care’ (Figure 1.1), was
developed in the early stages of this study, based on an initial review of the literature
in 2014. This framework sought to visually demonstrate the findings from the
literature review including the assumed relationship of the factors identified for
further study in the research objectives. The framework showed the likely relationship
between factors which influence deprescribing including broad external contextual
factors related to the healthcare environment and individual level attitudes,
characteristics and skills. The conceptual framework was used to systematically guide
the methods in this study in order to further explore these relationships, gain more
knowledge of their relative importance and understand the interactions between
factors that influence deprescribing.
Separate aspects of the framework were investigated either in the quantitative phase
or qualitative phase only or across both phases of the study. Study findings were then
used to develop the framework further, in order to confirm (or otherwise)
relationships and/or better visualise components of the framework and their
significance in influencing deprescribing, based on the improved knowledge of the
topic area. Further discussion of the ways the framework has been refined and
modified in light of the study findings are discussed in chapter 9.
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Figure 1.1 Formative conceptual framework: Deprescribing in primary care

5. Methods
A pragmatic mixed methods approach was chosen when considering the methodology
for this study as this is well suited to producing findings which are of practical use
(Feilzer, 2010, Greene and Hall, 2010). A pragmatic approach is most commonly
adopted when using mixed methods as it allows greater epistemological and
methodological flexibility (Greene and Hall, 2010). A mixed methods, sequential
explanatory design using quantitative analysis of survey data and qualitative semistructured individual interviews was used in order to first identify and then describe
in-depth the factors that influence deprescribing. Mixed methods allow quantitative
and qualitative approaches to be used within one study allowing for a better
understanding of the research question compared to the use of only one approach
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(NIH Office of Behavioral and Social Sciences, 2018). During this study two phases
were undertaken, each with two study arms. The viewpoints of both prescribers and
older adults were sought in both phases of the study. Firstly, quantitative methods
were employed using descriptive surveys. Following this, qualitative methods were
used to further explore the research objectives using individual interviews. Unlike
previous studies, this methodology moved beyond describing ‘what’ is happening in
regard to deprescribing to examine ‘how’ and ‘why’, to allow the generative
mechanisms that influence deprescribing decisions to be identified and described in
detail. These methods and the design will be explained further in chapter 4.
5.1 Study setting
Four areas (Southern Sydney, Illawarra, Shoalhaven and the Southern Highlands) that
were accessible to the researcher were selected for the study (Figure 1.2). However, the
majority of the participants came from the Illawarra and Shoalhaven regions. Focusing
on these two regions, when combined, the Illawarra and Shoalhaven have an
estimated population of 460,300 people (Australian Bureau of Statistics, 2019b).
Older adults make up a significant and growing proportion of the population. The
coastal location and lower cost of living, outside of the capital city, Sydney, has made
them a popular retirement area, with those aged 75–79 years making up the age group
that is increasing in number the fastest. The two regions include urban, peri-urban
and rural areas. They also have a wide-ranging level of socio-economic status. Several
disadvantaged communities are centred around a steelworks and also within migrant
and indigenous communities. Advantaged groups are located around a major
university (id community-demographic resources, 2019). The demographic profile of
the Illawarra and Shoalhaven broadly reflects Australia as a whole, including the total
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percentage of people aged over 65 years, socio-economic status and provision of and
utilisation of GP services (Ghosh et al., 2013).

Figure 1.2 Study area

6. Overview of chapters
The following overview presents a brief outline of each of the chapters within this
thesis.
Chapter 2 provides a scoping review of the literature to identify what is already known
of the factors that influence deprescribing for older community living adults in
primary care.
Chapter 3 explores the evolution of the concept of health literacy and its measurement
since the term was first used in the 1970s.
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Chapter 4 describes the methods used to conduct the research. A sequential
explanatory mixed methods approach was employed. This way of structuring a mixed
methods design is described.
Chapter 5 presents the first study conducted in Phase 1: a survey of GP attitudes and
practices toward deprescribing using a newly developed survey tool.
Chapter 6 presents the findings from the first study conducted in Phase 2: a qualitative
study using semi-structured interviews with GPs to further explore the results from
the phase 1 GP quantitative study.
Chapter 7 describes the findings of the second study conducted in Phase 1: a survey of
attitudes toward deprescribing among older community living adults, using five or
more medications. This survey also measured self-reported health literacy status.
Chapter 8 describes the findings from the second study in Phase 2: a qualitative study
of community living older adults, using five or more medications. Again, semistructured interviews were conducted in order to further explore the results from the
phase 1 older adult quantitative study.
Chapter 9 integrates the findings and examines each of the research objectives in turn.
This chapter explores how the study findings advance our understanding of the factors
which affect the process of deprescribing in Australia. A refined conceptual framework
is presented.
Chapter 10 provides a brief conclusion highlighting the major findings of the research
and their significance, including implications for practice. The strengths and
limitations of the study are discussed and recommendations for areas for future
research are provided.
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Please note that a collective reference list is included at the end of the thesis.

7. Summary of this chapter
This chapter presented an overview of the aims and objectives of this thesis and
provided a brief background to the topic area, including discussing key concepts. A
conceptual framework visually depicting relationships between factors which
influence deprescribing was introduced. Polypharmacy use and deprescribing were
positioned within the broader process of medication management. The chapter signals
the use of a sequential mixed methods design, incorporating the views of both older
adults and GPs across both quantitative and qualitative phases.
The overview of the topic area highlighted that a number of significant gaps in our
knowledge exist. In particular, the influence of health literacy on participation in
shared decision making in the context of deprescribing had not been explored. The
lack of deprescribing in practice, despite a willingness to consider it, suggested that
further work was required to understand what influences attitudes and practices from
both the GP and older adult perspective. These will be explored in the subsequent
chapters of this thesis.
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Chapter 2 A review of the deprescribing literature
Factors that influence deprescribing for older community living adults in
primary care
1. Introduction
Research into deprescribing has increased markedly over the last decade, including
the body of qualitative and quantitative studies examining patient and healthcare
professional experience of, or their attitudes toward, deprescribing. Deprescribing
research is part of a larger body of work about appropriate medication management,
however for the purposes of this review, the focus will be on the deprescribing
literature only.
A scoping review framework using the PRISMA-ScR checklist was used to structure
the steps undertaken in the review process and the presentation of the review findings
(Boeckxstaens and De Graaf, 2011, Tricco et al., 2018) (Appendix B). A scoping review
was determined to be appropriate in order to map the evidence of this developing
body of research for older adults with multimorbidity (Munn et al., 2018). The intent
of the review was to explore the available literature about attitudes of community
living older adults and GPs toward deprescribing and to identify what influences their
willingness to reduce polypharmacy by stopping medications. In order to achieve
these goals, this review asked the following questions:


From the literature what do we know about older adults’ and GPs’ attitudes
toward deprescribing?



What substantive issues have been identified that influence their willingness to
deprescribe medication? What reasons are given to stop medication or to
continue?
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In order to consider different aspects of these questions, data from primary research
including both qualitative, quantitative and mixed methods studies were included in
this review. It was anticipated that the scoping review would identify areas requiring
further research, or, because this is an emerging area, those requiring research at
greater depth.
1.1 Previous Reviews
An initial search was conducted to identify existing published reviews of either GP
attitudes, older adult attitudes or the attitudes of both toward deprescribing. Five
reviews were identified which focused on barriers and facilitators of deprescribing
(Anderson et al., 2014, Bokhof and Junius-Walker, 2016, Doherty et al., 2020, Gillespie
et al., 2018, Reeve et al., 2013b). The earliest review examined the barriers and
facilitators of deprescribing from the perspective of patients, using a narrative
synthesis of qualitative, quantitative and mixed methods studies (Reeve et al., 2013b).
Anderson et al. (2014) sought to understand barriers and facilitators from the
perspective of the prescriber, which also involved conducting a synthesis of qualitative
studies. These two initial reviews by Reeve et al. (2013b) and Anderson et al. (2014)
were conducted as interest in this research area started to gain momentum. As such,
they were exploratory and broad in scope, being conducted across all healthcare
settings, targeting deprescribing in the context of all adult patient groups and
included both general deprescribing and deprescribing of single medications. These
reviews were followed by an ethnographic review conducted by Bokhof & Junius
Walker (2016) which had a narrower focus on qualitative research conducted in
primary care settings only. This review investigated the management of and attitudes
toward reducing polypharmacy (including deprescribing), from the perspective of
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both community-living older adults and GPs. This narrower focus is important
because, as mentioned earlier, in chapter 1, deprescribing is most often considered in
the context of treating older adults with multimorbidity in primary care. This review
was then followed by a mixed-method review conducted by the PhD candidate,
Gillespie et al. (2018) (Appendix A), which focused on deprescribing for older
community living adults from the perspective of both GPs and older adults, in the
primary care setting. More recently however, Doherty et al. (2020) conducted a
systematic review also incorporating all study designs. The aim of their review was to
identify safe deprescribing interventions to use in primary care for adults with
multimorbidity and polypharmacy. This latest review focused on describing health
inequalities across different socioecological levels and how these interact with
identified barriers and facilitators of deprescribing. This scoping review updates the
earlier mixed methods review conducted by Gillespie et al. (2018), taking into account
more recent research studies.

2. Methods
2.1 Search method
A three-step approach was employed to identify all relevant literature. Initially, three
databases were searched: Web of Science Core Collection, Scopus and MEDLINE.
Following this, reference lists of relevant reviews and the included articles were
manually checked for additional studies. Alerts were also set up to provide
notifications of newly published relevant studies. The most recent search was
conducted on September 14th 2020.
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2.2 Inclusion Criteria
Studies were included in this scoping review if they related to attitudes or practices of
General Practitioners (family physicians) toward deprescribing for the target
population of community living older adults, in the primary care setting. Studies were
also included if they related to the attitudes and practices of autonomous older
community living adults (median age ≥65 years) toward deprescribing, as directed by
their GP. Original qualitative focus groups or individual interviews, quantitative crosssectional surveys or mixed methods studies available in English, in peer reviewed
journals and published between January 2010 and September 2020 were included.
2.3 Exclusion criteria
Studies were excluded if they were conducted in hospital in-patient settings or longterm residential aged care facilities. Studies were excluded if the healthcare providers
were only specialists, pharmacists or practice/clinical nurse specialists and/or if the
mean age (or median where the mean was not reported) of the adult participants was
younger than 65 years of age. Studies which related to discontinuing medications in
the context of the management of dementia, cognitive loss or during palliative stages
of care were also excluded, as the circumstances of medication deprescribing is
markedly different in these scenarios (Lindsay et al., 2014). Methodological quality
was not assessed and therefore study quality was not used as a basis for exclusion.
2.4 Search Strategy
The search was conducted using MeSH terms where appropriate and combinations of
the following search terms using the Boolean operator ‘OR’ and the Boolean operator
‘AND’.
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“older adult” OR senior* OR elder*



“general practice” OR “general practitioner” OR GP OR “family physician” OR
physician OR “primary care” OR doctor OR clinician OR prescriber OR “health
professional” OR “health care professional”



"prescription drug" OR prescribing OR medicines OR medication OR
polypharmacy



withdraw OR withdrawing OR withdrawal OR cease OR ceasing OR
cessation OR stop OR stopping OR discontinue OR discontinuing OR
discontinuation OR reduce OR reducing OR reduction OR deprescribe OR
deprescribing OR optim*

Search terms were applied to abstracts, keywords and titles. An example of a database
search result is included in Appendix B. Search results were screened for relevant
articles by considering titles and the content of abstracts and/or full texts to determine
if the article met the inclusion criteria.
2.5 Analytic approach
Key data from potential articles were extracted into tables including authors, year of
publication, country, research aim, participants, data collection methods and analysis.
This was a useful first step in order to chart the available evidence. The results section
of each study, including quotes where available, were uploaded into NVivo 12 (QSR
International Pty Ltd, 2018) to assist with organisation and systematic coding.
Included material was read and codes were developed iteratively. Sections of data were
coded within Nvivo 12. Coded data was then mapped, analysed and discussed to
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identify similarities, patterns and relationships. From this process themes were
identified (Braun and Clarke, 2006).

3. Results
The results of the search are illustrated in the flow diagram in figure 2.1. The inclusion
criteria were met for 57 studies, including 34 exploratory qualitative studies, 2 mixed
methods design and 21 quantitative studies.
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Figure 2.1 PRISMA flow chart of study inclusion

Screening

Identification

Records identified through electronic
database searches
Scopus n= 1725

Records identified
through review of
reference lists

Web of Science Core n=1,096
n= 9

MEDLINE n=653

Records after duplicates removed

Records
excluded=2,696

n=2791

Eligibility

Full text articles excluded n=38
Full text articles
assessed for
eligibility
n=95

Study setting not community
living older adults in primary care
=24
Study population not primarily
older adults =9

Included

Not available in English=3
Not available=2
Studies included in review
n=57

32

All except one study, (Tegegn et al., 2018), were conducted in healthcare systems
within developed countries. Of the included studies, the majority (n=26) were
conducted in European countries, 16 in North America, nine in Australia/New
Zealand, three in Asia one in the Middle East and one in Africa (Table 2.1). Most of the
European studies adopted a qualitative approach (21 out of 26 studies).

Table 2.1 Study country of origin and design
Region

Number

Study design

of studies
Europe

26

4 Quantitative
21 Qualitative
1 Mixed Methods

North

16

America

8 Quantitative
7 Qualitative
1 Mixed Methods

Australasia

9

4 Quantitative
5 Qualitative

Asia

4

4 Quantitative

Middle East

1

1 Qualitative

Africa

1

Quantitative

Confidence in comparing the articles was possible because of key similarities across
the majority of health systems. In general, global life expectancy is increasing and
multimorbidity prevalent resulting in the common use of polypharmacy (World
Health Organization, 2015). Other similarities include a biomedical approach to
treatment, the use of evidence-based medicine, primary care provided by generalists
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with specialty physicians available for the management of specific illnesses and access
to a large range of pharmaceutical products. However, it is also important to recognise
that differences also exist between countries, such as how GPs are reimbursed for
consultations, the cost of pharmaceuticals and the presence of direct-to-consumer
advertising of prescription medications (Ludwig and Schott, 2011).
Extracted data from the included studies were summarised in two tables according to
method, to assist with the organisation and analysis of results. The summary of
quantitative studies table (Appendix C) summarises the 21 quantitative studies,
including surveys of older adults’ and GP attitudes toward deprescribing.
The development of tools to measure patients’ attitudes toward deprescribing and the
translation of tools into other languages has resulted in a growing body of quantitative
surveys of older adults (n=15). The majority, (n=11), measured a hypothetical interest
in deprescribing using the validated Patients’ Attitude Toward Deprescribing (PATD)
(Reeve et al., 2013a) or revised version of this tool (rPATD) (Reeve et al., 2016c). Older
adult responses using the PATD or rPATD tools indicate that consistently high
numbers, between 67.7% (Kua et al., 2019) to 93.4% (Ng et al., 2017), would be willing
to consider deprescribing if their doctor recommended it (Gillespie et al., 2019a, Hao
et al., 2018, Kua et al., 2019, Omar et al., 2019, Reeve et al., 2019, Reeve et al., 2018,
Schiøtz et al., 2018, Sirois et al., 2016, Tegegn et al., 2018). However, when used at
baseline and then following an educational intervention, a Canadian study found that
despite 86% of older adults indicating an initial willingness to consider deprescribing,
only 41% successfully discontinued a medication at six months (Turner et al., 2019).

34

One other study (Vordenberg and Zikmund-Fisher, 2020) also measured hypothetical
interest in deprescribing using the Medical Maximiser-Minimizer Scale (MMS)
(Scherer et al., 2016) and the Beliefs about Medicines Questionnaire (BMQ) (Horne
and Weinman, 1999). This study found only half of participants would accept having a
medication deprescribed.
Another deprescribing specific tool, the Patient Perceptions of Discontinuation
(PPoD) has been developed and validated in the USA (Linsky et al., 2016). Using that
tool among a sample of veterans, higher education level and an interest in
deprescribing and medication decision making were associated with discontinuation.
Higher trust was associated with decreased deprescribing.
Awareness of medication harm was explored among a population based sample of
older adult Canadians. Key findings indicated 6.9% were aware of the term
deprescribing while 48% had researched medication related harm and almost two
thirds were aware that medication could cause harm (Turner and Tannenbaum, 2017).
Only six quantitative studies of GP attitudes toward deprescribing have been
conducted and no tools have been used consistently or have been validated. Most of
the existing studies suggest GPs are confident in their ability and comfort to
deprescribe but experience a significant gap between this confidence and action to
deprescribe. A Swiss study of 157 GPs, reported that 88% very frequently or frequently
considered deprescribing in the context of medication management for their older
patients (Mantelli et al., 2018) and in a French study 91.4% of GP participants agreed
they were comfortable to deprescribe. Notably, however, only 30% of GPs reported
that they very frequently or frequently deprescribed in the study conducted by
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Mantelli et al. (2018) and only a 34.7% in the study by Carrier (2019). A Canadian
study however indicated that although prescribers knew when to deprescribe they did
not know how and were looking for specific guidelines to inform practice (Farrell et
al., 2018) (see Appendix C).
A table summarising included studies of qualitative or mixed method studies is
included in Appendix D. Of the qualitative studies the majority, 23, targeted GPs,
three studies included both GPs and older adults and the remaining eight targeted
older adults, including two that included informal caregivers. These studies focus on
exploring deprescribing attitudes and practices in the context of older adults with
multimorbidity and subsequent polypharmacy.
It is important to include both quantitative and qualitative studies to gain a more
complete understanding of the attitudes and practices of GPs and older adults. While
the quantitative studies demonstrate that positive attitudes do not necessarily
translate into action to deprescribe they do not help us understand why this gap
exists. The following discussion of the studies included in this review, reveals that it is
important to consider these quantitative results in light of other findings within the
deprescribing literature, largely based on qualitative approaches. As discussed below,
the role of various attitudes, practices and individual characteristics and an
understanding of the influence of aspects of the healthcare environment allow
progress to be made in explaining why a gap exists between an expressed positivity
towards deprescribing and a decision to actively deprescribe.
The following section describes the literature in light of the review objectives. Two
overarching themes were identified from the analysis of the data: internal features
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such as attitudes, practices and characteristics of GPs and older adults and external
features that are characteristics of the healthcare environment influenced willingness
to consider deprescribing. These two themes were broken down into subthemes.
Internal features included six sub themes: attitude toward risk, the practice of
avoiding change, paternalism versus shared decision making, prescriber confidence,
patient characteristics and trust. External features included five subthemes: lack of
time and funding, lack of treatment alternatives, poor communication, lack of
evidence and appropriate treatment guidelines and, prescriber roles and
responsibilities.
3.1 Internal Features
In this theme, beliefs, attitudes, practices and characteristics that influence willingness
to deprescribe are described. While these can all be considered internal to the
prescriber or older adult they are nonetheless shaped by external influences such as
cultural norms, for example the dominant risk averse nature of western society and
the related requirement for trust in expert systems (Zinn, 2008) and the prevalence of
paternalism within healthcare and toward older adults (Sandman and Munthe, 2010).
Six subthemes are explored below that show the ways in which specific internal
features influence willingness to deprescribe.
3.1.1 Attitude toward risk
In this subtheme, two attitudes toward the role of deprescribing in relation to risk
reduction were apparent. In the first, deprescribing was viewed as an action that
should be avoided in order to reduce risk while in the second, deprescribing was
viewed as an action that should be considered in order to reduce risk.
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3.1.1.1 Deprescribing is viewed as a risk to be avoided
In the case of deprescribing, risks or benefits are often unknown because the
outcomes of deprescribing may be uncertain (Reeve et al., 2016a). In the studies
reviewed, the management of risk was valued by both GPs and older adults when
making health related decisions, including regarding deprescribing. Deprescribing was
often framed as the less safe choice for GPs and older adults to make because it
presented an unacceptable level of risk. This was based on the fear that poor health
outcomes, withdrawal symptoms or the return of previously well controlled symptoms
would occur (Anderson et al., 2017, Bell et al., 2015, Heser et al., 2018, Linsky et al.,
2015b, Luymes et al., 2016, Reeve et al., 2016b, Ross and Gillett, 2020b, Smith et al.,
2010, Thompson et al., 2020a, Thompson et al., 2020b, Weir et al., 2017). GPs
perceived that the choice to stop a patient’s medication in effect transferred the
responsibility for the risk of potential harm to themselves (D’Avanzo et al., 2020,
Wallis et al., 2017). Other options to manage risk, such as suggesting lifestyle changes
in the case of reducing cardiovascular risk were not seen to be viable, as GPs judged
that their older patients could not always be trusted to make appropriate lifestyle
choices, which is why medication such as statins were not deprescribed (Luymes et al.,
2016).
In practice, many GPs rated the risks of potential poor health outcomes, as a result of
stopping medications, above the risk of potential adverse drug reactions (Anderson et
al., 2017, Bell et al., 2015, Clyne et al., 2016, Fried et al., 2011, Nixon and Vendelø, 2016,
Sinnott et al., 2015, van Middelaar et al., 2018). Prescribers also feared the impact that
a poor choice to deprescribe, might have on their reputation with colleagues, their
patients and their patients’ family members (Wallis et al., 2017). Similarly, older adults
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often rated the risk of stopping medications above the experience of side effects or the
inconvenience of taking many medications (Clyne et al., 2016, Krska et al., 2013, Reeve
et al., 2016b, Ross and Gillett, 2020a, Weir et al., 2017). Ongoing medication use was
commonly viewed as beneficial to extend life, control symptoms and disease, prevent
the impacts of ageing such as reduced independence, mobility, cognition and to
protect quality of life (Clyne et al., 2016, Krska et al., 2013, Pickering et al., 2020,
Reeve et al., 2016b, Ross and Gillett, 2020a, Weir et al., 2017). Together these risk
concerns and belief in the ongoing benefit of medication use promoted negative
attitudes toward deprescribing.
3.1.1.2 Deprescribing is perceived as mitigating risk
A less dominant perspective presented the view of GPs who supported deprescribing
as a tool to manage risk. Deprescribing was viewed as a safe option, in order to reduce
the impact of polypharmacy, particularly when older adults had limited life
expectancy, were less able to metabolise their medications, when adherence problems
were apparent or when adverse drug events had occurred (Alrasheed et al., 2018,
Anderson et al., 2017, Linsky et al., 2015b, Thompson et al., 2020a, Wallis et al., 2017).
Notably, these reasons for deprescribing were reactive to an identified problem and
deprescribing was viewed as the best option to prevent the risk of ongoing medication
related problems. Other GPs took an approach to reassess risk by relaxing targets set
within treatment guidelines for the control of diseases such type 2 diabetes. This
allowed them greater freedom to consider deprescribing as a less risky option (Sinnige
et al., 2016, Sinnott et al., 2015).
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Repeated successful outcomes from deprescribing reinforced the perception of
deprescribing as a safe option and a decision that would reduce risk (Anderson et al.,
2017, Linsky et al., 2015b, van Middelaar et al., 2018, Wallis et al., 2017). Greater
clinical experience (Anderson et al., 2017, Mc Namara et al., 2017, Moen et al., 2010)
and a familiarity with the older adult, established over time, allowed GPs greater
confidence to take what might be considered potentially risky decisions, including to
deprescribe (Anderson et al., 2017, Sinnott et al., 2015). Some medications, such as
proton pump inhibitors, anti-hypertensives, bisphosphonates, complementary
medicines or statins, were also seen as being less risky to deprescribe, especially if they
were perceived to be less likely to result in poorer outcomes or withdrawal effects
(Anderson et al., 2017, Bell et al., 2015, Linsky et al., 2015b, Schuling et al., 2012,
Thompson et al., 2020b). These factors allowed GPs to form positive attitudes toward
deprescribing because they were less likely to perceive a significant level of risk.
Similar to GPs, some older adults’ perception of risk also supported positive attitudes
toward deprescribing, especially if they perceived that their medications posed risks to
their future health (Ross and Gillett, 2020a) or if they experienced severe or
unacceptable side effects (Krska et al., 2013, Pickering et al., 2020). Long-term
medication use was considered potentially risky, compared to the possible benefits
(Clyne et al., 2017, Heser et al., 2018, Krska et al., 2013, Linsky et al., 2015a, Reeve et
al., 2016b, Weir et al., 2017) especially of preventive medications (Clyne et al., 2017).
Some also viewed the risk of the use of many medications as being greater than the
benefit experienced (Reeve et al., 2016b, Ross and Gillett, 2020a). However, this
concern about multiple medication use was not personalised in that older adults did
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not view their own use of polypharmacy as risky, but referred to the experience of
others for whom they thought that was true (Ross and Gillett, 2020a).
3.1.2 The practice of avoiding change
Both GPs and older adults resisted changes to medications, preferring to maintain the
status quo. Examples from across the literature from both older adult and GP
perspectives included the observation that to deprescribe required an explicit choice,
whereas to continue a medication required no decision making burden (Anthierens et
al., 2010, Clyne et al., 2016, D’Avanzo et al., 2020, Linsky et al., 2015b, Nixon and
Vendelø, 2016, van Middelaar et al., 2018). GPs were more likely to make an explicit
decision to deprescribe only if the patient was not doing well, even if the decision to
continue was not in line with current evidence (Bell et al., 2015, Stryczek et al., 2020).
Older adults generally preferred to continue their medications because they were
familiar to them (Ross and Gillett, 2020a, Weir et al., 2017). They perceived these
medications to be safe and therefore did not consider the need for a medication review
and/or deprescribing (Reeve et al., 2016b). Furthermore, older adults assumed that if
their GP continued prescribing medications then they must still be necessary (Clyne et
al., 2017, Reeve et al., 2016b).
GPs often cited patient resistance to change as a reason why they did not deprescribe,
especially long-term medications which they believed patients thought of as being
necessary (Alrasheed et al., 2018, Bell et al., 2015, Clyne et al., 2016, Kuntz et al., 2018,
Wallis et al., 2017) and/or that they received ‘psychological comfort’ from taking them
(Kuntz et al., 2018, Linsky et al., 2015b). This resulted in GPs continuing to prescribe
potentially inappropriate medications, until an adverse event occurred or an external
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party, such as a hospital clinician or community pharmacist, recommended that the
medications be discontinued (Anderson et al., 2017, Bell et al., 2015, Clyne et al.,
2016). Repeats were often written without any review of their ongoing usefulness to
the patient (Anthierens et al., 2010, Riordan et al., 2017, van Middelaar et al., 2018,
Wallis et al., 2017), again providing no trigger for potential change. When both the
older adult and GP perspective are considered together it is clear that both
incorporate practices or hold beliefs that contribute toward maintaining the status
quo with little positive framing that would support action to deprescribe.
3.1.3 Paternalism versus the practice of shared decision making
In this subtheme two contrasting practices are described from the literature. The first
notes the way paternalism shaped the practices of GPs in how they acted toward their
older patients and the assumptions they operated within. Older adults’ practices often
perpetuated paternalism within interactions between themselves and their GP. The
second describes shared decision making which, unlike paternalism, assumed that
older adults were capable of engaging in decision making and was supportive of
deprescribing, however, it was rarely practiced.
3.1.3.1 Paternalism
GPs spoke of their older adult patients in paternalistic ways, regarding them as being
‘like children’ (Clyne et al., 2016 pg 4) and noted that many passively accepted their
medication decisions (Clyne et al., 2016, Sinnott et al., 2015, Thompson et al., 2020a).
In the case of decision making regarding deprescribing, older adults were sometimes
thought of as being incapable of entering into complex discussions about the risks
versus benefits of their medications (Sinnott et al., 2015). At times this resulted in GPs
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withholding information about medications, such as information pertaining to side
effects (Moen et al., 2010, Nixon and Vendelø, 2016, Thompson et al., 2020a,
Thompson et al., 2020b). GPs also used their power and greater medical knowledge
within the relationship to influence patients’ medication decisions (Clyne et al., 2016,
Fried et al., 2011, Reeve et al., 2016b), including to continue medication, by
downplaying the importance of patient reports of side effects (Krska et al., 2013,
Luymes et al., 2016, Nixon and Vendelø, 2016).
Ross and Gillett (2020a), (2020b) note that patients are generally accepting of the
power that prescribers have and that this is expected because of the nature of their
relationship. It was noted that older adults find it harder to express their view and
‘argue with doctors’ (Weir et al., 2017) and sometimes felt powerless (Krska et al.,
2013). For some, this sense of powerlessness resulted in them stopping their
medications of their own accord to avoid entering into conflict with their GP (Schöpf
et al., 2017, Weir et al., 2017). Others chose to be compliant because they viewed this
as an aspect of being a ‘good patient’ (Weir et al., 2017). In the case of deprescribing, it
is important to recognise this feature of the healthcare environment as it explains the
strength of the GPs’ position in influencing older adults’ attitudes toward
deprescribing and the GPs’ power to influence the decision to continue or stop
medications. It suggests older adults have less agency to form or express their own
attitude and preference regarding deprescribing, within the context of their
interaction with their GP.
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3.1.3.2 Shared decision making
Patient centred care and shared decision making were concepts which GPs ascribed to
in order to help support deprescribing (Bell et al., 2015, D’Avanzo et al., 2020, Luijks
et al., 2012, Luymes et al., 2016, Mc Namara et al., 2017, Schuling et al., 2012, Sinnige
et al., 2016, Søndergaard et al., 2015). When this was put into practice, it was noted as
being helpful to guide older adults to make an informed decision to deprescribe
(D’Avanzo et al., 2020, Sinnott et al., 2015, Thompson et al., 2020a). As a result of
shared decision making, some older adults chose to be included in deprescribing
discussions (Weir et al., 2017). As part of the shared decision making process they
wanted information about why deprescribing was being recommended, how it was
going to be managed and monitored and whether medications could be restarted if
necessary (Reeve et al., 2016b). However, it was also noted that shared decision
making was often not practiced (Mc Namara et al., 2017, Sinnott et al., 2015,
Søndergaard et al., 2015, Thompson et al., 2020a). GPs did not always ask their
patient’s preferences about medication continuation or deprescribing (Schuling et al.,
2012, Thompson et al., 2020a, Thompson et al., 2020b). Sometimes this was because
it was assumed that patients were not concerned about their use of polypharmacy
(Alrasheed et al., 2018, Schuling et al., 2012) or because they felt they knew what their
patient’s preferences would be (Thompson et al., 2020a). These findings suggest that
the treatment goals of patients may not be consistently elicited and that opportunities
for deprescribing may be missed.
3.1.4 Prescriber confidence
The review highlighted that when surveyed most GPs reported that they were
confident in their ability to deprescribe (Djatche et al., 2018, Gillespie et al., 2019b).
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However, data from the included qualitative studies, suggested a more nuanced view.
GPs were generally confident to deprescribe what they described as ‘low hanging fruit’
(Anderson et al., 2017) such as proton pump inhibitors, statins and opioid pain
medications (Anderson et al., 2017, Linsky et al., 2015b). In contrast however, they
were not confident to deprescribe others, such as psychotropic medications (Bell et al.,
2015). Other factors also influenced their confidence to deprescribe such as concerns
about explaining the risk (Anderson et al., 2014, Kuntz et al., 2018, Schuling et al.,
2012, Thompson et al., 2020a, Wallis et al., 2017) or confusion about whether a side
effect was actually a medical condition or age-related problem (Anthierens et al.,
2010).
GPs reported to be more confident to deprescribe when they had good interprofessional collaborations with and support from other healthcare providers such as
other GPs, pharmacists and specialists (Alrasheed et al., 2018, Anderson et al., 2017,
Bell et al., 2015, Gerlach et al., 2020, Schuling et al., 2012, Sinnige et al., 2016, Sinnott
et al., 2015, Wallis et al., 2017). Interestingly, at the same time, other GPs viewed
pharmacists’ recommendations to deprescribe as querying their competency and
undermining their authority (Gerlach et al., 2020).
3.1.5 Patient characteristics
Both older adults and GPs recognised that the decision to deprescribe was dependent
on a range of factors that were unique to the individual. Vordenberg and ZikmundFisher (2020) demonstrated that patient characteristics rather that attributes of
individual medications influence deprescribing preferences. Treatment burden
contributed towards negative attitudes toward medications for some older adults and
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a positive attitude toward stopping medications (Krska et al., 2013, Pickering et al.,
2020, Thompson et al., 2020b). The experience of or fear of side effects also
contributed to positive attitudes toward deprescribing, particularly if the side effects
were seen to impact on quality of life (Fried et al., 2011, Linsky et al., 2015a, Pickering
et al., 2020, Reeve et al., 2016b). The impact of side effects was considered against
other goals such as management of symptoms or goals to prolong life, all within the
context of managing multimorbidity, emphasising the complex decision making
demands placed on older adults (Fried et al., 2011, Pickering et al., 2020), not
dissimilar to demands placed on their prescribers.
GPs reflected on the importance of individualised approaches to deprescribing based
on the complexities of managing multimorbidity and the heterogeneous nature of the
older adult population (Anderson et al., 2017, Clyne et al., 2016, Luijks et al., 2012,
Moen et al., 2010, Sinnige et al., 2016). Besides managing multimorbidity, they
recognised the need to take into consideration factors including age, cognitive
impairment, life expectancy, medication adherence, quality of life, medication-related
side effects and the burden of the treatment (Anderson et al., 2017, Clyne et al., 2016,
Fried et al., 2011, Ie et al., 2017, Luijks et al., 2012, Thompson et al., 2020b).
The review highlighted that a patient’s perceived health literacy also influenced GPs’
willingness to deprescribe. According to the study findings, if patients were deemed to
be knowledgeable about their medications, GPs would consider entering into
conversations about deprescribing and to discuss the risks of ongoing medication use
(Linsky et al., 2016). Whereas, GPs were reluctant to deprescribe and to have such
conversations if they thought that their patient lacked the health literacy to
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understand the reason for the conversation and the recommendation (Schuling et al.,
2012). They also avoided these conversations if they perceived their older adult
patients to be resistant to stopping long-term medications (Alrasheed et al., 2018,
Anthierens et al., 2010, Bell et al., 2015, Kuntz et al., 2018, Linsky et al., 2015b).
Further investigation about the relationship of health literacy to deprescribing
discussions will be discussed in light of the findings of this study (see chapters 7,8 and
9).
3.1.6 Trust
The importance of trust in doctor patient interactions has been studied
comprehensively in the past (Brennan et al., 2013, Calnan and Rowe, 2008, Maidment
et al., 2011, Robinson, 2016). However, only one study has specifically focused on the
role of older adults’ trust in the context of deprescribing (Ross and Gillett, 2020b).
Other deprescribing studies have alluded to the role of trust.
Older adult trust was based on two key elements: interpersonal trust and trust in the
expertise of their GP. Long-term interactions with their GP who they felt knew them
personally, including their medical history, facilitated trust (Clyne et al., 2017, Linsky
et al., 2015a, Pickering et al., 2020, Ross and Gillett, 2020b, Weir et al., 2017). Second,
trust was based on their understanding that their prescribers had more medical
knowledge than themselves (Linsky et al., 2015a, Weir et al., 2017) and that this
knowledge was more trustworthy when compared to other sources such as family or
friends (Ross and Gillett, 2020b). Notably, some older adults trusted their specialist/s
more, especially in the case of deprescribing, because the specialist was thought to
have more knowledge than their GP. For others, a strong, long-term relationship was
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more important than authority or expertise (Pickering et al., 2020). Trust in their GP
or specialists’ expertise allowed many older adults to accept ongoing medication use
or advice to deprescribe and to choose to avoid raising any questions or concerns
(Clyne et al., 2017, Krska et al., 2013, Linsky et al., 2015a, Reeve et al., 2016b, Ross and
Gillett, 2020b, Schöpf et al., 2017, Weir et al., 2017). This was particularly important in
the context of the uncertainty of outcomes from deprescribing (Ross and Gillett,
2020b). Medications themselves were also trusted as effective agents to ‘keep you
healthy’ (Ross and Gillett, 2020b).
Patient trust in their long-term provider of primary care, their GP, was understood by
both older adults and GPs to facilitate discussions about medication management,
including deprescribing (Clyne et al., 2017, Linsky et al., 2015a, Linsky et al., 2015b,
Luijks et al., 2012, Reeve et al., 2016b, Ross and Gillett, 2020b). Where trust was
present, GPs were more confident to raise potentially difficult topics, such as life
expectancy and the ongoing usefulness of medications (Anderson et al., 2017,
D’Avanzo et al., 2020, Linsky et al., 2015b, Wallis et al., 2017). Conversely, GPs noted
that where they had only been seeing patients for a short time, it was difficult for them
to have these discussions (Anderson et al., 2017, Wallis et al., 2017). The fear of trust
being undermined sometimes prevented deprescribing from being discussed because
GPs thought that their older patients would interpret this as being ‘given up on’
(Schuling et al., 2012, Sinnott et al., 2015, Wallis et al., 2017) or that they were trying
to make cost savings (Gerlach et al., 2020).
The allusions to trust across the studies on deprescribing would suggest that this is an
important influence on older adult decisions to deprescribe and GP willingness to
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discuss deprescribing. The role of trust is investigated further in this study and
discussed in chapters 5, 6, 8 and 9.
3.2 External features
In this theme, the features of the healthcare environment that have an influence on
attitudes toward deprescribing and the continuation of medications are described.
These features worked together to shape the fabric of the healthcare environment in
which both GPs and older adults interacted. The review of the literature indicates that
the features discussed are persistent in that they appear to be resistant to change and
are pervasive in that they are reported in studies from multiple different countries.
The literature also demonstrates that the noted features of the healthcare
environment most often result in negative attitudes toward deprescribing or
undermine action to deprescribe, although occasionally, aspects of the environment
support deprescribing.
Six subthemes are explored below that demonstrate the ways in which specific aspects
of the healthcare environment influence willingness to deprescribe.
3.2.1 Lack of time and funding
GPs noted that there was little recognition across multiple health systems of the time
required to adequately manage the complex health needs of older adults who are also
growing in number as a patient group (Fried et al., 2011, Luijks et al., 2012, Moen et al.,
2010, Smith et al., 2010). Consultation times were viewed as being too short to
incorporate a discussion about deprescribing, including shared decision making (Mc
Namara et al., 2017, Søndergaard et al., 2015), especially when appointments had been
made to address acute or ongoing issues (Alrasheed et al., 2018, Sinnott et al., 2015,
49

Wallis et al., 2017). This was also due to GP perceptions that deprescribing is a
complex task which requires increased time, effort and workload capacity (Anderson
et al., 2017, Bell et al., 2015, Kuntz et al., 2018, Linsky et al., 2015b, Mc Namara et al.,
2017, Wallis et al., 2017). GPs also noted a lack of time to keep up with changes in
prescribing guidelines for older adults (Stryczek et al., 2020). Older adults shared the
view that consultation times were too short. They commented that they perceived
there was not enough time to raise their concerns about their medications during
their GP visits (Gillespie et al., 2019a, Krska et al., 2013).
Some GPs tried to address the issue of the lack of time in consultations by adopting
sequential and consecutive appointments to help manage complex issues (Mc Namara
et al., 2017, Sinnott et al., 2015). Others outsourced time consuming aspects of the
deprescribing to process, such as reviewing medications, to pharmacists (Gerlach et
al., 2020, Mc Namara et al., 2017, Riordan et al., 2017, Sinnige et al., 2016).
Lack of specific funding for deprescribing was also noted as a disincentive for GPs to
undertake complex medication management issues (Luijks et al., 2012, Søndergaard et
al., 2015) and to deprescribe (Wallis et al., 2017). Some claimed that there was not
enough funding for tasks related to medication management issues and deprescribing,
such as medication counselling or undertaking medication reviews (Gerlach et al.,
2020).
3.2.2 Lack of treatment alternatives
GPs noted that current guidelines for different chronic conditions focused on the
initiation of medications rather than considering potentially suitable nonpharmacological alternatives, such as lifestyle changes and behavioural therapies
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(Kuntz et al., 2018, Moen et al., 2010). GPs were more likely to consider deprescribing
when they assessed that their patients would adopt lifestyle changes and behavioural
therapies which could reduce the need for certain preventative medications, such as
statins, (Luymes et al., 2016). Others were not aware of non-pharmacologic
alternatives (Stryczek et al., 2020) or perceived that such options would not be
accepted by patients as suitable alternatives to medications (Kuntz et al., 2018). In
support of this perception, Heser et al.(2018) did note that some older adults who had
tried non-pharmacological treatments to reduce the use of potentially inappropriate
medications, had found them to be ineffective.
3.2.3 Poor communication
Deprescribing patients’ medications in the primary care setting was hampered by
delays in communicating medication information from other prescribers (Clyne et al.,
2016, Sinnott et al., 2015), missing medication information (Anderson et al., 2017, Bell
et al., 2015, Gerlach et al., 2020, Mc Namara et al., 2017, Wallis et al., 2017) and the
lack of coordination of communication between professionals involved in the care of
the older patient (Mc Namara et al., 2017, Smith et al., 2010). In addition, GPs noted
that patients were often unaware of the indication for an existing medication, adding
uncertainty to deprescribing decisions (Alrasheed et al., 2018, Linsky et al., 2015b,
Moen et al., 2010). Both GPs and older adults described times when conflicting advice
about medications from specialists, other GPs and pharmacists had resulted in
confusion about whether medications should be continued or stopped (Gerlach et al.,
2020, Linsky et al., 2015a).
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Sometimes GPs commented that patients withheld information about their
medications (Clyne et al., 2016). Again, this created uncertainty about the patient’s
current medications which deterred GPs from deprescribing. For example, GPs
understood that some patients would not inform them when taking additional over
the counter medications or if they had decided to reduce or stop their prescribed
medications (Anthierens et al., 2010, Clyne et al., 2016, Moen et al., 2010). Other
patients withheld information about adverse medication events, either because they
did not want a medication to be discontinued (Bell et al., 2015) or because they
interpreted these adverse events as age related, rather than medication related
problems (Schuling et al., 2012). GPs made mention that patients often communicated
medication related issues with their pharmacist, rather than themselves, partly
because pharmacists were more accessible and offered a free service. However, they
noted that because there are often no formal communication routes between
pharmacists and GPs, important medication information might not be exchanged
(Gerlach et al., 2020, Smith et al., 2010).
3.2.4 Lack of evidence and appropriate treatment guidelines
GPs commented that there was little evidence to guide or support their prescribing
decisions, in part, because older adults with multi-morbidities are not generally
included in clinical trials (Bell et al., 2015, Fried et al., 2011, Mc Namara et al., 2017,
Moen et al., 2010, Nixon and Vendelø, 2016, Sinnott et al., 2015, van Middelaar et al.,
2018). For this reason they relied on their knowledge of the patient’s history and their
prior experience as clinicians (Mc Namara et al., 2017, Sinnott et al., 2015). They also
relied on IT prescribing support (Anderson et al., 2017, Bell et al., 2015, Gerlach et al.,
2020, Mc Namara et al., 2017, Sinnott et al., 2015, Wallis et al., 2017) to form the basis
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for decisions regarding medication prescribing. Coupled with this, they observed that
there is little evidence available to support them in their decision to deprescribe
(Alrasheed et al., 2018, Anderson et al., 2017, Nixon and Vendelø, 2016, Smith et al.,
2010). As a result, GPs often found it hard to justify their decision to deprescribe both
to themselves, to their colleagues and to their patients (Nixon and Vendelø, 2016,
Wallis et al., 2017).
The studies included in the review identified that GPs were often critical of the use of
treatment guidelines. They felt guidelines promoted the use of polypharmacy as they
did not take into account prescribing in the circumstances of treating multimorbidities (Anthierens et al., 2010, Bell et al., 2015, D’Avanzo et al., 2020, Fried et al.,
2011, Mc Namara et al., 2017, Nixon and Vendelø, 2016, Schuling et al., 2012, Smith et
al., 2010, Wallis et al., 2017). Furthermore, polypharmacy was promoted because the
guidelines provided decision support to initiate a medication and little guidance to
take a wait and see approach (van Middelaar et al., 2018) or cues to consider when it
might be appropriate to deprescribe (Anthierens et al., 2010, Nixon and Vendelø,
2016). In countries such as the USA where treatment benchmarks were set as a part of
the treatment guidelines, continued prescribing was supported to achieve treatment
goals regardless of patients’ preferences or age (Linsky et al., 2015b). It was felt that
guidelines established ‘good behaviour’, as defined by key authoritative bodies, and so
the pressure to conform to these was considerable (Nixon and Vendelø, 2016) and
caused concerns over potential legal action if deprescribing could be interpreted as
going against a guideline (D’Avanzo et al., 2020, Riordan et al., 2017, Sinnott et al.,
2015). However, some GPs were supportive of the use of guidelines and thought that
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the best care was achieved by following them (Fried et al., 2011, Moen et al., 2010,
Sinnige et al., 2016, Sinnott et al., 2015).
3.2.5 Prescriber roles and responsibilities
Several of the studies highlighted that GPs felt unable to deprescribe medications that
had been prescribed by others, and in particular specialists (Alrasheed et al., 2018,
Anderson et al., 2017, Linsky et al., 2015b, Schuling et al., 2012, Sinnige et al., 2016,
Stryczek et al., 2020, Wallis et al., 2017) which they believed limited their autonomy
(Clyne et al., 2016). Patients themselves also questioned whether GPs could
deprescribe a medication that had been prescribed by a specialist, whom they
perceived to be a greater authority (Linsky et al., 2015a, Reeve et al., 2016b).
GPs feared that they would be criticised by specialist colleagues for deprescribing
(Gerlach et al., 2020, Nixon and Vendelø, 2016). Many believed that specialists were
more skilled than themselves (Anderson et al., 2017, Gerlach et al., 2020, Linsky et al.,
2015b, Munn et al., 2018) and believed there to be a hierarchy of power in decision
making with specialists at the top (Gerlach et al., 2020). GPs felt that specialist
prescribers regarded the ongoing management of the illness they had diagnosed as a
priority, in terms of continuing medications (Schuling et al., 2012, Sinnott et al., 2015).
Consequently, these perceptions and attitudes resulted in poor collaborations between
GPs and specialists, especially in terms of deprescribing discussions and
responsibilities (Gerlach et al., 2020, Mc Namara et al., 2017, Sinnige et al., 2016,
Sinnott et al., 2015, Smith et al., 2010, Stryczek et al., 2020). Other GPs noted that,
because of their generalist knowledge, as well as their awareness of their patients’
history and complete medication lists, they could take overall responsibility for the

54

coordination of their older patient’s medication , including deprescribing (Anderson et
al., 2017, Anthierens et al., 2010, Gerlach et al., 2020, Linsky et al., 2015b, Luijks et al.,
2012, Riordan et al., 2017, Smith et al., 2010).

4. Conclusion
This review has shown that a large range of factors coexist and influence attitudes
toward and willingness to deprescribe. Some factors are common to both prescribers
and older adults while others are unique to each group. Importantly, a number are
supportive of a willingness to deprescribe. These include trust within interactions
between GPs and older adults and good communication and collaborative
relationships between GPs and other healthcare providers, especially specialists.
However, constraints within the healthcare environment led to a reduced willingness
to deprescribe. Factors which contribute to this attitude include managing a complex
and heterogeneous group of patients in a time limited environment, with inadequate
funding, information gaps and confusion about deprescribing roles and
responsibilities. The review also demonstrates the mixed attitudes older adults and
GPs have toward the ongoing use of medications in terms of the level of risk posed.
Significant gaps in the literature were also identified. Although research into
deprescribing has increased over the last decade, this review indicates that data about
the factors which influence deprescribing for both GPs and community living older
adults remains limited and is generally confined to a narrow discussion of barriers and
facilitators. This finding is supported by a recent review of deprescribing interventions
in primary care (Doherty et al., 2020). To address this narrow focus, a greater
examination of contextual factors is required and thought given to how each barrier
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and facilitator interacts. Lau et al. (2016) argue that this approach to exploring context
and articulating the interrelationships between barriers and facilitators is necessary to
advance our understanding of how to increase the adoption of interventions in
primary care. This of course is relevant to deprescribing in that current evidence
suggests it is not often practiced in primary care (Linsky et al., 2015b, Turner et al.,
2019, Weir et al., 2017).
Older adults have previously been described as the most heterogeneous patient group
(Boeckxstaens and De Graaf, 2011, Steinman and Hanlon, 2010). In order to account
for this diversity, more still needs to be understood about the factors which shape the
attitudes of older adults toward deprescribing. For example, trust was identified in this
review as facilitating the acceptance of deprescribing but also preventing discussions
of medication concerns. More research needs to be conducted to understand this
paradox.
It was evident from this review that paternalistic attitudes were still prevalent in the
interactions between GPs and older adults. However, there has been no research
attention focused on ageism, even though it is also known to be prevalent in
healthcare settings (Burnes et al., 2019, Levy and Macdonald, 2016, São José et al.,
2019). Just as paternalism appears to influence discussions of deprescribing we need to
understand how ageism might have a similar influence on the likelihood of
deprescribing conversations.
Many constraints described in this review foster negative attitudes and reduce
willingness to deprescribe. They have remained unchanged over time and across
countries. This suggests that, despite the growing awareness of deprescribing there is
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still much work to be done in this area of research. In particular health literacy has not
been examined in the context of the deprescribing literature. The following chapter
introduces the concept of health literacy.
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Chapter 3 A review of health literacy concepts and measurement
1. Introduction
This chapter explores the evolution of the concept of health literacy and explains the
understanding of health literacy that was used throughout this study. The chapter also
notes a recent trend of researchers in specific health related disciplines redefining
health literacy for their own contexts in ways which are practical and accessible. These
include discipline specific definitions of health literacy such as ‘public health literacy’
(Freedman et al., 2009) and ‘oral health literacy’ (Institute of Medicine, 2013).
Relevant to this thesis is the use of the term ‘medication literacy’ (Pouliot et al., 2018).
‘Medication literacy’ and related terms are critiqued, exploring their limitations and
underlying assumptions.
In parallel to the evolution of concepts and definitions of health literacy, measurement
tools have been created. Like health literacy definitions, such tools have also become
more complex, attempting to measure multiple domains. The usefulness of
measurement tools will be discussed. The chapter argues that there is a widening gap
between theoretical discussions about the conceptualisation of health literacy and the
ability to measure these in practice, particularly using stand-alone quantitative
measures. A justification for the use of a mixed methods approach, using both
quantitative measures and a qualitative exploration of health literacy in the context of
deprescribing decision making is given.

2. How has health literacy been conceptualised and defined?
Health literacy is a developing concept and as a result definitions vary (Berkman et al.,
2011, Haun et al., 2014, Malloy-Weir et al., 2016, McCormack et al., 2013, Soellner et
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al., 2017, Sorensen et al., 2012). A recent review noted as many as 250 unique
definitions (Malloy-Weir et al., 2016). Conceptualisations and definitions have grown
in complexity and have been influenced by diverse theoretical foundations including
broader literacy and sociological theories. The literature that discusses the history of
the evolution of the term describes a movement from conceptualising health literacy
as an individual skill, closely linked to functional literacy capability, to one that views
health literacy as a multifaceted asset, developed and used collectively to make health
related decisions in the course of everyday life. Four major ways of conceptualising
health literacy are outlined below.
2.1 Health literacy as an individual skill and source of risk
The earliest conceptualisations of health literacy viewed it as a narrow individual skill
focused on the domains of reading, comprehension and writing. The term ‘health
literacy’ was first coined in 1974 in a social policy context regarding the need for the
provision of health education in US schools (Simonds, 1974). Simonds (1974),
suggested that health education had a beneficial impact on health behaviours and
subsequently morbidity and mortality rates. It would therefore be socially
irresponsible to ignore its promotion in schools, via platforms of mass communication
and as a part of quality healthcare delivery by the health system. His proposal assumed
that the only factor preventing individuals from adopting habits that would support
health was a lack of education.
This suggested association between education, especially literacy levels and health
behaviours began a period of intense research, mainly in the US. The 1992 National
Adult Literacy Survey results galvanised interest in this area with findings that
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indicated almost one third of US adults had inadequate functional literacy and lacked
the ability to use written information to accurately navigate everyday tasks (Parker et
al., 1999). Researchers held concerns over the gap between the reading level of
patients and the complexity of written content such as in health education material
(Leichter et al., 1981, Meade and Byrd, 1989), consent forms (Grundner, 1980) and
discharge instructions (Spandorfer et al., 1995). In response, researchers within the
disciplines of health promotion and health education sought to simplify health
information to accommodate those with low functional literacy levels (Cooley et al.,
1995, Rudd et al., 1999).
Within medicine, low literacy came to be thought of as a risk to be managed within
clinical practice (Nutbeam, 2008, Pleasant and Kuruvilla, 2008). Findings of two key
reviews of a large number of observational studies conducted from the 1990s and into
the first decade of the 21st century supported this view. The initial review of 44 studies
demonstrated a clear association between low literacy (measured by reading ability)
and poor health outcomes (DeWalt et al., 2004). An updated systematic review of a
further 96 studies was completed in 2011 (Berkman et al., 2011). This later review
confirmed the earlier findings and also noted that low health literacy was associated
with poor utilisation of health services, including inappropriate use of medications
(Berkman et al., 2011).
Efforts were directed toward creating specific measures in order to understand levels
of health literacy and identify population groups at most risk. A narrow
conceptualisation of ‘stand–alone’ literacy skills such as reading ability,
comprehension and numeracy required to be literate in health settings was adopted
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and used as the basis of the development of measurement tools. This
conceptualisation allowed relatively easy measurement of these individual skills
(Peerson and Saunders, 2009). It was assumed that such measures could be
transferred or applied to indicate the level of ability individuals would have to
negotiate real world health related decisions (Papen, 2009, Pleasant et al., 2011).
In rapid succession a number of health literacy measures were created. The Rapid
Estimate of Adult Literacy in Medicine (REALM) (Davis et al., 1991, Davis et al., 1993)
was developed to screen for medical context and content specific reading ability.
Parker et al. (1995) critiqued this measure as being too narrow and adopted the term
functional health literacy to refer to the ability to use reading, writing and
computational skills in the context of everyday healthcare encounters. The Test of
Functional Health Literacy in Adults (TOFHLA) scale was developed to include
comprehension and numeracy tasks (Parker et al., 1995). The original 67 item scale
was later revised to improve its usefulness resulting in a 40 item scale, cutting
administration time by ten minutes (from 22 to 12 minutes) (Baker et al., 1999). Again,
in an attempt to improve usefulness outside of research settings, the six item Newest
Vital Sign (NVS) was developed which also measured reading, comprehension and
numeracy (Weiss et al., 2005). Even shorter scales were also validated such as the
three -item Health Literacy Screening (Chew et al., 2004) and the Single Item Literacy
Screener (Morris et al., 2006) however both only measured reading ability. In the
following years, the development of definitional and context specific measures
continued with a recent review identifying 51 unique scales (Haun et al., 2014).
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The medical view of health literacy has been criticised in that its description and
measurement of individual health literacy levels has obscured the impact of the
healthcare environment and broader society on the acquisition and use of health
literacy (Baker, 2006). Furthermore, it has encouraged an emphasis on the
improvement of individual skills in order to achieve better health outcomes thus
placing the responsibility for reducing risk at the individual patient level rather than
within and across health systems (Green et al., 2007, Peerson and Saunders, 2009).
2.2 Health literacy as an individual asset and source of autonomy and empowerment
A major shift in the conceptualisation of health literacy occurred when scholars
argued for a more expansive view of health literacy as an asset able to be used by the
individual to gain more control over decisions relating to their own health (Nutbeam,
2008). More expansive conceptualisations were developed that moved away from the
early definitions of health literacy as the relationship between individual functional
literacy levels and the ability to comprehend health related material within healthcare
settings (Peerson and Saunders, 2009). Critics suggested it was more appropriate to
describe this way of using the term as ‘health related literacy’ (Baker, 2006), ‘clinical
health literacy’ (Pleasant and Kuruvilla, 2008) or ‘medical literacy’ (Peerson and
Saunders, 2009). In contrast, Peerson and Saunders (2009) suggested that health
literacy applies to a broader set of skills that are used more widely. They argued that
people gain and apply health knowledge in many contexts, beyond healthcare settings
and make everyday decisions in order to ‘keep well’. They illustrated the difference
between ‘medical literacy’ and health literacy below:

62

“‘Medical literacy’ involves the ability to read, understand and act on instructions
for taking a cholesterol-lowering drug; ‘health literacy’ involves the ability to
access information about cholesterol, to understand it and to apply it to one’s
own life.” (Peerson and Saunders, 2009 pg 288)
This moved the conceptualisation of health literacy from being thought of as a skill,
(adequate or inadequate, low or high) and therefore a risk to be managed, to being
considered an asset. It also implied that health literacy was dynamic rather than static
and that it was influenced by the quality, availability and accessibility of information
useful to make health related decisions (Baker, 2006).
Parallel to the developments noted above, Nutbeam applied contemporary
understandings of literacy based on Pablo Freire’s theories of critical pedagogy
(Nutbeam, 2000, Nutbeam, 2008). He argued for the use of two further forms of
literacy to be considered as integral to health literacy: (i) communicative/iterative
literacy which describe skills which allow the ability to gather meaning from different
forms of communication, participate in everyday activities and apply new information,
and (ii) critical literacy: the ability to critically analyse information and apply this to
allow greater autonomy and empowerment (Nutbeam, 2000, Nutbeam, 2008). This
broader conceptualisation implied a shift in outcomes associated with higher health
literacy from improved compliance to medical directions to increasing patient
autonomy and empowerment (Kickbusch, 2001). This way of thinking aligned with
other concurrent movements considering patient/person-centred care and shared
decision making which both aim to facilitate autonomy and empowerment.
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Initially, Nutbeam suggested that these three forms of literacy are developed within an
individual progressively, allowing greater autonomy and personal empowerment
(Nutbeam, 2008). In a later investigation, Smith et al. (2013) conducted a series of
qualitative and quantitative studies in the context of shared decision making in a
sample of people with low literacy and demonstrated that people use each literacy
type (i.e. functional, communicative, critical) iteratively, with no emphasis being
placed on one above the other. Furthermore, lower functional health literacy did not
necessarily result in lower communicative or critical health literacy skills. Nutbeam
(2018) has further clarified that his conceptualisation of heath literacy is a content and
context specific subdomain of literacy, referring to the possession of a set of literacy
skills that are available to be applied in order to understand health information in the
context of everyday life.
Measures of Nutbeam’s conceptualisation have been developed by Ishikawa et al.
(2008) in the context of diabetes self-management in Japan (Functional,
Communicative and Critical Health Literacy tool (FCCHL)) and by Chinn and
McCarthy (2013) in primary healthcare settings in the UK, (All Aspects of Health
Literacy Scale (AAHLS)). The FCCHL tool has since been translated and applied in the
Netherlands (Heijmans et al., 2015) and a revised tool developed in the USA (Zegers et
al., 2020). A revised version of the AAHLS has been developed in the USA based on a
more accurate psychometric testing process (Barsell et al., 2020). The original AAHLS
combined an adapted version of Chew et al.’s (2004) three item measure of functional
health literacy, items from Ishikawa et al.’s (2008) scale measuring communicative
and critical health literacy plus additional items to measure capabilities for
empowerment. The tool is designed to be self-administered and quick to complete
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(Chinn and McCarthy, 2013). However, Chinn and McCarthy (2013) caution that any
quantitative measures of health literacy oversimplify the exploration of a set of
complex competencies and argue that qualitative methods should also be used in
order to capture a more nuanced understanding of health literacy.
2.4 Socio-ecological views of health literacy
Other health literacy researchers have applied Brofenbrenner’s socio-ecological model,
originally developed in the late 1970s (Bronfenbrenner, 1977), in order to identify the
individual, interpersonal, organisational, community and policy level influences on
health literacy. The US Institutes of Medicine (2004) report outlined the complexities
that influence literacy, describing health literacy as ‘arising from a convergence of
education, health services, and social and cultural factors’. Green et al. (2007)
described (health) literacy as a variable and socially situated skill that is shaped by
class, ethnicity, gender and generation, that cannot be dichotomised into those who
are literate or illiterate (Green et al., 2007). These views are supported by Jordan et
al.’s (Jordan et al., 2010) qualitative research to conceptualise health literacy from the
patients’ perspective. Participants in Jordan’s study consistently identified factors at
both the individual (e.g. educational background, previous experience, state of
health/emotional wellbeing), healthcare system (e.g. time pressures, information
delivery), and community level (e.g. support networks, financial and time constraints)
that influenced their ability to seek, understand and apply health information in a
consistent and accurate manner. This suggests that achieving adequate health literacy
requires far more than working to improve individual communication exchange
between patients and providers as such efforts do not address the complex root causes
of health illiteracy (Freedman et al., 2009).
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Work by Paashe Orlow et al. (2007), Squiers et al. (2012), Sorensen et al. (2012) and
McCormack et al. (2017) also considered the health literacy of organisations e.g. the
skills of health professionals to communicate and the attributes of healthcare
institutions. This approach recognises the bi-directional relationship between health
system factors that facilitate engagement in health decisions and health literacy of
individuals situated within communities McCormack (2017).
McCormack et al. (2017) argue that interventions are more likely to create a
supportive environment to both improve health literacy and facilitate patient
engagement if they target change at multiple levels within a socio-ecological model.
That is: at the individual level, working to use plain language best practices when
communicating information; at the interpersonal level, using patient centred
communication, including shared decision making; at the organisational level,
electronic medical records, co-ordinating care and providing staff training; at a
community level to provide social marketing campaigns, social media ‘influencers’ and
advocacy; and finally at a structural level, clinical guidelines and supportive public
policy.
Measures have been developed that attempt to capture the influence of individual and
structural determinants of health literacy. Examples of these measures include the
Health Activities Literacy Scale (HALS) (Rudd et al., 2004), Health Literacy
Questionnaire (HLQ) (Osbourne, 2012), Health Literacy Management Scale (HeLMS)
(Jordan et al., 2013) and the European Health Literacy Questionnaire (HLS-EU-Q)
(Sørensen et al., 2013). Of these measures only the HALS measures literacy and
numeracy skills. All scales measure the ease of navigating the health system, while the
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more recently developed HQL, HeLMS and HLS-EU-Q measure social support for
healthcare. HeLMS and HLS-EU-Q assess the impact of socio-economic factors e.g.
the ability to pay to visit a doctor. However the usefulness beyond research settings of
each of these scales is questionable as all are lengthy measures, ranging from 29 items
(HeLMs) to 191 items (HALS).
2.5 Health literacy as a collective social practice
New Literacy Studies (Street, 2003) also challenged an individualistic approach to
health literacy. In this conceptualisation literacy is thought to be a collective social
practice that is applied in various contexts to enable meaning making (Green et al.,
2007, Lo Bianco and Freebody, 2001). This is supported by Papen’s (Papen, 2009) UK
study of adult literacy students which demonstrated that, in practice, health literacy is
a shared resource that is achieved and used collectively.
Edwards et al. (2012), (2015) built on the notion of health literacy as a characteristic of
individuals within communities and used the term ‘distributive health literacy’ to
describe how health knowledge and health literacy skills and practices are distributed
through family and social networks. Additionally they emphasise that health literacy is
not a static skill but rather is a capacity that is developed over time. They developed
the health literacy pathway model based on a longitudinal qualitative study of people
with long-term health conditions. This model seeks to demonstrate the ways in which
health literacy is developed over time and within a community. It notes the
development of health literacy through five stages and identifies outcomes such as
participation in shared decision making and communication with healthcare
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professionals and increased knowledge and skills in managing a condition (see Figure
3.1).
Batterham et al. (2016) critique the notion of distributive health literacy and suggest it
may only apply to culturally specific contexts (for example, where community is highly
valued such as in rural villages in developing countries). This view does not take into
account the emerging role of virtual social communities. These communities often
form with the purpose of providing support and health information centred on
specific illness experiences (Yan et al., 2016) and suggest that distributive health
literacy can be broadly applied.

Figure 3.1 Health literacy pathway model (from Edwards et al. 2012, 2015).
A distributive conceptualisation views health literacy as a characteristic of families,
communities and organisations that is changeable over time (Batterham et al., 2016).
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The source of health literacy is no longer tied to health professionals and healthcare
services but is available and accessible beyond these formal institutions (Green et al.,
2007).
“Health literacy resides in the community, not in individuals. An individual’s health
literacy depends on all the resources they have to draw on” Mark Harris (Cited in
Armstrong, 2018)
Unlike earlier conceptualisations, measuring the concept of distributive health literacy
has focused on the use of qualitative methods. Ethnographic research has informed
the development of a social practice view of literacy (Street, 2002) however in the
context of health literacy, other qualitative techniques have been used. Investigating
health literacy among adults with chronic kidney disease and HIV, Lloyd et al. (2014)
used semi-structured interviews. Their findings emphasised that patients may be
specifically health literate in relation to their illness but this may not transfer to other
contexts. Also health information is gained from multiple sources, including but not
confined to health professionals. McGrath et al. (2016) used focus groups to explore
older adults’ strategies to find health information and services in Ireland. They
described strategies where older adults relied on community participation and shared
knowledge to facilitate finding information about health services supporting the view
that health literacy is a distributed asset. Black et al. (2017) used observation of
consultations and semi-structured interviews to explore diabetes self-management
noting that nearly all participants drew on informal social networks in order to
interpret and apply health information to their context.
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3. Broad critiques of the usefulness of health literacy as a concept
As noted earlier, a large number of definitions of health literacy exist however these
remain contested. The World Health Organisation has adopted a definition for health
literacy developed by the European Health Literacy Consortium:
‘Health literacy is linked to literacy and entails people’s knowledge, motivation
and competences to access, understand, appraise and apply health information in
order to make judgements and take decisions in everyday life concerning
healthcare, disease prevention and health promotion to maintain or improve
quality of life during the life course’ (World Health Organization, 2013 pg 13)
Malloy-Weir et al. (2016) have critiqued this definition suggesting it contains terms
that are not well defined, it assumes individuals will have the freedom to use
information to maintain or improve quality of life and does not make clear if there is a
threshold for being health literate.
Major critiques of common definitions of health literacy note that definitions can be
interpreted in multiple ways and that the underlying assumptions of these are not
always justifiable (Berkman et al., 2010, Malloy-Weir et al., 2016, Peerson and
Saunders, 2009). Most health literacy definitions assume the use of information to ‘be
used to promote or maintain health’, or reduce health risks and increase quality of life
(Malloy-Weir et al., 2016 pg 342). This assumption may not hold true for those whose
real choices are constrained by structural factors that influence health such as the
affordability and accessibility of healthcare services or an inability to access, afford or
grow healthy food, or in the case of those who have a terminal diagnosis or
degenerative disease (Hunter and Franken, 2012, Malloy-Weir et al., 2016). The focus
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on the individual in many definitions and their ability to be health literate loses sight
of broader societal or health systems contextual issues.
Health literacy definitions also make assumptions about the relationship between
health literacy and the making of appropriate health decisions (Malloy-Weir et al.,
2016, Peerson and Saunders, 2009). Decisions related to health may be influenced by
many other factors including personal values and beliefs, life context and the
perceived acceptability of options (Malloy-Weir et al., 2016). Motivation and
activation are also key to taking action on health knowledge (Peerson and Saunders,
2009). Furthermore, what would classify as an appropriate health decision and who
would determine that is not clear (Berkman et al., 2010, Malloy-Weir et al., 2016,
Soellner et al., 2017). Such external judgements may undermine a person’s autonomy
in decision making.
Key to common definitions of health literacy is that a person’s skills or abilities are
central (Berkman et al., 2010, Malloy-Weir et al., 2016). However the number or type
of these skills may vary across different definitions and thus influence the definition of
a health literate person (Malloy-Weir et al., 2016, Soellner et al., 2017). Furthermore,
the noted purpose or value of these skills when they are enacted by the person, also
varies.

4. Context specific definitions of health literacy: Defining ‘Medication
Literacy’
As the definitions for health literacy have grown more complex, discrete health
discipline specific definitions have been developed that seek to redefine health literacy
for specific contexts in ways which are practical and accessible. As an example of the
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above, recent studies have worked to define a specific concept for health literacy in the
context of medication use (King et al., 2011, Koster et al., 2018, Pouliot et al., 2018,
Raynor, 2009). A variety of terms have been suggested including ‘medication literacy’,
‘pharmacy health literacy’ ‘ pharmaceutical literacy and ‘pharmacotherapy literacy’.
Most recently Pouliot (2018) conducted a delphi study and derived this definition:
‘Medication literacy is the degree to which individuals can obtain, comprehend,
communicate, calculate and process patient-specific information about their
medications to make informed medication and health decisions in order to safely
and effectively use their medications, regardless of the mode by which the content
is delivered (e.g. written, oral and visual).’ (Pouliot et al., 2018 pg 797)
Applying such a concept may appear to be relevant to this study, however reviewing
the proposed definitions in light of the development of the broader term ‘health
literacy’ reveals limitations in how this more specific term has been considered. All of
the proposed definitions of ‘medication literacy’ focus on the individual and their
literacy capacity rather than taking more contemporary evidence into account which
consider literacy skills to be collective and influenced by social and healthcare system
factors. Current conceptualisations suggest that medication literacy is a potential risk
to be managed within clinical encounters by healthcare providers. There remains an
assumption that the ability to make informed decisions and ensure the safe and
effective use of medications is reliant on the capacity of the individual ‘to obtain,
comprehend, calculate and process specific information about their medications’
(Pouliot et al., 2018 pg 797). Similar to the critique of health literacy, this overlooks
the many other complex factors that might influence a person’s ability or motivation
when making a decision in relation to their medication. On a positive note, the
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definition does suggest outcomes of greater adherence as well as empowerment to
make informed decisions.

5. Implications for measurement
This chapter has described the development of multiple ways of conceptualising and
defining health literacy over time. In parallel to the creation of new definitions, each
major school of thought has also devised tools and methods of measurement. A
diverse number of tools have been developed that seek to capture a varying number of
domains. However, no gold standard health literacy tool has been developed that
adequately measures health literacy (Berkman et al., 2010). The lack of consistency in
both defining and measuring health literacy has resulted in an absence of consensus
within health literacy research, interventions and policy.
5.1 What is being measured?
Previously, completed education level was assessed as a variable that may influence
health however, individuals may have diverse reading, writing and comprehension
skills despite having a similar education level so its usefulness as an indicator for
individual health outcomes was poor (Berkman et al., 2010). More specific measures of
health literacy were needed to demonstrate associated differences in health outcomes.
A review by Haun et al. (2014) identified 51 health literacy measurement instruments.
These varied in relation to their purpose. Some tools have been developed as screening
tests while others allow comprehensive, performance based assessments (Haun et al.,
2014). Some measure health literacy in specific disease contexts while others target
general or specific populations (Haun et al., 2014). Within these measures, 11 distinct
dimensions of health literacy were identified (literacy, interaction, comprehension,
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numeracy, information seeking, application/function/decision making/critical
thinking/evaluation/responsibility, confidence (self-efficacy) and navigation). The
number of dimensions identified across existing measures as described by Haun et al.
(2014) hints at the difficulty of capturing the complexities of recent conceptualisations
and definitions of health literacy. No instrument measured all 11 dimensions.
Because of the variability between measures, including how categories or levels of
health literacy are described or scored, results cannot be easily compared across
studies, between settings, cultures and population groups (Haun et al., 2014, Pleasant
et al., 2011). Given the variety of measures, researchers need to be clear about what
aspects of health literacy they are measuring (McCormack et al., 2013) and
acknowledge the limitations of measures and the degree to which the test they have
selected actually measures what it claims to measure (Pleasant et al., 2011).
Current measures do not account for the many other factors which may influence
healthcare decisions or actions arising from biological, psychological, cultural and
social determinants. This may explain why initiatives to promote health literacy have
been unable to determine why change did or did not occur (Pleasant et al., 2011).
Many existing measures of health literacy are critiqued as being narrow measures of
‘medical literacy’ or functional health literacy only (Peerson and Saunders, 2009).
Most focus on reading and numeracy skills, overlooking other aspects of literacy such
as listening, speaking and writing (Haider et al., 2008). Neither do they take into
account the visual or cognitive capacity of participants (Paasche‐Orlow et al., 2005).
They do not indicate how people seek and use health information (Jordan et al., 2010)
or measure how health professionals or health services communicate with patients
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(Pleasant et al., 2011, Rudd, 2015). They do not take into account the person’s own
health status at any point in time, the social determinants of health such as the
accessibility and affordability of healthcare services and an individual’s motivation
(Malloy-Weir et al., 2016). Definitions which assume that health literacy is a dynamic,
distributed asset imply that measurement of individual health literacy skills at a point
in time may be meaningless. Some indication of the dynamic nature of health literacy
could be demonstrated by longitudinal studies however these have been limited
(McCormack et al., 2013). Additionally, Rudd (2015) cautions that an individualistic
approach to health literacy measurement may cause researchers and policy makers to
lose sight of other factors that influence decision making and action, such as the
complexity of health services and health information (Rudd, 2015).
An approach to address some of the shortcomings noted above is to include
qualitative explorations of health literacy. As noted previously, Chinn and McCarthy
(2013) recommend that qualitative data should be gathered alongside quantitative
methods of assessing health literacy in order to adequately account for the
complexities that contribute to health literacy. Qualitative methods recognise that
health literacy should be considered a latent construct as it is “only an indirect
approximation of an unobservable construct” (Pleasant et al., 2011). A mixed methods
approach to the investigation of health literacy has been adopted in this study. This
will allow an exploration of health literacy in a hypothetical context and in the context
of a situated practice where older adults need to solve health related problems that are
specific to their own needs or of those around them (Papen, 2009).
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6. Conclusion
In conclusion, definitions of heath literacy have been influenced by developments in
literacy and sociological theories however health literacy remains a poorly defined
term. Context specific definitions such as medication literacy have not addressed the
shortcomings that characterise broader definitions of health literacy. Developing
measurement tools that accurately capture individual health literacy levels remains
elusive. Because of the limitations of the available measurement tools, the best
approach to exploring health literacy requires the use of both qualitative and
quantitative methods in order to capture the dynamic practice of health literacy in
everyday health related events.
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Chapter 4 Methods
1. Introduction
This chapter provides an overview of the mixed methods research methodology used
in this study. Both older adult polypharmacy users and GPs were invited to participate
throughout both phases of the research process, in order to produce evidence that
represented the views of both polypharmacy users and clinical practitioners. The aim
was to gain a better understanding of the perspectives and experiences of older adults
and to produce knowledge of practical use in clinical the clinical setting. A sequential
explanatory mixed methods design was employed. This way of structuring a mixed
methods approach is described and the reason for its use explained. Mixed methods
studies commonly adopt a pragmatic theoretical stance. Pragmatism is described and
the ways in which it has shaped and informed this study to allow a practical approach
to design are noted. A pragmatic approach was appropriate given the study aimed to
produce findings that are relevant and transferrable into practice. Following this, the
specific methods employed during the two phases of the study and their individual
arms are described and their choice justified. Measures that ensured methodological
quality are also documented, including the key ethical considerations that
underpinned this study.

2. Methodology: mixed methods
Creswell and Plano Clark describe mixed methods as research whose “central premise
is that the use of quantitative and qualitative approaches, in combination, provides a
better understanding of research problems than either approach alone” (Cresswell and
Plano Clark, 2007 p5). This was the case in this study where the research question and
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objectives would not have been answerable in detail without employing both
quantitative and qualitative methods. By combining these methods to investigate the
research question, real life contextual and socio-cultural influences and multiple
perspectives were all able to be considered (Greene, 2008, NIH Office of Behavioral
and Social Sciences, 2018).
Glasgow and Emmons (2007) recommend the use of mixed methods research in order
to increase the potential for translation of research into practice. They argue that
mixed method research designs allow multiple types of evidence to be gathered and
integrated. The result is a greater depth of knowledge that captures current practice.
This knowledge can then be used to determine the relevance or appropriateness to
practice, of recommendations, potential interventions or changes (Glasgow and
Emmons, 2007). This approach was justified given that one of the gaps identified in
the literature was a lack of translation of research findings regarding deprescribing
into practice (see Chapter 2 section 4).
Mixed methods research allows a flexible approach to investigating research
questions, adopting whichever combination of research methodology best suits the
exploration of that question (Johnson and Onwuegbuzie, 2004). This ‘methodological
eclecticism’ is a key defining characteristic of any mixed methods study (Teddlie and
Tashakkori, 2010 p8). Three basic mixed methods designs have been described in the
literature: exploratory sequential, explanatory sequential and convergent. Sequential
designs use one phase of the study to build on the other while convergent designs
merge phases to allow a comparison of quantitative and qualitative results (Creswell
and Clark, 2017).

78

In this study a sequential explanatory mixed methods approach was employed. The
different methods of inquiry allowed diverse components of the research question to
be explained. The sequential nature of the design allowed the initial quantitative data
to be analysed first. The findings were then able to be used to refine the focus of the
following qualitative stage, clarifying which aspects of the research question needed to
be further investigated. This strengthened the later qualitative stage.
The design could be considered ‘fixed’ in that the order of the mixed methods used
was predetermined. However there were elements that could also be considered
emergent, rather than fixed. The findings from the initial quantitative phase were used
to inform the design and focus of the later qualitative phase, for example, the
development of the question guide (Creswell and Clark, 2017).
The choice of mixed methods has been justified by others by claiming that such
designs allow triangulation of results which then demonstrate the validity of findings
(Torrance, 2012). However, this claim has recently been critiqued as it implies that
findings across the studies must confirm each other (Fetters and Molina-Azorin,
2019). Morgan (2019) argues that, rather than aiming for triangulation in the sense of
a confirmation of results using multiple methods of investigation, mixed methods
researchers consider how results converge, complement or diverge from each other
(Morgan, 2019). Convergence occurs when the same results are found across methods,
allowing confirmation of findings between each arm of the study. When results
converge or confirm each other they lead to the same interpretation, regardless of
whether quantitative or qualitative methods were used (Fetters and Molina-Azorin,
2019). Complementarity allows the strengths of each method to produce different
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forms of data that are then used for different purposes i.e. to investigate different
aspects of the research question within the overall study (Morgan, 2019). Thus they
allow an expanded understanding of the research question. Data across methods are
said to be complementary when findings illustrate diverse but non-conflicting
interpretations (Fetters and Molina-Azorin, 2019). Divergence occurs when
contradictions in the results of both arms are discovered. Divergent results prompt
further research or a return to a deeper investigation of the possible reasons for
different results across both qualitative and quantitative arms (Morgan, 2019). These
three ways of considering findings have been applied in this study when integrating
the results of both the quantitative and qualitative phases, considering both within
group (GP to GP and older adult to older adult) and across group (GP and older adult)
similarities and divergences.
2.1 Paradigm Pluralism
Mixed methods approaches are characterised by paradigm pluralism in that
practitioners accept that it is possible to mix methods that have a basis in different
philosophical foundations (Teddlie and Tashakkori, 2010). It is accepted that a variety
of epistemological and ontological perspectives can be used and valued within the one
study (Creswell and Clark, 2017).
Traditionally, there have been two main epistemologies discussed in research:
objectivism and constructionism. The two main epistemological stances lead to
distinct understandings of the nature of the social world. Broadly, an objectivist
position would hold that there is only one reality and that it is observable and remains
constant overtime and regardless of context (Johnson and Onwuegbuzie, 2004). Data
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is quantified or measured using standardised tools and methods which allow study
findings to be replicated. The aim of such objective research is to test theories, predict
patterns and develop generalizable findings (Bryman, 2012). Meanwhile a
constructivist position would hold that there are multiple perspectives or opinions or
beliefs as determined by how each person encounters their world and that this reality
is socially constructed (Crotty, 1998, Johnson and Onwuegbuzie, 2004). A
constructivist stance would infer that research needs to be carried out in the field, in
the context of where people go about their daily lives, in order to capture from
individuals their own reasoned accounts of their understanding of their world
(Cresswell, 2013). This approach implies that each person’s everyday understanding of
their world is valid. Data are gathered using qualitative research methods. The aim of
such research is to generate theories rather than make generalizable findings that
apply to populations (Bryman, 2012).
Generally, the two philosophical foundations have resulted in a dichotomy of thought
and research practice. Researchers have argued that because a constructionist or
objectivist understanding of the nature of knowledge is so fundamentally different it is
not possible to combine research relying on both of these within the one study
(Greene, 2008). However, mixed methods practitioners emphasise continua over
dichotomies allowing the use of a range of philosophical options (Teddlie and
Tashakkori, 2010 p10). Maxwell (2011) justifies this position noting that
epistemological stances can be thought of as a lens through which we can view the
world. Each lens is, in some way, fallible and incomplete and therefore a more
accurate and in-depth view of what is being studied can be gained when multiple
lenses or philosophical stances are considered, tested for their usefulness and applied
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(Maxwell, 2011). Rather than adopting only one epistemology there can be a process of
‘dynamic interplay between theory and practice’ (Greene, 2008 p8). Johnson and Gray
call this ‘dialectic pragmatism’ (Johnson and Gray, 2010 p88). This stance aims to
resolve the duality that has arisen from the two major epistemologies, seeking to end
what has been coined as the ‘paradigm wars’ (Maxwell, 2011).
2.2 Theoretical perspective: Pragmatism
As a result of the position of paradigm pluralism, noted above, the mixed methods
research community commonly (although not always) takes a pragmatic approach to
the philosophical foundations of research methodologies (Creswell and Clark, 2017,
NIH Office of Behavioral and Social Sciences, 2018). Pragmatism allows both
epistemological and methodological flexibility (Greene and Hall, 2010). It is argued
that a pragmatic approach to research seeks to value the insights from both qualitative
and quantitative forms of enquiry within one study in order to offer the best prospects
for answering research questions (NIH Office of Behavioral and Social Sciences, 2018).
Thus, pragmatism values both objective and subjective knowledge, permitting
evidence gathered through either quantitative or qualitative methods to be considered
useful (Pluye and Hong, 2014). This movement between methods encourages an
ongoing dialogue between the methods used and the data generated so that results
can be synthesised and understanding deepened (Greene and Hall, 2010).
The early proponents of pragmatism thought the main value of research should be to
determine practical consequences (Johnson and Onwuegbuzie, 2004).
‘Pragmatism, when regarded as an alternative paradigm, sidesteps the
contentious issues of truth and reality, accepts, philosophically, that there are
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singular and multiple realities that are open to empirical inquiry and orients itself
toward solving practical problems in the ‘‘real world’’’ (Feilzer, 2010 p8).
‘The pragmatic rule states that the current meaning or truth value of an
expression is to be determined by the experiences or practical consequences of
belief in or use of the expression in the world (Johnson and Onwuegbuzie, 2004
p16).’
This position changes the aim of research from wanting to generalise findings or
establish theories to seeking transferability, asking: How can the results be of practical
use to solve real world problems? How can the results be used in other settings?
(Greene and Hall, 2010).
A pragmatist view believes there is a dynamic interaction between ‘thinking/knowing
and acting/doing’ (Greene, 2008 p8); trying different approaches or applying different
solutions to see what works best. This implies that pragmatism relies on knowledge
acquisition through a process of action and reflection (Biesta, 2010). For example, the
outcome of doing X can be thought about, or the experience of doing X known, or the
consequences of applying a rule can be tested or observed (Johnson and
Onwuegbuzie, 2004). Knowledge then is always about the relationship between
actions and consequences aligning with Dewey’s transactional theory of knowing and
supporting explanatory rather than interpretive research aims (Biesta, 2010).
Pragmatism holds that there are multiple routes to generating knowledge (Johnson
and Gray, 2010). Scientific inquiry is not held in higher regard than common sense or
practical everyday knowledge (Greene and Hall, 2010). An objective approach will
produce one ‘story’ about a social reality while a subjective approach will produce
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another however both ‘stories’ may equally represent reality, even if they are
conflicting (Harrits, 2011).
This study reflected the key principles of pragmatism described above. The aim of the
study was to explain deprescribing from the perspective of older adults and GPs with
the aim of generating knowledge that can be of practical use. Both quantitative and
qualitative studies were conducted to gather more than one explanatory ‘story’ of
older adults’ and GPs’ attitudes toward and experiences of deprescribing. Both forms
of data were considered equal, not elevating the findings of one over the other. In the
final analysis phase, when results from both the quantitative and qualitative arms were
considered together, there was an active moving backwards and forwards, a dialogue,
between sets of results. This process was guided by observing for complementary,
convergent or divergent patterns or findings within the data, allowing a greater depth
of understanding to be gained.

3. Study Design
Figure 4.1, describes the mixed methods approach and design of the study. Two phases
were conducted, each with two study arms. Phase one collected quantitative data and
phase two qualitative. These two methods are explored and the reasons for their use
explained in the following section.
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Figure 4.1 Study design
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The initial phase of two quantitative data collection rounds was conducted, one with
GPs and another with older adults. Descriptive statistical analysis of the data was
completed. The results of this analysis were then used to inform the development of
question guides for two further qualitative rounds, again, one with GPs and another
with older adults. Qualitative data for each round were coded and themes developed.
Finally, the results for each of the study arms were integrated and analysed together in
order to determine the overarching findings of the study.
Research objective 1, exploring the influence of the healthcare environment and
research objective 3, investigating the influence of health literacy were explored in
both the qualitative and quantitative phases. Research objective 2 examining
perception of ageing and its influence on deprescribing discussions was best suited to
an exploration using qualitative methods only. While objective 4, exploring the
relationship between attitudes to medication use, age cohort, socio-economic status
and the likelihood of discussions about deprescribing and polypharmacy was only
explored in the quantitative phase.
A formative conceptual framework, introduced in chapter 1, section 4 was used to
guide the development of the studies within each phase. The conceptual framework
guided the systematic examination of separate factors identified in the framework and
their relationship to deprescribing. Elements of the formative conceptual framework
were explored in each of the phases of the study. The aspect of the conceptual
framework explored in each study arm is highlighted in green in the following
sections.
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4. Phase 1
The two quantitative arms in phase one allowed the collection of descriptive
information and enabled the relationship between key variables to be examined.
Quantitative methods, specifically cross-sectional surveys, were used to allow for the
collection of data that provided a description of characteristics of the study population
at a point in time. Surveys were deemed appropriate because they can be used to ask a
group of people a set of the same (i.e. standardised), usually closed questions, with the
aim of producing quantifiable data in order to measure variables i.e. characteristics,
behaviours, attitudes, or opinions (Creswell and Hirose, 2019, O'Leary, 2017). Unlike
most qualitative methods, surveys allow for data to be collected anonymously and
from a potentially larger number of respondents. They allow for statistical analysis of
comparisons of variation between groups and of relationships (associations) between
variables (Bryman, 2012). Thereby allowing theories to be tested. However, because
data are gathered simultaneously, it is not possible to determine the direction of
causation between related variables (Bryman, 2012).
4.1 Phase 1 GP survey
4.1.1 Survey aim
The phase one GP survey measured aspects of the conceptual framework including
attributes of the healthcare environment and GP attitudes that might influence
deprescribing. Healthcare environment aspects such as length of consultation, the role
of other prescribers, use of guidelines and evidence, and GPs’ perceptions of patient
expectations and involvement in decision making were explored. GP attitudes toward
polypharmacy use and the acceptability of deprescribing for older patients were also
measured. Demographics collected allowed the influence of factors such as years of
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experience and the age of the GPs to be assessed in terms of their responses. The
aspects of the conceptual framework explored in the phase one GP study are
highlighted in Figure 4.2.

Figure 4.2 Phase 1 GP survey exploration of conceptual framework
4.1.2 Study population and recruitment
The phase one, cross-sectional survey of Australian GPs was conducted between
October 2015-November 2016 (not limited to the Illawarra Shoalhaven area). GPs were
initially invited via email to complete an online survey. Email addresses were accessed
from an Australian medical database purchased from Core List Australia (Core List
Australia, 2015). However, the response rate via email was very poor (n=5). To increase
response, a paper based version of the survey was delivered to general practices
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located in the Illawarra, Shoalhaven, Southern Highlands and Southern Sydney areas
of NSW, Australia.
4.1.3 Survey instrument
In the absence of a validated survey tool to measure GP attitudes toward deprescribing
a survey tool was developed and piloted for use in this study. This survey tool was
based on the available international literature regarding GP attitudes toward
deprescribing in the management of polypharmacy in older adults (Anthierens et al.,
2010, Bell et al., 2015, Linsky et al., 2015b, Moen et al., 2010, Schuling et al., 2012).
Survey items were piloted with five GPs. Following the pilot study, one question was
removed because it was deemed to be repetitive, resulting in a 21 item survey. A five
option Likert scale was used ranging from strongly agree to strongly disagree, for each
of the survey items. Six demographic questions were added, as well as the following
open response question, “Is there anything else you would like to tell us about
medication management for your older patients?” The survey tool is included in
Appendix E.
Since the development of this tool others have also developed surveys to explore GPs’
attitudes toward deprescribing. Two of these have used case vignettes to explore GPs’
responses (Carrier et al., 2019, Mantelli et al., 2018). Djatche et al., (2017) developed a
nine item questionnaire which covered similar questions as those utilised in the
current study. The nine questions explored GPs’ confidence and attitudes toward
deprescribing however were designed to investigate GPs’ deprescribing for elderly
patients with limited life expectancy.
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4.1.4 Data analysis
The data were analysed using SPSS version 24 (IMB corp, 2016). Frequency
distributions, descriptive analyses and bivariate analysis using Chi-Square statistics
were conducted. Statistical significance was assumed where a p value reached 0.05.
To improve the expected cell counts, Likert responses were collapsed into three
groups. Strongly agree and agree were grouped together as were strongly disagree and
disagree. The postcode supplied for the location of the GP practice was used to
calculate the SEIFA rating (Socio-Economic Indexes for Areas) and the urban/regional
location. SEIFA is an Australian ranking system that identifies an area’s level of socioeconomic advantage and disadvantage relative to other areas (Australian Bureau of
Statistics, 2013). Gender, age, level of experience, location of practice (SEIFA,
urban/rural), place of training and birth were all examined to determine the
differences, if any, among GP responses based on their demographic characteristics
recorded.
4.2 Phase 1 Older Adult Survey
4.2.1 Survey aim
The phase 1 older adult survey measured aspects of the conceptual framework
including older adult attitudes toward polypharmacy and medicines use and the
acceptability of deprescribing. It also measured the extent of health literacy skills
among the older adult participants. Older adult perspectives of the healthcare
environment were explored including their involvement in decision making,
perceptions of adequate time in consultations and recall of medication reviews.
Demographic data collected in this arm allowed the influence of age cohort (‘younger’
older adults and ‘older’ older adults) and socio-economic status to be assessed. The
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aspects of the conceptual framework explored in this phase one older adult study are
highlighted in Figure 4.3

Figure 4.3 Phase 1 older adult survey exploration of conceptual framework
4.2.2 Study sample and recruitment
Independent community living older adults, aged 65 years or older, taking five or
more medications, were invited to complete an anonymous, paper based, selfadministered survey between October 2015-November 2016. Two different approaches
were used to recruit participants. The first involved a purposive sample of 23
community pharmacies, located in the Illawarra, Shoalhaven and Southern Highlands
regions, who were invited to assist with distributing surveys to eligible participants.
Eleven pharmacies volunteered and were provided with a total of 330 surveys for
distribution. It is not known whether all the surveys were distributed. The second
approach involved 415 surveys distributed by the author to eligible participants
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attending older adult community groups located within the same regional area. Only
those who were literate in English were able to complete the survey, which they
returned via reply paid envelopes.
4.2.3 Survey
The 42 item phase 1 older adult survey (Appendix F) included: 15 demographic items;
13 Patients’ Attitude Towards Deprescribing (PATD) questionnaire items (Reeve et al.,
2013a); 10 All Aspects of Health Literacy Scale (AAHLS) items (Chinn and McCarthy,
2013); three items from the Canadian Survey of Experiences with Primary Health Care
(Statistics Canada, 2009); and one additional item to measure the actual impact of
cost.
The original validated PATD questionnaire (Reeve et al., 2013a) was chosen because it
measures medication users’ attitudes toward deprescribing and polypharmacy. Two of
the PATD questions were removed because they focused on attitudes toward
pharmacist involvement and follow-up which was not relevant to the aim of this
study. No scoring system was established when the PATD was created so the removal
of the two items will not affect the overall validity of findings from the measure. Since
the publication of the PATD tool, it has been used extensively, in a variety of
community settings in both developed and developing countries, across both broad
age groups and older adults alone and amongst those exposed to polypharmacy and
those not (Weir et al., 2021a). There is no evidence to date that the PATD tool has
been used by clinicians to assess their patients’ attitude toward deprescribing (Weir et
al., 2021a).
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The PATD was the only tool available at the time this study was developed. Other
similar tools have been developed since, including a revised version of the PATD
(rPATD) (Reeve et al., 2016c) and the Patients’ Perceptions of Discontinuation (PPoD)
tool (Linsky et al., 2017). Turner (2019) argues that specific items from the Beliefs
about Medications Questionnaire (BMQ) can also be used to calculate a person’s
attitude toward deprescribing by measuring their perception of the benefits compared
to the risks of their medication use.
Notably the results from the PATD survey may need to be considered with caution.
The predictive ability of actual deprescribing as opposed to a hypothetical interest, has
been questioned (Chock et al., 2021, Weir et al., 2021a). In the context of two
deprescribing interventions, willingness to deprescribe measured at baseline using the
PATD was not predictive of successful deprescribing following the intervention
(Anderson et al., 2020, Turner et al., 2019).
The weakness of the PATD tool to be able to predict successful deprescribing may also
be an outcome of the difficulty of measuring ‘attitudes’. Gawronski (2007) notes that
attitudes have been conceptualised previously as inner tendencies, object-evaluation
associations, momentary constructions or states of pattern activation. However, the
developers of the PATD tool (including the developers of the PPoD and the rPATD) do
not define how they have conceptualised ‘attitudes’. Because of this lack of clarity it is
not clear as to what the PATD is intended to measure. Furthermore, regardless of
whether any conceptualisation of attitude was considered, all uses of the term rely on
a person carrying out a process of evaluation or assessment of their attitude, within
their own context. This suggests that it is important to understand what aspects
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within the person’s context are most influential in forming their attitude. Qualitative
studies that take into account attitudes toward deprescribing alongside the use of the
currently available survey tools, may be important to overcome the shortcomings of
the survey tool and allow an understanding of influential contextual factors. Even this
approach would have limitations as it is difficult to account for change in context, for
example, as a result of becoming frail, or losing a spouse or partner and how this may
influence attitudes over time.
The All Aspects of Health Literacy Scale (AAHLS), was chosen because it is a validated
scale that attempts to assess multiple dimensions of health literacy: functional,
communicative and critical health literacy skills (Chinn and McCarthy, 2013). These
three domains are based on Nutbeam’s health literacy model which acknowledges the
importance of a wider set of cognitive and social skills to enable individuals to interact
with and interpret health systems and health information (Nutbeam, 2000). The
functional health literacy items in the AAHLS measure reading and writing skills and
the ability to access support networks when reading and/or writing skills are limited.
The communicative health literacy items measure information gathering and
interactive skills required to consult with health practitioners. Critical health literacy
items measure respondents’ information appraisal skills in assessing the relevance,
reliability, credibility and validity of health information (Chinn, 2011, Chinn and
McCarthy, 2013). For this study, three of the AAHLS questions which address health
literacy capabilities at the level of community engagement were not included because
they were not relevant to the study objectives. At the time the AAHLS was selected, it
had not been previously used in an older adult population however it was the most
suitable measure of a broader conceptualisation of health literacy available, as
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discussed in chapter 3 section 2.2. The limitations of only conducting quantitative
measurement of health literacy have been previously discussed, also in chapter 3.
4.2.4 Statistical analysis
Descriptive statistics were used to analyse the data using SPSS version 24 (IMB corp,
2016). Frequencies and percentages were reported for responses to the PATD
questions 1-10 and the additional questions 11-17. For the AAHLS, potential scores for
each individual item ranged from 1 (lowest) to 3 (highest) (Chinn and McCarthy,
2013). Items that were negatively worded were reverse coded. Responses to each item
were summed and a summed score was calculated for each subscale (potential
functional scores 3-9; communicative scores 3-9; critical scores 4-12) and for the
AAHLS as a whole (potential scores 10-30). Based on evidence (Chinn and McCarthy,
2013), no cut-off for adequate health literacy was determined using this scale.
However, for the purposes of analysis, lower summed scores (for each subscale and the
AAHLS as a whole) were assumed to indicate lower health literacy capabilities.
For analysis purposes, age was grouped into younger (76 years) or older adults (77+)
based on the median age of the sample being 76 years. Socio-Economic Index For
Areas (SEIFA) was divided into high or low (Australian Bureau of Statistics, 2013) and
the number of medications were grouped into polypharmacy (5-9 medications) and
excessive polypharmacy (≥10 medications) (Jyrkkä et al., 2009). Spearman’s
correlations were used to test for any associations between PATD items. MannWhitney U tests or Kruskal Wallis H tests were used to investigate differences between
groups of dichotomous or multinomial non-parametric ordinal items. Significant
associations were assumed if the p value was  0.05.
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5. Phase 2
In phase two, the two qualitative arms allowed detailed data to be collected from both
groups of key participants within deprescribing decision making: GPs and older adults.
The following points list specific reasons why the choice of a qualitative method was
deemed appropriate for this section of the study. Qualitative methods:


Are well suited to studying a small number of individuals and their experiences
in-depth (O'Leary, 2017).



Are useful for research occurring in natural as opposed to controlled settings
(O'Leary, 2017). Participants are more likely to share their subjective
experiences in settings in which they would normally operate such as their own
home, in the case of older adults or work environment, in the case of GPs.



Facilitate the expression of participant’s responses to be formed in their own
words without imposing a limited set of responses (Silverman, 2011). This allows
multiple perspectives and realities to be expressed, heard and valued.



Allow data to be gathered through spoken words and to use thematic
exploration of those words to generate knowledge (Bryman, 2012).



Recognise the role of context in the construction of meaning for example social,
historic and cultural influences on peoples’ representations of meaning
(Liamputtong, 2010).

Individual semi-structured interviews were chosen as the qualitative data collection
tool as they enable the collection of rich in-depth data. They allow open ended
responses to a series of set questions, while also allowing the interviewer to explore
answers given in order to gain further relevant details. One of the disadvantages of
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semi-structured interviews is the lack of anonymity which may influence the
participants’ willingness to divulge sensitive information (O'Leary, 2017).

7. Ethical considerations and approvals
The study design and tools were reviewed and approved by the University of
Wollongong and Illawarra Shoalhaven Local Hospital District Health and Medical
Human Research Ethics Committee (HREC No: 15_086). The ethics approval letter is
included in Appendix M. Phase one self- administered surveys were designed to be
completed anonymously. Completion and return of surveys implied tacit consent.
Written, or verbal consent in the case of interviews conducted by telephone, was
gained from participants in the phase two semi-structured interviews. Steps were
taken to remove any identifying information during transcription and analysis of the
data and pseudonyms were allocated to participants to ensure their anonymity.
5.1 Study sample and recruitment
No predetermined sample size was set for either the GP or older adult qualitative
round. Instead, sampling continued until a decision was made that enough data had
been collected to enable the research question to be addressed in a way that captured
the complexity and richness of the older adult and GP interviews (Braun and Clarke,
2021).
GPs were recruited via professional networks and snowballing. Sixteen GP interviews
were conducted between November 2018-May 2019 by the PhD candidate. Of these,
eight were in person and the remainder via telephone, which was a more convenient
option for some participants. Telephone interviews were on average shorter in
duration (range 16-19 minutes) compared to face to face interviews (range 15-31
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minutes). The older adult interviews were conducted in two sets. An initial set of 12
interviews were conducted between January and May 2018. Initial analysis was carried
out and it was determined that is would be useful to carry out further interviews to
ensure data saturation. A further set of 13 interviews were conducted between August
and October 2018. All 25 older adult interviews were conducted by the candidate, in
the participants’ own home. Interviews ranged in length from 17 to 53 minutes and
field notes were taken following the interviews. Data saturation was achieved with
both groups (GPs and older adults) with no new material arising in later interviews.
Interviews were recorded with permission, transcribed verbatim and checked for
accuracy.
Participants from the earlier older adult survey arm had indicted their willingness to
be involved in the later qualitative arm and these were contacted and included in the
initial set of interviews. A snowball sampling technique was used to gather additional
participants, including others known to the researchers, from the Illawarra,
Shoalhaven and Southern Highlands. Once again, older adults were only included if
they were living independently in the community, aged 65 years or older and taking
five or more medications.
5.2 Semi-structured interview question guides
Separate interview question guides were developed for the GP and older adult
participants based on the results from the phase one surveys and the literature
exploring attitudes and practices toward deprescribing (Anderson et al., 2014,
Anthierens et al., 2010, Linsky et al., 2015a, Linsky et al., 2015b, Moen et al., 2010,
Reeve et al., 2013b, Schuling et al., 2012) (see Appendix G and H). The GP question
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guide explored their experience of managing prescribing for their older community
living patients specifically managing polypharmacy and deprescribing. Optimal
medication management goals from the perspective of the GP were explored. This
allowed further study of aspects of the conceptual map as show in Figure 4.4.

Figure 4.4 Phase 2 GP semi-structured interview exploration of conceptual
framework.
The older adult interview question guide was developed to allow this sometimes
under-represented group a voice. More detailed data was gathered regarding
deprescribing experiences and their context and older adults’ attitudes toward
medicine taking and polypharmacy use. Health literacy skills and how these were used
were also further examined. Optimal medication management goals from the
perspective of older adults were also explored. The aspects of the conceptual
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framework investigated in this arm of phase 2 are shown in Figure 4.5. The question
guide is included in Appendix H.

Figure 4.5 Phase 2 older adult semi-structured interview exploration of
conceptual framework.
5.3 Analysis
Thematic analysis was used to analyse the data comprised of the verbatim
transcriptions of the audio recorded interviews. Thematic analysis is described as a
method for identifying, analysing and reporting patterns of meanings (themes) across
a data set (Braun and Clarke, 2012). The aim is to make sense of commonalities of
meaning or experience that are relevant to the research topic and question (Braun and
Clarke, 2012). Thematic analysis was considered as an appropriate approach to the
qualitative analysis in this study as it is recommended in for use in mixed method
studies (Braun and Clarke, 2012). This is because it is a relatively easy to use, yet
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rigorous form of analysis (Braun and Clarke, 2012). It is also a flexible approach that
can be used for either deductive, inductive or theory driven analysis and recognises
that no analysis is purely inductive or deductive (Braun and Clarke, 2006).
In this study, theme development arose from a process of systematically working
through all transcripts to initially organise the data into meaningful sections (codes)
that were relevant to the research aim. This was done initially for each qualitative arm
separately and then for all qualitative responses when integrating the results in the
final stage of the study design. Saldana (Saldaña, 2021) defines codes as words or short
phrases that symbolise an important, ‘essence capturing’ attribute with data. They
operate as prompts or triggers that allow deeper, more complex meanings to be
understood across the data set. NVivo data analysis software version 12 was used to
assist with the coding process and as a tool to help organise and explore the data (QSR
International Pty Ltd, 2018). The coding allowed for complex and large quantities of
data to be ‘purposefully managed, locating, identifying, sifting, sorting and querying
data’ (Bazeley, 2013 p125). Coding can only take place after the researcher has become
familiar with the data set (Braun and Clarke, 2012). In this study, familiarity was
gained during the interview itself, via field notes taken following the interview, by
reading and re-reading transcriptions and listening again to sections of the audio
recordings. An example of coded transcript is included in Appendix J.
The development of a theme is an outcome of coding (Bazeley, 2013). Braun and Clark
(2006) define a theme as the following:
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‘A theme captures something important about the data in relation to the research
question and represents some level of patterned response or meaning within the
data set’ (Braun and Clarke, 2006 p. 82).
NVivo, was used to group similar codes in order to identify patterns within the data
and relationships between codes (Saldaña, 2021). Notes were written about possible
themes and assessed to check if they represented a meaningful concept and were
coherent across the entire data set. Formative thematic ‘maps’ were created to
visualise and explore the relationships between the codes. An example of a thematic
map is included in Appendix K. These were developed during the analysis phase when
integrating results from both phase 1 and 2.

6. Rigour
Demonstrating rigour in research is important to establish a distinction between what
may be classified as social commentary or anecdotal evidence as opposed to social
science (O'Leary, 2017). To ensure transparency, the epistemological and pragmatic
theoretical perspective adopted has been described earlier in this chapter. The surveys
and interview guides have been included in Appendix E, F, G and H and details about
how the data were collected and analysed have been given in order to provide an audit
trail of how the research was conducted.
To ensure systematicity, methods have been chosen that are consistent with a
pragmatic mixed methods perspective, being practical and appropriate to answer the
research questions. Using multiple methods and integrating the results has allowed
the complexity of the research question and objectives to be explored and understood.
The GP survey guide and the interview protocols for both the older adult and GP
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interviews were piloted, feedback reviewed and changes made. These refined tools
were then used consistently within the appropriate phase of the study. The
assumptions of both qualitative and quantitative methods have been respected by
sampling appropriately and by conducting the analysis of each separately, using
appropriate techniques. Advice from a University of Wollongong Consultant
Statistician (Professor Marijka Batterham) was sought prior to and during the
quantitative analysis. As previously mentioned, examples of coding and thematic
mapping are included in Appendix J and K respectively.
6.1 Researcher characteristics
The lead investigator, the PhD candidate, has a background in nursing, public health
and has previous experience in qualitative research. Her highest credential is a Master
of Public Health. The primary supervisor is a pharmacist who is very experienced in
the management of polypharmacy and research and is currently the Director of the
Centre for Health Research, Illawarra Shoalhaven Population. The third researcher has
a background in nursing, social anthropology and public health and is a very
experienced qualitative researcher. Both supervisors hold PhDs. The second and third
researcher supervised data collection and analysis and both bought their perspective
to the interpretation of results at weekly team meetings. The lead researcher knew
four of the older adults who participated in the qualitative arm through current or
past community group participation. All older adult participants were told that the
study was being conducted as part of a PhD study.
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8. Conclusion
A sequential explanatory mixed methods approach was used to study older adult and
GP attitudes and experiences of managing polypharmacy and deprescribing. The
details of the phases of the design have been explained indicating how each study arm
was used to explore the research question and specific study objectives. The
description of the methods have also illustrated how and when results have been used
sequentially to inform the investigations in later study arms. Specific details of
recruitment and analysis of each stage have been given. This study design allowed a
greater depth of understanding to be gained rather than relying on one method of
data collection. As will be demonstrated in the following chapters, the pragmatic
design allowed practical and relevant data to be generated in order to increase our
understanding the factors which influence deprescribing within the medication
management practices of GPs and daily lives of older adults.
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Chapter 5 GP quantitative study
1. Introduction
In this chapter the results of the first of two quantitative study arms are presented.
These results are also reported in the publication Deprescribing for older adults in
Australia: factors influencing GPs, Australian Journal of Primary Health 2018, see
Appendix A. The purpose of this arm of the study was to explore factors that influence
deprescribing among Australian GPs using a newly developed 21 item survey (see
Appendix E). As described in chapter 4, the survey items were developed after a review
of the available qualitative studies of GPs’ experiences of deprescribing in the context
of polypharmacy use in older adults (Anthierens et al., 2010, Bell et al., 2015, Linsky et
al., 2015b, Moen et al., 2010, Schuling et al., 2012). These studies focused on
investigating the barriers and enablers facing GPs as they attempted to reduce the
number of medications being taken (see literature review Chapter 2). At the time of
the formation of the survey tool, no previous survey of GP attitudes toward
deprescribing had been developed.
In this arm of the study, the following research objectives were explored from the
perspective of the GP participants:


How does the healthcare environment influence deprescribing discussions?



What is the relationship between perceptions of ageing and the likelihood of
discussions about polypharmacy and deprescribing?



What is the role of health literacy in managing polypharmacy and making
decisions about deprescribing?
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The design of this study arm including recruitment was described in the methods
chapter (Section 4.1).

2. Results
A total of 85 completed surveys were received. The response rate to the survey varied
between 14.3% (83/578) for the paper based version and 9% (5/56) for the emailed
version. Response rates to unpaid surveys of GPs in Australia are generally low and
these rates are comparable with other studies (range 1% to an unsolicited emailed
survey (Parkinson et al., 2015) to 28% for a mailed survey (Jones et al., 2012).
Despite the small sample size, data quality was high. The median percentage of
missing responses per item on the Likert scale questions was 0.09% (range 0%-1.17%)
and the median percentage missing for the demographic questions was 1.3% (range
0%-2.3% ).
2.1 Demographic Characteristics of GP Respondents
The demographic characteristics of the sample are shown in table 5.1. The median age
of GP respondents was 52 years and 57% were male. Almost half (47.6%) were very
experienced having worked 21 years or more as a GP, with the majority (74.1%)
completing their medical training in Australia. More GP respondents worked in
practices that were situated in higher SEIFA locations (57.3%) and in major cities
(60%). The demographics of the sample were similar to those recorded for GPs in the
state of New South Wales in 2016 in regards to age and gender. However, GPs who
trained in Australia were over-represented (71% compared to 60%) (Department of
Health, 2017).
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Table 5.1 GP demographic characteristics
Characteristic

Age, years
35yrs
35-44
45-54
≥55
Missing
Gender
Male
Female
Missing
Years in general practice
2 years
2-5 years
6-20 years
≥21 years
Missing
Place of graduation:
Australia
Asia
UK/Ireland
Africa and Middle East
Europe
Missing
SEIFA index of practice
High
Low
Missing
Location (ASGC)
Major city
Inner regional
Outer regional
Remote
Missing

Number of
respondents
a
n

Percentage of
respondents
b
(%)

NSW data (%)^

11
17
19
36
2

(12.9)
(20.0)
(22.4)
(42.3)
(2.4)

12
23
24
41

48
36
1

(56.5)
(42.3)
( 1.2)

55
45

10
9
24
41
1

(11.8)
(10.6)
(28.2)
(48.2)
(1.2)

59
4
11
6
3
2

(69.4)
(4.7)
(12.9)
(7.1)
(3.5)
(2.4)

47
35
3

(57)
(43)

48
32
1
1
3

(56.5)
(37.6)
(1.2)
(1.2)
(3.5)

60

^Department of Health 2017
Abbreviations:

ASGC: Australian Statistical Geography Standard

SEIFA: Socio-Economic Indexes For Areas
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2.2 Factors influencing deprescribing
The findings of this study arm suggest that several factors contributed to the
respondents’ attitudes and practices toward deprescribing for their older patients.
These factors relate to the GPs’ role as coordinator of medications, the impact of
managing multiple morbidities and subsequent polypharmacy use, resource
constraints and capabilities, as well as their perceptions about patient related factors.
2.2.1 GP role
GPs were asked about their perception and the nature of their role within medication
management and the role of others, such as specialists. The majority of GP
respondents agreed (95.3%) that their role involved being the overall co-ordinator of
their older patients’ medications (Table 5.2). However, their other responses indicated
that their ability to fulfil this role was often hampered. For example, while 58.8%
agreed that specialists would respect that role, fewer (24.7%) agreed that specialists
would respect their decision to deprescribe. Notably, these two items recorded high
neutral response rates, 30.6% and 43.5% respectively, and so were further investigated
in the later qualitative arm (see chapter 6, section 2.3). Importantly, over three
quarters of the GP respondents (77.6%) thought that communication about
deprescribing decisions was difficult when multiple prescribers were involved.
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Table 5.2: GP role
Question

Agree
n (%)

Neutral
n (%)

Disagree
n (%)

I see my GP role as the over-all
co-ordinator or manager of my

81 (95.3)

2 (2.4)

2 (2.4)

50 (58.8)

26 (30.6)

9 (10.6)

21 (24.7)

37 (43.5)

27 (31.8)

8 (9.4)

11 (12.9)

66 (77.6)

older patients’ medications
I feel confident that other
prescribers, such as specialists
would respect my role as the overall
co-ordinator of my older patients’
medications.
Where specialists are involved in
the care of my older patients, I feel
confident they would respect my
decision to deprescribe a
medication.
Where multiple prescribers are
involved in the care of an older
patient, it is easy to communicate
between those prescribers about
decisions to deprescribe
medications.

2.2.2 Managing medications in the context of multiple-morbidity
Table 5.3 presents the results of items exploring GP management of polypharmacy.
The respondents were clearly aware of the problems of polypharmacy when managing
their older patients and nearly all (95.2%) recognised the impact it had on their
patient’s quality of life. Most agreed (79.8%) that the use of clinical treatment
guidelines contributed to generating complex medication regimens for their older
patients. Many respondents (61.2%) suggested that they were confident to deviate
from clinical treatment guidelines to reduce the complexity of regimens. However,
when this was explored further, in the following question, there were mixed responses
109

as to how easy it was to prioritise medications (38.8% agreed, 25.9% neutral, 35.3%
disagreed). Difficulties prioritising medications may be a barrier to deprescribing and
this is explored further in the GP qualitative study arm (see chapter 6, section 2.2.2).
Table 5.3 Polypharmacy and its management
Question

Agree n (%)

I regularly consider the potential

Neutral n (%)

Disagree n (%)

80 (95.2)

3 (3.6)

1 (1.2)

33 (38.8)

22 (25.9)

30 (35.3)

67 (79.8)

13 (15.5)

4 (4.8)

52 (61.2)

23 (27.1)

10 (11.8)

impact of polypharmacy when
considering the ongoing quality of
life of my older patients.
I find it easy to prioritise
medications to adequately manage
the needs of my older patients with
multiple morbidities.
I believe that applying individual
clinical treatment guidelines often
results in older patients having to
manage complex medication
regimens.

a

In the case of an older patient with
multiple morbidities, I feel
confident to deviate from clinical
treatment guidelines to help
reduce the complexity of their
medication regime.
a

Respondent counts do not sum to 85 due to missing responses.

2.2.3 Resources and capabilities
The resources and capabilities available to GPs to enable them to manage their older
patients’ medications and deprescribe were investigated. These results are reported in
table 5.4. Over half the GP respondents (60%) disagreed that there was enough time
during consultations to check medication regimens and yet there were mixed
responses regarding whether they had enough time to deprescribe (37.6%, agreed,
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24.7% neutral, 37.6% disagreed). It was unclear why such mixed responses were
received as the current literature suggests that GPs do not have enough time and that
lack of time is a barrier to deprescribing (Anderson et al., 2017, Linsky et al., 2015b,
Wallis et al., 2017). This was further explored in the later GP qualitative study arm, see
Chapter 6 section 2.2.3.
In support of the GPs’ confidence to discuss deprescribing with their patients, many of
the GPs agreed they had enough information about the risks and benefits of
medication to guide deprescribing (64.7%). They believed that they could easily
explain risks and benefits to their older patients (68.2%). Most (80%) agreed that they
were aware if their older patients were unable to understand the rationale for
deprescribing, suggesting that they understood, in practical terms, what could be
described as the health literacy level of their older patients (Table 5.4). This suggests
that the majority of GPs believe they have the ability to provide and communicate
accessible and understandable information. They are also mindful of their older
patient’s health literacy levels, in order for their older patients to participate in
decision making regarding deprescribing. These findings are not well supported by
other qualitative studies which found that GPs were uncertain of the risks/benefits of
ongoing use of medications, especially in the case of preventatives, such as statins and
found it difficult to communicate risk/benefit information to their older patients.
(Anderson et al., 2017, Moen et al., 2010, Schuling et al., 2012, Wallis et al., 2017). This
was investigated in more detail in the GP qualitative arm see Chapter 6, section 2.1.2.
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Table 5.4 Resources and capabilities
Question

Agree n %

Neutral n %

Disagree n %

I feel there is enough time during

16 (18.8)

18 (21.2)

51 (60.0)

32 (37.6)

21 (24.7)

32 (37.6)

55 (64.7)

16 (18.8)

14 (16.5)

58 (68.2)

16 (18.8)

11 (12.9)

consultations to regularly check all
the current medications being used
by my older patients.
I feel there is enough time during
consultations to consider
deprescribing one or more regular
medications taken by my older
patients.
I have enough information about
the risks and benefits of medication
use to incorporate deprescribing of
medications where appropriate, for
my older patients.
I find it easy to explain the risks and
benefits of discontinuing one or
more medications to guide my older
patients through a decision making
process.
I can identify when an older patient

68 (80.0)

14 (16.5)

3 (3.5)

is finding it difficult to understand
the appropriateness of
deprescribing one or more
medications.

2.3.4 Patient related factors
Table 5.5 details responses to items exploring GPs’ perceptions of their older patients’
involvement, capability and preferences regarding decisions about their medications.
Most GPs (84.7%) agreed that their older patients were capable of engaging in
decisions to consider deprescribing. Again, this was investigated more fully in the GP
qualitative study (Chapter 6, section 2.1.2) as this finding is contrary to the results of
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earlier qualitative studies (Linsky et al., 2015b, Schuling et al., 2012). In those studies,
GPs believed that their older patients were not capable of engaging with a decision
making process to deprescribe because they were too old, poorly educated (Schuling
et al., 2012) or did not have a good understanding of their illnesses and medications
(Linsky et al., 2015b).
While most agreed their older patients were capable of being involved in a
deprescribing decision making process, fewer (66.3%) asked their deprescribing
preferences (Table 5.5). This suggests that further opportunities to deprescribe may
exist, but remain unexplored.
When asked about their perceptions of older patients’ decision making, just under half
thought that older patients preferred to make decisions by themselves while others
thought that their patients preferred that they made decisions for them. However
64.3% agreed that their older patients preferred shared decision making. An
Australian qualitative study by Weir et al. (2017) which investigated older adults’
involvement in deprescribing decisions confirms this variability in willingness to be
involved. Knowledge of medications, attitudes to deprescribing and medicines in
general, and personal preferences for participation all influenced involvement. GPs’
perceptions about older adult decision making capabilities will be further explored in
Chapter 6, section 2.1.2. Additionally, older adults’ preferences for inclusion in
decision making will be discussed in Chapter 8.
Almost all GPs (96.4%) perceived that their older patients trusted their prescribing
decisions and most (72.9%) disagreed that their patients would feel given up on if they
mentioned deprescribing. The finding regarding trust is supported by the consistently
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high levels of patient acceptance of deprescribing (at least hypothetically), if
recommended by their doctor (Chock et al., 2021, Weir et al., 2021a). Although once
again contrasts with previous qualitative studies of GPs where they suggest resistance
to deprescribing is a common barrier to deprescribing (Alrasheed et al., 2018, Bell et
al., 2015, Kuntz et al., 2018, Linsky et al., 2015b, Wallis et al., 2017). Additionally, fear
that patients would interpret such discussions as being ‘given up on’ have been
reported as a barrier to deprescribing (Schuling et al., 2012, Wallis et al., 2017). The
role of trust in the decision making process will be further explored from the
perspective of both the older adult and the GP in the subsequent qualitative arms (see
chapters 6, section 2.1.3 and chapter 8, section 2.3.2).

The response was mixed regarding GPs’ perception of their older patients’
expectations that there is a ‘a pill for every ill’, with similar numbers agreeing 32.9%
and disagreeing 29.4% and a high neutral response (37.6%). This unclear result may
reflect the differences in how GPs’ interpret the ambiguity regarding attitudes to
medication use, expressed by their older patients. For example, older adults may
indicate a willingness to take less medication while also agreeing that all their
medications are necessary (Sirois et al., 2016). More work is required to better
understand GPs’ view of their older patients’ attitudes toward medications and
deprescribing and this is also explored in Chapter 6 (section 2.2.4).
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Table 5.5 GP perceptions of patient related factors
Question

Agree n (%)

Neutral n (%)

Disagree n (%)

Overall, I believe my older patients

72 (84.7)

11 (12.9)

2 (2.4)

55 (66.3)

19 (22.9)

9 (10.8)

11 (13.1)

34 (40.5)

39 (46.4)

54 (64.3)

15 (17.9)

15 (17.9)

42 (50.0)

31 (36.9)

11 (13.1)

82 (96.5)

3 (3.5)

0 (0.0)

28 (32.9)

32 (37.6)

25 (29.4)

8 (9.4)

15 (17.6)

62 (72.9)

are capable of engaging in a
decision making process regarding
medication continuation or
deprescribing.
I always ask my older patients what
their preference is regarding
medication continuation or
deprescribing.

a

Most of my older patients prefer to
make decisions on their own about
their medications, after seriously
considering my opinion.

a

My older patients prefer to share
responsibility for making
a
medication decisions with me.
My older patients prefer me to
make their medication decisions for
a
them.
I believe my older patients trust my
medication prescribing decisions.
My older patients have an
expectation that there is a ‘pill for
every ill’.
I feel if I discuss deprescribing
medication with one of my older
patients they will interpret this as
being ‘given up on’.
a

Respondent counts do not sum to 85 due to missing responses.

2.4 Association between respondent characteristics and survey items
Three significant associations were noted between GP respondent characteristics and
their responses to survey items. Firstly, compared to younger GPs, older GPs were
significantly more likely to agree that they were confident to deviate from clinical
guidelines (42.9% v 72.7%; P=0.030). Secondly, older GPs were more likely to disagree
that their older patients would feel ‘given up on’ if they mentioned deprescribing
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(57.1% v 80%; P=0.012). Thirdly, compared to those who had trained in Australia, GPs
trained overseas were significantly more likely to note that it was easy to prioritise
medications (38.8% v 58.3%; P=0.037). There were no significant associations between
gender, country of birth, years of experience or location of practice (city/inner regional
or socio-economic area) and any of the survey items.
The first association is not surprising given that older GPs were more likely to have
trained and worked prior to the introduction of clinical treatment guidelines in the
early 1990s (Greenhalgh et al., 2014). Notably the same association was not seen when
levels of experience were compared. The second association may be a result of older
doctors being more likely to have established long-term, trusting relationships with
their older patients and is further investigated in both qualitative chapters. The
reasons for the final association between location of training and ease of prioritising
medications are unclear but this could be investigated in future research.
2.5 Responses to the open ended question
In addition to the responses to the survey items, thirty six open responses were
received (42% of respondents) (See Appendix I). Overall, these responses confirm the
survey findings, making comments concerning the lack of time available and the lack
of communication and coordination between GPs and specialists when managing
medications and deprescribing. Two respondents commented on the lack of
homogeneity in older age, particularly around interest and capability to be involved in
decision making. By this they meant that some oldest old were still quite capable and
interested in participating in decision making while others, even those who were
younger older adults, were not. They remarked that this made it difficult for them to
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know how best to respond to the questions posed in the survey in order to report their
more nuanced viewpoint accurately. This emphasises the importance of qualitative
research methods which allow such variability to be captured. Some (n=14) suggested
strategies that they used to assist with deprescribing. These included conducting
medication reviews, either themselves or via pharmacists undertaking a home
medicines review, arranging longer consultations, conducting annual health
assessments and seeking support for deprescribing decisions from others, such as
geriatricians or specialists. Most of these strategies were mentioned again by
participants in the later GP qualitative arm and are described in more detail in chapter
6.

3. Conclusion
This study arm identified several factors that suggest there is a strong positive
foundation for deprescribing for Australian GPs. The participants expressed a positive
view of their relationship with their older patients, including their patients’ trust in
their decisions. They were generally optimistic about their older patients’ capability
and interest in participation in shared decision making. The results suggested that
most respondents engaged in practices that would support shared decision making,
exploring patient preferences and were confident to communicate complex
medication risk and benefit information. They also suggested that they could identify,
in practical terms, their older patients’ lower health literacy, as demonstrated by
observations of their patients’ level of understanding of deprescribing. As noted
throughout this chapter, some of these results vary from findings of earlier qualitative
studies. The results were investigated in more detail in the later GP qualitative study
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arm to determine whether a more detailed exploration of GPs’ description of their
practice would support the survey results or confirm earlier qualitative findings.
Unsupportive factors, mostly within the healthcare environment, were found to still
constrain practice as GPs sought to carry out their role as coordinators of their older
patients’ medication regimens. These included limited time to review medications,
inadequate communication between prescribers and a perception that other
prescribers did not respect the GPs’ role as overall coordinators of their older patients’
medications.
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Chapter 6 GP Qualitative Study
1. Introduction
This chapter presents the results from the first of two qualitative arms, this one
examining the attitudes of GPs toward the medication management of their older
patients, including deprescribing. It argues that medication management for older
adults with polypharmacy is a complex task that even experienced GPs found difficult.
Participants focused on tailoring individualised medication regimens aiming to
balance medication benefits over potential harms. Most noted there was little time to
prioritise deprescribing as an aspect of medication management, even though the
majority of participants thought that it was beneficial, where possible, whilst still
maintaining good quality of life and functionality for their older patients. The
participants’ attitudes toward their older patients influenced their perception of their
older patients’ capability to engage in decision making regarding their medications.
In this arm of the study three of the four research objectives were explored from the
perspective of the GP participants:


How does the healthcare environment influence deprescribing discussions?



What is the relationship between perceptions of ageing and the likelihood of
discussions about polypharmacy and deprescribing?



What is the role of health literacy in managing polypharmacy and making
decisions about deprescribing?

As described in the methods chapter (Chapter 4), the use of a sequential mixed
methods approach allowed different aspects of the research question to be
investigated and for results across the different methodologies to be considered
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alongside each other. These qualitative results were explored in the light of the earlier
survey results to consider whether they confirmed, contradicted or produced data
which were largely complementary (Morgan, 2019). Following the mixed methods
design, in this study arm the reasons for mixed responses to some GP survey questions
(see chapter 5) were clarified and expanded. As will be discussed, some responses were
unexpectedly different to the earlier survey responses. The contributions of the GP
participants in the qualitative arm complemented the earlier analysis, moving beyond
the hypothetical to allow an account of how they believe they practice and their
reasoning for this. Additionally, the results from this study were able to add
complementary data, from an Australian perspective, when considered in the light of
results from earlier qualitative research conducted primarily in Europe and North
America (Anderson et al., 2017, Anthierens et al., 2010, Bell et al., 2015, Clyne et al.,
2016, Linsky et al., 2015b, Moen et al., 2010, Schuling et al., 2012, Sinnige et al., 2016,
Sinnott et al., 2015, Wallis et al., 2017).

2. Results
Sixteen GPs were interviewed for this arm of the study and their characteristics are
noted in Table 6.1, GP characteristics. The table is ordered according to the GPs’ years
of experience as it became apparent during the analysis that this characteristic often
had more bearing than others on patterns of responses. Most (n=9) had worked for
more than 21 years in general practice. The majority of the participants were male (n=
10) and worked in low socio-economic areas (n=10). Female GPs were more likely to
work in larger practices. No other distinctive patterns were noted.
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Table 6.1 GP interview participant characteristics
GP Years in practice Gender SEIFA index of practice Number in practice
1

≤2

female

high

11 or more

2

2-5

male

high

2-5

3

2-5

male

low

2-5

4

2-5

male

low

2-5

5

2-5

male

high

2-5

6

2-5

female

low

6-10

7

6-20

female

high

6-10

8

21+

male

high

2-5

9

21+

female

low

6-10

10

21+

female

high

6-10

11

21+

male

low

2-5

12

21+

male

low

2-5

13

21+

male

low

2-5

14

21+

female

low

2-5

15

21+

male

low

2-5

16

21+

male

low

2-5

Three major themes were identified from the GP interviews. A number of subthemes
were also identified, as illustrated in Figure 6.1. These will be explored in the sections
that follow.
The first theme included the GP perspectives of their older patients. The participants
focused their responses during the interview on their very old patients, despite the
broader focus of this study on community living older adults aged 65 years and over.
Some held quite negative views of the capabilities of their older patients to manage
their medications independently and safely. All recognised the importance of their
older patients’ trust in their medication management decisions. The results of the
earlier survey items in relation to GP perceptions of their older patients’ capabilities to
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engage in decision making, GP engagement of older adults in decisions regarding
deprescribing and GP perceptions of their older patients’ trust, are further explored in
the first theme.
The second theme focused on the GPs’ desire to create individualised medication
regimens for their older patients. This task was complex and challenging. GPs gave
reasons why this was not an easy task and their responses help to clarify some of the
varied results to items investigated in the earlier GP survey arm. The participants
talked of the many strategies, including deprescribing, that they employed to address
the medication management needs of their older patients, whilst aiming to maximise
benefits and avoid harm. Different approaches were spoken of across the group,
suggesting a lack of consistency in the strategies that were practiced.
The third theme highlighted health system based factors which influenced the
participants’ medication management strategies, including deprescribing. Participants
suggested that inadequate communication with other healthcare providers involved in
the care of their older adult patients, made it difficult for them when they approached
medication management decisions. This result confirmed the earlier GP survey
findings. Specifically, it was more difficult to know what medications their older
patients were taking and why. It was difficult to implement their medication
management strategies to better address individual patient needs, against a
background of competing demands, especially from specialist prescribers. Lines of
authority for deprescribing decisions were unclear. The lack of time in consultations
and funding, particularly for the care of frail older patients, was also problematic.
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Figure 6.1 GP results: themes and subthemes
2.1 GP perspectives of their older patients (Theme 1)
2.1.1 A focus on the very old
Throughout their interviews the majority of GP participants focused their responses
on describing the medication management challenges and concerns they experienced
when treating what would typically be thought of as frailer older patients. For
example, in their descriptions of their older patients all mentioned dementia,
cognitive loss or confusion, thirteen out of the sixteen participants mentioned
informal carers such as family members and nine mentioned physical limitations such
as reduced mobility or swallowing difficulties or reduced renal and hepatic function.
These characteristics are not typical for the majority of older adults, even those with
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polypharmacy, who do not suffer from cognitive loss or confusion and live
autonomous lives without requiring a carer. Few responses recognised the
heterogeneity of older age. The participants’ focus on the very old suggests that some,
if not all, of the following findings may not be applicable to their management of the
vast majority of older polypharmacy users. It also suggests that for many GP
participants, their perception of their older patients, and therefore older age, is that it
is inevitably characterised by loss of function, capability and agency to make decisions.
Again, while this may be true for some, it may not be true for all of their older
patients. The following quote, from the beginning of one GP’s transcript is illustrative
of how participants framed their responses:
‘So I guess from a medication perspective, with really elderly people living in the
community, we're either withdrawing, starting new medications or titrating
medications it’s is very difficult. Just… balancing risk associated with making
medication changes…the difference in their physiology and metabolism,….social
situations. Depending on who’s home with them, how their cognition is in terms
of compliance and reliability of taking medication.’ GP 13
2.1.2 GP narratives of their older patients’ capabilities
In addition to focusing their responses during the interview on older frail patients,
there was a noticeable pattern in how the participants depicted their older patients’
capability to manage medications. None of the GPs interviewed displayed an
awareness of the capabilities and knowledge employed by their older patients to
manage their medications between consultations. Furthermore there was a lack of
awareness of the extent to which older adults used the internet to explore medication
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information. Seven of the participants, irrespective of gender, experience or location of
their practice, described their older patients using a narrative that consistently
emphasised the limitations of their older patients’ capabilities. The remainder
acknowledged these limitations, however, they also discussed additional factors which
contributed to their older patents having reduced capabilities. Only two consistently
acknowledged their older patients’ capabilities throughout their interview. Notably,
this did not include recognition of their older patient’s capabilities demonstrated by
their management of their medications between consultations.
2.1.2.1 Negative narratives regarding older patients’ medication management
GPs who expressed consistently negative views (n=7) perceived that their older
patients were incapable of managing their medications independently. They described
deficiencies which included poor compliance, forgetfulness and errors when managing
medications at home. They portrayed their older patients as being unreliable and
often incapable of following their advice. Participants in their management of
polypharmacy therefore, presented older patients’ medication management
behaviours as a major challenge; a challenge that they perceived was out of their
control.
Participants who had negative views about their older patients’ medication
management capabilities also perceived that they had low health literacy. They
described them as lacking education and the motivation to improve health or to seek
additional health and/or medication information. They perceived that older patients
couldn’t communicate their medication concerns readily and in many instances were
not aware of why they were taking medications.
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‘Often they actually feel that you are just there to put your signature on that
script or that something. Often there’s not that idea that you’re going to be
preventing health issues or helping them in other domains. So that education can
sometimes be lacking and a lot of older patients as well don’t feel that they can
communicate their agenda. They are just there presenting their complaint and
then you solve it.’ GP 1
The GP participants in the current study suggested that they used various strategies to
accommodate the perceived limitations of their patients’ health literacy capabilities.
For instance, they provided medication instructions slowly and/or repeatedly, as well
as by providing instructions to the patient’s relatives or caregivers. Notably, such
strategies would only address functional health literacy limitations, were not an
exchange of information and appear patronising in that they assume a level of
incapacity to function. They held a pessimistic view of the potential usefulness of
trying to improve some of their older patients’ understanding.
‘I mean you can always say you want to educate patients but health literacy
depends on each individual patient and no matter what you do, there's always
going to be some patients that just don’t get it.’ GP 5
The participants described other concerns about their older patients’ capabilities when
seeking information about medications. They noted that they were not discerning
regarding medication information sourced elsewhere such as from pharmacists,
complementary health practitioners, magazines, TV and friends. Some gave examples
of patients stopping medications based on the advice of others and not letting the GP
know. However, unlike younger patients, participants thought that it would be rare
that their older patients would access the internet for information about their
126

medicines. As will be explained in chapter 8, this was contradicted by the older adult
qualitative results. Those results indicated that the majority of participants accessed
medication information on the internet. The above descriptions of older adults’
information seeking, again suggests a negative view of their health literacy capabilities,
specifically critical health literacy skills.
More GPs (n=7) held pessimistic views about their older patients’ capabilities than was
expected, when compared to the earlier GP survey arm (chapter 5). In the survey, the
majority of GPs (85%) thought their older patients were capable of engaging in a
decision making process regarding deprescribing. More than two thirds also thought it
was easy to explain the risks versus benefits of deprescribing and guide their older
patients through a decision making process.
Negative views of their older patients’ capabilities influenced practice when
considering deprescribing. The GPs’ responses in this group suggested they took a
paternalistic approach to discussions about medications and involvement of older
adults in decision making. They perceived that older patients were resistant to change
and much less likely to be willing to stop long-term medications. They suggested that
it was harder to communicate risk versus benefit information regarding medications
to older patients. GPs were also more likely to be cautious about deprescribing
because of concerns that any changes would result in confusion and potentially
contribute to further medication management errors.
‘Getting confused. Yeah. Because you're taking away medications that have been
there for a long time.’ GP 9
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2.1.2.2 Nuanced narratives about older patients’ medication management
Participants who expressed more nuanced attitudes toward their older patients often
described similar concerns about compliance and forgetfulness as noted in the views
expressed by the GPs discussed above. However, this group of GPs were more likely to
detail the contextual reasons behind why older patients may face these challenges,
when managing their medications. For example, they explained why their older
patients were sometimes unsure of the reasons for their medications. They observed
this was because patients did not always have medication changes explained during
hospitalisations or during specialist consultations. Also, they felt the use of blisterpackaged medications resulted in patients becoming less knowledgeable about their
medications. This was primarily because the information on the blister pack only
included the name and dose of the medication with no reference to why it was
prescribed or the provision of other relevant information. They also acknowledged
that the use of generic medications may cause confusion, rather than attributing
confusion about medications to reduced cognitive impairment alone. Some in this
group recognised the heterogeneity within their older patients. For example, GP 11
remarked that some 80 year olds may be very frail and not interactive, while others
might still be ‘playing football’.
GPs in this study arm, from the more positive group, added further insight to the GP
survey results. In the survey, the majority of respondents acknowledged that applying
individual treatment guidelines resulted in older adults having to manage complex
medication regimens. GPs in this arm noted that the outcome of complex medication
regimes for some older adults is a lack of compliance because of the burden of their
complex daily medication regimens.
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‘I would imagine most people can juggle you know two or three medications
reasonably easily but, obviously the more you have, the harder it potentially
becomes and the more room for error there is. I guess two or three is relatively
easy for most people but four or more is not.’ GP 13
Participants who were more positive about their older patients’ capabilities explained
the risks versus benefits of ongoing medication use and engaged their older patients in
decisions, including about deprescribing. They took time to hear and respect their
preferences. For instance, they sought to encourage their older patients to ask
questions, such as ‘”do I really need to take all these pills?”’ (GP 8). The related item in
the GP survey arm found that two thirds of respondents agreed that they asked their
older patients their deprescribing preferences. The result in this study arm did not
support such a high percentage with only six mentioning purposefully asking their
older patients’ preferences. For example, they acknowledged patient preferences to
prioritise quality of life rather than prolong life. They encouraged patients to make an
informed decision based on a discussion of risks and benefits. This included exploring
potential fears such as reoccurrence of symptoms or occurrence of preventable events.
These fears were recognised, discussed and managed with dose reductions or trials of
stopping.
‘Sometimes they're very reluctant to do it. I think it's fearful of something going
wrong and that’s understandable too….And sometimes you've got to work with
people to either say, “Well, let's cutback the dose. Let's stop it for a week and
catch-up again and see how you feel,” and it gives them a way to do it where they
feel that they're comfortable.’ GP 10
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They also acknowledged it was easier to address patient fears and concerns with some
medicines compared to others, for example, proton pump inhibitors (PPIs) or statins
compared to benzodiazepines.
The wording of the survey item exploring GP perceptions of older adult’s capability to
understand an explanation of risk and benefit produced mixed results. The qualitative
results indicate this is an important area so the wording of this item has been modified
in order to better capture GPs’ views (see Appendix L).
2.1.3 GPs’ perception of older patients’ trust
In the GP survey almost all respondents agreed that their older patients trusted their
prescribing decisions. However, the GP qualitative arm revealed more nuanced
responses and explained GPs’ opinion of what formed the basis of interpersonal trust.
The extent of perceived trust was in part linked to the GP’s level of experience. Those
who were less experienced were more likely to share anecdotes of patients who they
had inherited and had resisted or refused to stop medications. When less experienced
participants felt they had gained their patient’s trust they were more confident to
enter into a conversation about deprescribing. The reverse was also true.
Participants, regardless of level of experience observed that trust took time to develop
or be transferred to a new GP.
‘I would like to stop prescribing this – if the patient has known me for a while,
they’re more likely to accept that rather than if they were meeting me for the first
time…over time, you understand the patient better. Even their past history….So,
that’s the advantage that we have in general practice. We get to see our patients
often.’ GP 3
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Participants noted that sometimes suggested changes to an established medication
regime were met with suspicion as such advice questioned the good intentions and/or
safety of the recommendations of the original, trusted prescriber.
‘People often trust the initiator of the medication. “So why are you telling me to
stop what Dr Blogs has prescribed for me? He's very competent. He saved my life.
He told me I should be on this medication forever, albeit 18 years ago. And who
are you, you young whippersnapper? I don’t know who you are. How dare you –”’
GP 8
Those who had been in practice for many years and had long-term, established
relationships, perceived that their older patients trusted their prescribing decisions.
Participants believed that long-term care provision was the basis of this trust and that
the nature of general practice enabled this. They described how, over time, they felt
their patients developed a trust in their competency, medical knowledge and their
specific knowledge of the patient’s medical history. They understood this to be why
patients were not worried to accept and follow their advice, including their advice
about deprescribing. In this way, trust facilitated good medication management.
‘It's about trust in your competence, and your knowledge of them, and their
history, and all that kind of stuff, so yes. If you're too early in your acquaintance
to embark on this deprescribing conversation, it can all go awry.’ GP 8
While most previous reviews and studies support the view of the GP participants that
trust facilitates good medication management (Bokhof and Junius-Walker, 2016, Ng et
al., 2017, Reeve et al., 2013b), a small number of studies suggest it can also act as a
barrier to patients’ questioning (Belcher et al., 2006, Linsky et al., 2017, Schöpf et al.,
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2017). The participants in the current study did not acknowledge that trust may also
result in patients being passive, uncritical and unquestioning, regarding decisions
about their medications. However, they did acknowledge that trust was based on
social norms, as suggested by GP 5 who observed that older patients ‘were bought up
in…a culture of respect for GPs’. This notion will be discussed further in chapter 8, the
older adult qualitative arm. The original survey item investigating trust has been
amended in response to the findings of the qualitative arm and an additional item has
been added to further explore the relationship between trust and participation in
decision making (see Appendix L).
2.2 Creating individualised medication regimens (Theme 2)
This theme highlights the strategies GPs used as they sought to provide individualised
medication regimens for their older patients. Conducting medications reviews were
the foundation of assessing the ongoing appropriateness of their older patients’
complex regimens. The challenges facing GPs as they attempted to find the best
regimen for their older patients was described with the majority of descriptions
focusing on what principles guided prescribing, although deprescribing was also
discussed.
While the difficulties of managing complexity and devising an individualised
medication regimens for older adults with multimorbidities have been discussed in
previous studies (Anderson et al., 2017, Luijks et al., 2012, Magin et al., 2015, Muth et
al., 2019), this study highlights that approaches to developing an individualised
medication regime vary from GP to GP. When comparing the responses, it is clear that
individual participants adopted different approaches, across the group, in how
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strategies were applied to medication management, including deprescribing. This may
be because participants understood key definitions differently or held differing views,
for example of the impact of polypharmacy and the need for deprescribing.
2.2.1 Reviewing medications regimens
Undertaking medication reviews was a common strategy used by the GP participants
to assess the ongoing appropriateness of each of their patients’ medications. This was
an important strategy in maintaining an appropriate, individualised medication
regimen. However, some reflected that, in practice, reviews may not be used to assess
the ongoing appropriateness of medications:
‘I think sometimes we just have the tendency to add things on and not look at
what's there.’ GP 9
When and how reviews were conducted, how often, and who conducted reviews,
varied. All participants conducted informal reviews themselves on an ad hoc basis as a
part of other medication management tasks, such as when new medications were
being added, as part of writing a new referral to a specialist, writing up a new care plan
or as part of an annual health check. These ad hoc reviews did not always involve the
patient but were a desktop review of the record of the patients’ current medication
list. The aim of these reviews was to note any inappropriate medications as a result of
allergies, drug–drug interactions or drug–disease interactions particularly as a result of
declining renal and hepatic function and to keep up to date with new medications
such as immunotherapies for the treatment of cancers.
Many participants used IT prescribing support systems when performing ad-hoc
medication reviews. Some observed that IT prescribing support was helpful to clarify if
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a presenting problem may be being caused by current medication/s. Although one
thought that the information provided was limited, being theoretical in nature and
needed to be considered in discussion with the individual patient:
‘You’ve got to be careful of interactions and that’s basically true, although many
of the interactions on prescribing software are more theoretical than real. But
there are some risks as well and you need to discuss those things with the patient
and see what the patient wants to do, whether they want to take the risk.’ GP 7
Other GPs noted that they periodically reviewed their record of the patient’s
medication list and asked the patient if they felt each medication was still beneficial or
if there were side effects or other concerns. Some used the Home Medications Review
service conducted by community pharmacists. Two described how they asked patients
to bring in all their current medications to conduct a ‘brown bag review’. One practice
sent their practice nurse to conduct a home visit to review medications. The aim of
these forms of review was to get an accurate list of current medications, check
compliance and/or to find out from patients if they had any concerns about their
medications. These types of reviews allowed the participants to explore patient
preferences to stop or continue particular medications.
2.2.2 The challenge of competing priorities
Creating an individualised medication regime was described as a challenge: a
‘balancing game’ (GP 4). GPs noted that they needed to simultaneously consider their
patient’s life expectancy, quality of life, physiological and cognitive impairments, as
well as their other morbidities, medications and regimen complexity.
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‘You always try to balance out the good effects of the medicine versus the bad
effects and that balance is different for each medicine and for each person.’ GP 11
Various strategies to find the right balance were described. Some tried to introduce
one medication at a time in order to be able to assess benefit or adverse effects and
asked for feedback from the patient about effectiveness or side effects associated with
the medications. Others talked of general principles they applied when making
decisions such as ‘first do no harm’ and ‘start low, go slow’; starting medications on
the lowest effective dose. Some took a watch and wait approach before prescribing.
Others stressed the importance of trying non-pharmacological approaches first,
wherever possible. However, the barriers to this were noted, including cost, for
example to access physiotherapy, and declining mobility, increasing frailty and poor
motivation making access difficult.
The process to assess the ongoing benefit versus harm of each medication was
explained as a complex task, reliant on their own clinical judgement skills and often
required multiple changes to doses of medications before an appropriate dose was
found. Sometimes competing priorities meant it was not always possible to find a good
balance:
‘There are some patients that there's always a conflict. I had one last week….they
had the pain killer and had effectively no pain but significant nausea, we stopped
the painkiller and we lost the nausea and had the pain.’ GP 10
Sometimes adverse effects had to be weighed up against potential current or future
benefit for individual patients.
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‘I’m asking myself and you can ask the patient, “Do you mind having slightly
puffy ankles or kidneys that don’t work?”’ GP 15
The earlier GP survey explored this area however there were mixed results when GPs
were asked if they found it easy to prioritise medications in order to manage the needs
of their older patients. The wording of that item has been modified in light of the
subsequent qualitative findings (see Appendix L). These qualitative results allow
greater insight into the challenges facing GPs in order to manage the often competing
prescribing priorities presented by their older patients. The qualitative results also
identify the varied approaches GPs used in an attempt to ‘find the right balance’ of
medications for their older patients.
2.2.3 Using clinical guidelines to guide prescribing
It was commonly noted that clinical guidelines were only one consideration taken into
account when prescribing. The results of the GP survey item which investigated
preferences for the use of clinical guidelines was further explained. Participants
acknowledged that the recommended therapeutic guidelines were based on research
evidence derived from younger, relatively healthy patient populations, who were very
different to their older patients, in terms of comorbidities. One again, clinical
judgement was used alongside clinical guidelines when making prescribing decisions.
Clinical judgement was based on the GP participants gathering their own evidence
using several strategies to assess the effectiveness of medications/dosage on individual
patients. They used objective measures to check patients’ response, such as measuring
blood pressure, repeating mini mental tests or checking blood results.
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2.2.4 Varied definitions of polypharmacy
The way participants defined polypharmacy, either numerically or according to what
was thought to be appropriate, regardless of number, influenced how they managed
medication regimens. Concurring with the earlier GP survey results, most participants
commented that they tried to prescribe as little as possible for their older patients,
while still trying to achieve good quality of life and functionality. However, exactly
what was meant by ‘as little as possible’ was unclear. No consistent definition of
polypharmacy was used. Some discussed polypharmacy in terms of numbers of
medications although a variety of numbers were given: four, five, seven or eight
medications. Others thought that, rather than focusing on numbers of medications
and adhering strictly to therapeutic guidelines, it was more important to adopt a
pragmatic approach and consider the patient’s individual context and preferences to
determine how many medications were manageable and required.
‘So I guess I try to limit medications used, but if someone needs pain relief, then
I’ll provide pain relief. I don’t think you deny pain relief just because it cracks
number six.’ GP 2
No item in the original GP survey explored GPs’ view of the definition of
polypharmacy. Two additional items have been added to the revised survey given that
the qualitative results indicate a variety of views regarding definitions for
polypharmacy (see Appendix L).
There was wide recognition among GP participants that it was difficult to avoid
polypharmacy despite its known risks, given the number of comorbidities that many
of their older patients presented with and the ethical need to treat these conditions.
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‘It’s somehow unavoidable. Many older people have multiple medical problems. I
have 80-year-olds who take one medication. They’re lucky. But most people will
require more than one medication and there’s really no way around it….Somebody
needs a medication. We need to give the person medication’. GP 3
2.2.5 Deprescribing as a strategy
When devising an individualised medication regimen, participants mentioned they
would stop medications if they thought medications were no longer needed, if they
were causing side effects and/or if their patient’s health was deteriorating. For
instance, all participants mentioned deprescribing statins for these reasons. However,
one participant, GP 11, felt that the current emphasis on taking five or less medications
and deprescribing encouraged decisions that ignored individual patient needs.
‘Researchers say you shouldn't give them more than five medicines – basically
you’re saying that this patient has no choice in this. We’re going to treat everyone
like this.’ GP 11
Concerns about compliance and the need to simplify medication regimens were
another prompt for deprescribing. To this end, participants considered deprescribing
to involve reducing the number of medications, reducing doses or reducing the
number of times medications needed to be taken each day. Deprescribing was thought
to help their older patients continue to manage their medications independently,
thereby avoiding unnecessary costs and was thought to deliver overall benefits to their
patients’ wellbeing. This led to most holding positive attitudes toward deprescribing.
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‘I have seen both in the hospital and community patients who have done a lot
better once we’ve gotten rid of medications and have done worse when we’ve
added them in.’ GP 1
Some participants were cautious to deprescribe, especially when the medication had
been prescribed by someone else or where the initial indication was not clear. They
also commented that they found it difficult to deprescribe because the outcome of
stopping some medications was unknown, with little evidence to guide how or what
medication to stop. This view of deprescribing was observed regardless of years of
experience as noted below by GP 2 (four years experience) and GP 13 (33 years
experience).
‘…this lecture they gave….was very heavy on the complication rates of multiple
medications and the evidence of people going to hospital and all the rest of it,
there was very little detail of exactly what we could stop, that was like, “Right,
you bad people, you’re doing all this,” but there was no kind of guidance of what
we could do better.’ I’ve always found the topic a little bit ruled by the high and
mighty people saying, “You shouldn’t do this, you shouldn’t do that, you shouldn’t
do that,” but without actually any practical advice of what you should do.’ GP 2
‘It’s very challenging if somebody has got multiple conditions and they're on
multiple medications, treating different things. Sometimes you just think, “Well,
it can be hard to stop anything.”’ GP 13
2.2.6 Accommodating patient and family preferences
Accommodating the attitudes and preferences of patients and sometimes their
families, was a further consideration noted by participants when individualising
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medication management strategies. GP participants described the variability of their
older patients’ attitudes to taking medications, with some wanting to take as few
medications as possible, while others were happy to take many medicines.
Participants reported that patient preferences to deprescribing also varied. Some
sought to influence these by proactively introducing the topic to their patients. For
example, they discussed the increased risk, associated with ageing, of experiencing
adverse events from particular medications. Despite the efforts of some to
communicate information about the benefits and risks of deprescribing individual
medications, they noted patients or family members were often not willing to accept
that it was appropriate to deprescribe. They managed those who resisted by either
deciding not to go ahead, reducing doses or negotiating with the patient to trial
stopping.
Another reason why some thought that patients resisted deprescribing was because
they overestimated the ongoing benefits of continuing medications. This influenced
patient expectations regarding ongoing prescribing.
‘Because a lot of patients will say, “Well, I’ve got to here with all of these. So,
therefore, I will get to there if I continue those.” The expectation and the value
that they attribute to what they’re on can be quite a lot more than what it is
actually doing.’ GP 1
Other participants sought to reset patient expectations about reasonable outcomes
from their medications. For example, they discussed changes in usual sleep patterns in
older age in the context of suggesting deprescribing of sleeping tablets.
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‘And some people are terribly fearful of not sleeping. And sometimes you’ve got to
normalise things…. If you can't sleep at night, get up, have a cup of tea, read a
book, put the TV on and it's okay not to sleep for eight hours all in one go,” and
they go, “Oh, really?”… and that changes their expectations. GP 10
Participants talked about conversations to gauge preferences for goals of care such as
prioritising quality of life over prevention/tighter symptom control. In the context of
their frail older patients, these conversations were characterised as difficult because
they involved frank discussions about life expectancy. They noted that during such
conversations the patient needed to feel valued and that their GP was not giving up on
them if they suggested deprescribing. Some commented that patients themselves
often triggered such conversations, when they asked if they still needed to take all
their medications and participants saw this as an opportunity to give patients (and
their families) permission to stop their medications.
‘I think that you need to understand who the patient is, and where they are, and
what their attitude to their life is, what they're frightened of…. So there's this
segue between active and palliative care that needs to be sensitively managed and
it's something that the carers, the general practitioner, and if possible the
patient…they need to all be on the same page about.’ GP 8
2.3 Health system factors influencing GPs’ medication management (Theme 3)
Respondents to the earlier GP survey indicated that, in practice, their role in managing
older patients’ medications was often made more complicated when other prescribers
were involved in providing care. This was attributed to poor communication between
prescribers and a lack of clarity around the responsibility for prescribing (and
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deprescribing). These earlier findings were confirmed and further explored in this
qualitative arm, in order to gain a better understanding of how and why relationships
with other prescribers influenced practice.
Although the survey focused on interactions with mainly specialist prescribers, the
qualitative results indicated that other health professions, specifically community
pharmacists, were also involved in the management of their older patients’
medications. The number of others involved and their sometimes competing agendas
resulted in complex interactions and generated sources of potential poor
communication and coordination of medication management. The influence of these
other ‘players’ left most participants feeling that their autonomy to deliver what they
perceived as the best outcome for their patients was sometimes compromised. This
confirmed results found previously (Anderson et al., 2017, Anthierens et al., 2010,
Clyne et al., 2016, Linsky et al., 2015b, Wallis et al., 2017).
2.3.1 Unclear lines of authority
All participants mentioned the problematic relationship with specialists. Despite the
vast majority of GPs who responded to the earlier survey noting that they saw their
role as the overall co-ordinator of their older patient’s medications, this was not
reflected in the commentary of GPs during the interviews. Concerns were raised over
the unequal authority and power of specialists in decision making about medication
regimens. One GP captured the essence of the participants’ comments, describing the
relationship between herself and specialists as a ‘power play’ (GP 1). This ‘power play’
had implications for clarity around overall authority or responsibility for prescribing
decisions.
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When deprescribing, less experienced participants were more likely to be cautious
about challenging a specialist’s request or stopping a medication started by a
specialist, as they felt the specialist had more clinical expertise and they would be
criticised for deprescribing. Others, usually those who were more experienced, were
prepared to take responsibility for a decision, regardless of the opinion of specialists.
‘As long as I'm confident that there's no good reason for continuing that I'm
aware of…. I don't care what the specialist has said.....“Look, this is what I want to
do,” but more often than not, they're not that happy with that.’ GP 10
In the above example the GP appeared to base their decision to deprescribe based on
clinical patient need. Another sought to prioritise their patient’s preferences over that
of the specialist.
‘If the patient wants to do something and the specialist doesn’t, then I will
support the patient.’ GP 11
The survey item exploring the influence of specialist’s opinion over GPs’ deprescribing
decisions produced mixed results. The wording has been revised from exploring a
hypothetical viewpoint to ask GPs to reflect on an experience of deprescribing a
medication prescribed by a specialist (see Appendix L).
The role of the specialist in the care of their older patients was commonplace, with
many noting that their older patients with multimorbidity were seeing multiple
specialists. Participants noted that this was driven by the increasing specialisation of
medicine. Some expressed a sense of powerlessness over the need or expectation to
refer. Others noted that an aspect of their coordinating role was to reduce the number
of referrals to specialists wherever possible. Participants commented that the need to
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see multiple specialists added unnecessary burdens, in terms of costs and time, for
their older patients and resulted in increased polypharmacy and over prescribing, as
each specialist addressed specific problems, in isolation.
‘Things are getting out of hand with all the different specialists…. it's just causing
more and more problems because each specialist looks at one thing and they
often don't know what all the other ones are doing so you just see all these
medications started and you just know that's going to cause problems.’ GP 4
Coordinating care and negotiating the demands of each specialist created another
source of competing priorities in the context of prescribing and deprescribing
decisions. GP 8 suggested that no specialist wanted their patients to die of the
problem they were responsible for treating so they were keen for GPs to continue
medications, regardless of other priorities.
2.3.2 Communication challenges
Participants commented on problematic communication between themselves and
hospitals, other prescribers within the primary care setting and with community
pharmacists. The most commonly noted source of communication problems was
between hospital prescribers and the GP. Incomplete hospital discharge summaries
were sometimes received which did not clearly provide reasons for stopping or
starting medication/s. The timeliness of the availability of discharge summaries was
also critiqued with summaries often received after the patient had been seen for
follow-up care in the primary care setting. These communication problems resulted in
GPs being unsure if they could safely deprescribe medications commenced in hospital.
Several participants also commented on the practice of deprescribing many
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medications while patients were admitted to hospital. They noted that they were not
consulted prior to such decisions being made and sometimes medication regimens
needed to be re-established after their patients were discharged because of poor pain
and symptom control.
‘If a patient gets in into the hospital and a geriatrician might cease a whole lot of
medications thinking they’re doing the right thing, and then come out and they’re
on no pain medication or they’re just not – their symptoms are not
controlled….the hospital has decided – okay, “because you’re polypharmacy, let’s
just cease everything.”’ GP 5
GPs also commented on sources of poor communication about medications with
prescribers in the primary care setting. They mentioned delays in letters coming from
specialist prescribers to communicate medication changes and their rationale. Less
experienced participants were more likely to be working in bulk billing medical
centres and commented that their patients often saw more than one GP within the
centre. They noted that because of this, it was often difficult to be sure of the accuracy
of the patient’s medication list and the indications for medications and these were not
always updated. In addition there was no longer one point of contact for hospitals,
pharmacists and specialists. These factors, and not having a good understanding of the
patient’s history and preferences made it hard for them to manage medications,
including to deprescribe.
The participants also discussed their communications with community pharmacists
involved in the care of their older patients. Two GPs, who had a pharmacist working in
the same building as the practice had established good communication and felt this
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enabled them to make medication changes, confident that these could be acted on
quickly. Additionally some participants spoke positively of the role of pharmacists in
prompting patients to go to their GP to have a medication related issue properly
investigated or in picking up prescribing errors. As noted earlier, community
pharmacists were valued by some GPs to conduct formal medication reviews.
However, for most there was not such a close relationship and communication
problems often arose, for example negotiating changes to blister packaged
medications when prescribing, deprescribing or altering doses and avoiding generics
to minimise patient confusion. Furthermore, participants noted that some patients
used more than one pharmacist, again hampering communication. Others noted times
when pharmacists gave unhelpful advice about side effects, causing patients to worry.
‘When they arrive at the pharmacy, and the pharmacist gives them a printout of
all the side effects with no explanation that side effects do not universally
accompany every prescription of this drug, and sometimes they won't take them
as a result, but they don't tell you they haven't taken them.’ GP 8
2.3.3 Inadequate funding and time
The participants in the interviews made it clear that they often felt as though they had
insufficient time in consultations to consider deprescribing because of the complex
needs of their older patients and they discussed the ways they attempted to work
around this. These qualitative findings unpack some of the reasons why most GPs
noted in the earlier survey that they lacked time to regularly review all of their older
patients’ medications.
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All participants mentioned the limited time they could spend with their older patients
and, linked to this, the inadequate funding for primary care in Australia. In practice
this meant that longer term medication management planning, including
deprescribing was sometimes put off, in the hope it could be addressed during a later
consultation. This finding confirms an earlier Australian study (Anderson et al., 2017)
and international studies suggesting that, regardless of the country under study, short
consultation times are a barrier to providing medication management, including
deprescribing for older patients, (Bell et al., 2015, Linsky et al., 2015b, Sinnott et al.,
2015, Wallis et al., 2017).
Some participants worked around short times in consultations by asking patients to
book longer appointments or to return for multiple follow-up appointments to
address complex medication management issues. They recognised that access to
attend multiple appointments for their frailer older patients was sometimes a barrier,
again because of the lack of funding to support programs such as community
transport for community living older adults. However, this reduced access may come
at a time when careful medication management is most needed. Only one mentioned
doing home visits to those who could not easily access GP services. This GP was
located in a semi-rural area that was not well covered by an after-hours GP service.
‘Longer term planning time isn’t as available….the reviews are prioritised by them
because often they might have issues either getting in or accessing
healthcare….they might not be as ready for you to say you’re coming in every
fortnight so that we can actually get on top of things…. and often when they are
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more unwell, consults take longer to do, so you’ve got less time to actually focus
on other things.’ GP 1
The impact of short consultations on deprescribing action confirmed the results of
previous qualitative studies (Anderson et al., 2017, Linsky et al., 2015b, Wallis et al.,
2017). This finding contradicted the unclear results from the earlier GP survey. The
survey item pertaining to this factor suggested that many GPs thought there was
enough time to deprescribe. This item has been amended in the revised survey as it
appears to be producing results that are inconsistent with those of multiple qualitative
studies (See Appendix L).
2.3.4 Poor access for frail older adults
Several participants commented on the lack of in home support services available in
Australia to frailer community living older adults. They observed this had an impact
on their medication management decisions, including deprescribing, as they could not
be confident that their older patients would be able to manage their medications or
were being monitored, for instance after medications had been deprescribed. Others
worked unpaid hours to try to coordinate medication management themselves, in the
absence of these other services.
“Right, what are you taking?” and they don't know and then you have to ring the
chemist….. –I don't get paid for calling the chemist or calling the specialist or
chasing things up. It's like all time at the time at the end of my day, away from
family, uncompensated, just for the safety of the patient.’ GP 6
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3. Conclusion
GPs’ management strategies for their older multimorbid patients remained focused on
finding the right pharmaceutical medication regimen, suited to the needs of their
individual patient. Strategies for achieving this varied. Deprescribing was only one
strategy used, with other strategies focused on continued prescribing of
polypharmacy, albeit sometimes with altered doses. When establishing an appropriate
individual regimen, clinical judgement was privileged over knowledge gained from
research, such as recommendations regarding polypharmacy use in older age.
Deprescribing appeared hard for many participants to incorporate in practice. They
needed to manage complex medication regimens in the context of a very structured
healthcare environment with limited consultation times and input into care decisions
from multiple sources for example, specialists, hospital based prescribers, other GPs
and community pharmacists. The GP participants found the complexity of medication
management for their older patients very difficult to manage because of the need to
balance competing priorities, patient, and sometimes family preferences, and noted a
lack of suitable research evidence to guide practice.
Attitudes toward older adults and an understanding of their everyday circumstances
and capabilities, including health literacy, varied. Some GPs described their older
patients’ as having limitations in their understanding of their medications, medication
management capabilities and information seeking, using examples which would
typically be used to describe someone with low health literacy. This view resulted in
them taking on decision making themselves and limiting opportunities for patient
involvement in shared decision making. In contrast, others who held more positive
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views of their older patients’ capabilities actively encouraged participation in shared
decision making, encouraging patients to express their preferences, providing helpful
information on potential risks and discussing options to deprescribe.
Much variation was noted in this sample in attitudes toward older adults, approaches
to shared decision making, definitions of polypharmacy, approaches to medication
reviews and medication management in general. This suggests that there is a potential
for older Australians to receive markedly different medication management, including
approaches to deprescribing and involvement in decision making, depending on
which GP they attend.
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Chapter 7 Older adult quantitative study
1. Introduction
The results of the older adult quantitative survey findings are presented in this
chapter. These results are also reported in the publication Attitudes toward
deprescribing and the influence of health literacy among older Australians, Primary
Health Care Research and Development 2019 (see Appendix A). The purpose of this
survey was to investigate attitudes toward deprescribing in a sample of community
living Australians, who were aged 65 or over and using polypharmacy. Results for
items measuring attitudes toward deprescribing were correlated against health literacy
levels to determine if there were any significant relationships between these two
attributes.
In this study arm, the following research objectives were explored from the
perspective of community living older adults using polypharmacy:


How does the healthcare environment influence deprescribing discussions?



What is the role of health literacy in managing polypharmacy and making
decisions about deprescribing?



What, if any, is the relationship between attitudes to medication use, age
cohort or socio-economic status and the likelihood of discussions about
polypharmacy and deprescribing.

The methods used in the design of the study have been described in Chapter 4, section
4.2.
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2. Results
A total of 187 respondents returned the survey, suggesting a 25.1% response rate if all
745 surveys were distributed. This response rate compares well with evidence that
27.9% is an average response rate for paper based surveys (Guo et al., 2016). Fifty
survey responses were excluded from the final analysis because respondents were less
than 65 years old, gave no indication of their age and/or number of prescribed
medications, or were taking fewer than five prescription medications. Data quality was
high. For the first 10 items of the PATD questions the median percentage of missing
responses per item was 1.0% (range 0.0–4.4%) and for the AAHLS items the median
percentage missing was 1.5% (range 0.7%–5.1%).
Table 1 presents the demographic characteristics of the 137 respondents included in
the analysis. The median age of respondents was 76 years which included more
females (60.5%) than males. The ratio of males to females, aged 65 years or over, in
Australia, in 2016 was 86:100 (Australian Bureau of Statistics, 2017). However, the
ratio in this sample was 63:100 indicating that this sample had a higher number of
females than expected. Respondents reported using a median of seven medications
and were living with a median of three self-reported diseases. Over two thirds (66.4%)
responded as having good to excellent health and most (76.6%) reported experiencing
a good to excellent quality of life (QoL).
The majority of respondents were born in Australia (73%) which is a slightly higher
proportion than expected given that, nationwide, 63% of those aged 65 or older were
born in Australia (Australian Institute of Health and Welfare, 2018b). A further 20.4%
of the sample had emigrated from English speaking countries. This reflects data of
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Australia’s population by country of birth and the higher median age of immigrants
from English speaking countries. For example, immigrants to Australia from England
remain the largest group of immigrants (4% of the total population) and they make up
a larger proportion of Australia’s older adult population having a median age of 56
(Australian Bureau of Statistics, 2019a). This explains the higher percentage of
immigrants from English speaking countries in this sample.
More than half the sample (51.1%) had completed a non-school qualification such as a
certificate, diploma or degree. Once again, this is higher than the national average of
40% (Australian Bureau of Statistics, 2017). Respondents resided in locations which
were almost evenly distributed between high (48.9%) and low (50.4%) SEIFA. Only
one in five lived in inner regional locations, as defined by the Australian Statistical
Geography Standard (ASGS), with the remainder (79.6%) living in a major city. This is
slightly higher than the average across Australia where 70.9% live in a major city
(Bureau of Infrastructure Transport and Regional Economics, 2019).
In summary, this sample were more likely to be female, educated, Australian born and
living in a major city compared to national statistics. No significant associations were
found between individual respondent characteristics (listed in Table 7.1) and
willingness to stop medications.
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Table 7.1 Older adult demographic characteristics
Respondent
n=137 (%)

Characteristic
Age (years), median (IQR)
Gender
female
male
missing
Number of medications (median) (IQR)
Number of illness (self-report) (median) (IQR)

76 (73–83)
83 (60.5)
52 (38.0)
2 (1.5)
7 ( 5–9)
3 (2–4)

Self-reported health status
very good or excellent
good
fair or poor
missing

30 (21.9)
61 (44.5)
42 (30.7)
4 (2.9)

Self-reported QoL
very good or excellent
good
fair or poor
missing

54 (39.4)
51 (37.2)
29 (21.2)
3 (2.2)

SEIFA decile
high
low
missing

67 (48.9)
69 (50.4)
1 (0.7)

Location (ASGC)
city
inner regional
missing

109 (79.6)
27 (19.7)
1 (0.7)

Highest education completed
primary or less
high school (year 10 or below)
high School (year 12 complete)
TAFE/Trade/Apprenticeship
university or higher
missing

3 (2.2)
48 (35.0)
13 (9.5)
41 (29.9)
29 (21.2)
3 (2.2)

Country of birth
Australia
UK/Ireland
Europe
N.Z.
Other
missing

100 (73)
25 (18.2)
5 (3.6)
3 (2.2)
1 (0.7)
3 (2.2)

Abbreviations:
QoL quality of life
IQR: interquartile range

ASGC: Australian Statistical Geography Standard
SEIFA: Socio-Economic Index For Areas.
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2.1 Responses to the Patients’ Attitudes Toward Deprescribing (PATD) questions 1–10
The PATD questionnaire measures medication users’ attitudes toward deprescribing
and polypharmacy (Reeve et al., 2013a). The PATD responses for questions one to ten
(Figure 7.1) show that almost half of the respondents strongly agreed/agreed (49%)
that they were taking a large number of medications. However, the majority of them
were comfortable with the number they were taking (80%) and believed they were
necessary (80%). Nearly all respondents (91%) believed that they understood why they
were taking their medications and most (74%) agreed that they would accept taking
more medications if required. While polypharmacy use in older age has been
problematised (Fried and Mecca, 2019), these results indicate that the majority of
respondents were unconcerned about their use of five or more medications.
Most respondents were unsure or disagreed (82%) that they were taking unnecessary
medications and yet 88% agreed that they would be willing to stop one or more of
their medications, if their doctor thought it possible (Figure 7.1). This result aligns
with previous research conducted in community living older adults using
polypharmacy in other countries (Ng et al., 2017, Schiøtz et al., 2018, Tegegn et al.,
2018, Turner et al., 2019). Importantly, over half (56%) agreed that they would like to
reduce the number of medications they were taking. Approximately one fifth of the
respondents (22%) agreed that their medications were giving them side effects and a
similar proportion (20%) agreed that the opportunity to reduce costs would impact on
their willingness to stop one or more medications. Clearly, there were several potential
motivators for deprescribing for the respondents, the most notable being their
doctor’s suggestion to stop a medication/s. The importance of these motivations will
be further explored in the subsequent older adult qualitative study.
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Figure 7.1 PATD responses, questions 1–10 (Likert scale items)
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2.2 Responses to the PATD questions 11–13
The results for the remaining questions in the PATD (questions 11–13), shown in Table
7.2, suggest that less than half of the respondents (45.3%) reported having actually
stopped a medication in the past. Perceptions of what constituted ‘a lot’ of
medications varied, with almost one third (32.1%) considering 5–9 medications was ‘a
lot’ and a greater proportion (41.6%) considering that 10–14 was ‘a lot.’ The majority of
respondents (62.7%) indicated that that they would be comfortable taking eight
medications per day. Once again, these results of the respondents’ attitude to taking
multiple medications suggest that their view of an appropriate number of medications
may vary from common definitions of polypharmacy used in research literature. This
variation is similar to that noted within the GP qualitative study, where a number of
different numerical descriptions of polypharmacy were given.
Table 7.2 PATD responses (questions 11–13)
PATD responses (questions 11–13)
Q. 11 Have you ever tried to stop a regular
medication
Q. 12 How many tablets/capsules taken each
day would you consider to be a lot?

Q. 13 What is the maximum number of
tablets/capsules that you would be
comfortable taking in one day? (Pictorial
response options)

Answer
Yes
No
Missing
5–9
10–14
15–19
20
Missing
4
8
12
16
20
24
Missing

N (%)
62 (45.3)
74 (54.0)
1 (0.7)
44 (32.1)
57 (41.6)
21 (15.3)
10 (7.3)
5 (3.6)
35 (25.5)
51 (37.2)
31 (22.6)
5 (3.6)
2 (1.5)
2 (1.5)
11 (8.0)

157

2.3 Additional questions 14–17
Four additional questions (questions 14–17) were added at the end of the original
PATD measure. These further explored the role of actual medication costs and
investigated the respondents’ experiences of primary care management of their
medications. The results are presented in table 7.3.
Table 7.3 Responses to questions 14–17
Additional questions 14–17

N

(%)
Q. 14 In the past 12 months, have you delayed
or not bought one or several medications
because you needed to spend your money on
other items?

Yes

Q. 15 In the past 12 months, has your doctor
taken time during a consultation to check all
the different medications you are using,
including medication prescribed by other
medical doctors?

Yes

90 (65.7)

No

42 (30.7)

Missing

5 (3.6)

Q. 16 In the past 12 months, how often did
your doctor involve you in decisions related to
your medications?

Rarely

21 (15.3)

No
Missing

128 (93.4)
5 (3.6)

Sometimes 41 (30.0)
Often

57 (41.6)

N/A

10 (7.3)

Missing
Q. 17 Does your doctor allow you enough time
to discuss your feelings, fears or concerns
about new medicines or medicines you may
have been taking for some time?

4 (3.0)

Rarely

8 (5.8)
13 (9.5)

Sometimes 39 (28.5)
Often

73 (53.3)

N/A

7 (5.1)

Missing

5 (3.6)

N/A Not applicable
As polypharmacy rates continue to increase, costs may become a greater burden and
this could motivate medication users to deprescribe. However, only 3% of respondents
noted that they had delayed accessing medication because of the need to prioritise
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other purchases. That result is less than the 6.8% of older Australians who reported
out of pocket cost as a contributor to poor adherence in a national cross-sectional
survey (Morgan and Lee, 2017). Controlling medication related costs may be an
important motivation to stop medication for older adults in countries where
prescription costs are not subsidised to the same extent as in Australia (Morgan and
Lee, 2017, The Commonwealth Fund 2017). However, cost considerations should not
be the basis on which deprescribing decisions are made, either by older adults or their
GPs.
The results, shown in table 7.3, highlight that most (65.7%) recalled their doctor
checking their medication in the past 12 months. Just over half (53.3%) believed that
their doctors often allowed for enough time to discuss their feelings, fears and
concerns about their medications and 41.6% believed that their doctor often involved
them in decisions about their medication(s). These results differ somewhat from the
earlier GP survey where 66.3% agreed that they ask their older patients what their
preferences are regarding continuation or deprescribing of medications. Similarly,
64.3% agreed that their older patients preferred to share the responsibility for making
decisions about medications.
The extent of and perception of shared decision making during medication
management has been explored further in both the GP qualitative study (Chapter 6)
and the older adult qualitative study (Chapter 8).
2.4 Association between number of medications taken and PATD items
Analysis was undertaken to investigate if there were any correlations between two
groups of medication users: those taking 5–9 medications and those taking ≥10 or
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more and responses to the first ten PATD items (See Table 7.4). Those who were using
ten or more were significantly more likely to want to reduce the number of
medications taken, felt that they were taking a large number of medications, and that
they were taking medications they no longer needed. They were also significantly
more likely to feel that one or more of their medications were giving them side effects.
In contrast, respondents in the group taking five to nine medications were
significantly more likely to be comfortable with the number of medications they were
taking, more likely to believe that all their medications were necessary and more likely
to understand why they were taking their medications. While it was not statistically
significant, all the respondents taking ten or more medications were willing to
consider stopping one or more of their regular medications.
While these results suggest that those using more medications were more likely to be
motivated to consider deprescribing, further research is required to understand in
more detail why this difference exists between those who use five to nine medications
and those who use more. This was further investigated in the qualitative arm of the
study (Chapter 8).
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Table 7.4 Differences in responses to PATD items and polypharmacy status
PATD item

5–9 medications
N (%) agreed/
strongly agreed **

p-value

46 (44.2)

≥10 medications
N (%) agreed/
strongly
agreed**
21 (77.8)

I feel that I am taking a large
number of medications.
I am comfortable with the
number of medications that
I am taking.
I believe that all my
medications are necessary.
If my doctor said it was
possible, I would be willing to
stop one or more of my regular
medications.
I would like to reduce the
number of medications that I
am taking.
I feel that I may be taking one
or more medications that
I no longer need.
I would accept taking more
medications for my health
conditions.
I have a good understanding of
the reasons I was
prescribed each of my
medications.
Having to pay for fewer
medications would play a role
in my willingness to stop one or
more of my medications.
I believe one or more of my
medications is giving me side
effects

90 (84.1)

19 (63.3)

p=.015*

89 (83.2)

20 (66.7)

p=.042*

91 (85.0)

30 (100.0)

p=.062

56 (52.3)

21 (72.4)

p=.019*

13 (12.1)

11 (37.9)

p=.008*

78 (73.6)

23 (76.7)

p=.350

101 (95.3)

23 (76.7)

p=.003*

22 (21.0)

5 (17.2)

p=.986

19 (17.9)

11 (36.7)

p=.042*

p=.005*

*Mann-Whitney is significant at the p<0.05 level
**Proportions are included to assist with the interpretation of the results
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2.5 Relationship between PATD items and the willingness to stop or reduce medications.
The current study investigated if there was an association between a willingness to
stop medication/s and the first 10 PATD items (Table 7.5). The results highlight that
there was a positive correlation between willingness to stop and a desire to reduce the
number taken. However, there was also a positive correlation between willingness to
stop and accepting more medications to manage health conditions. This later
unexpected positive correlation may suggest that the item measuring willingness to
consider stopping is more closely measuring the respondents’ trust or willingness to
accept their doctor’s advice, rather than measuring the acceptance of taking more
medication or of stopping. The role of trust was explored in the later older adult
qualitative study.
When considering an association between the respondents’ desire to reduce the
number of their medication(s) and the first 10 PATD items (Table 7.5). There was a
positive correlation between wanting to reduce medications and feeling that they were
taking a large number of medications, taking a medication that is no longer needed
and experiencing side effects. Negative correlations were noted between wanting to
reduce medications and being comfortable with the number taken and believing that
all current medications were necessary.
It should be noted that most correlations were weak. There was only one moderate
correlation (r2 .442) between wanting to reduce the number of medications and taking
one or more medications that may no longer be needed (Table 7.5).
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Table 7.5 Associations between PATD responses
PATD item

If my doctor said it was
possible, I would be
willing to stop one or
more of my regular
medications.
rs.065, p<.462

I feel that I am taking a large
number of medications.
I am comfortable with the
number of medications that
I am taking.

I would like to reduce
the number of
medications that I am
taking
rs .299, p< .001*

rs -.004, p<.966
rs -.335, p<.000*

I believe that all my
medications are necessary.
If my doctor said it was
possible, I would be willing to
stop one or more of my regular
medications.

rs -.003, p<.977

rs -.256,p< .003*

____

rs.194, p< .024*

I would like to reduce the
number of medications that I
am taking.

rs.309, p< .000*

I feel that I may be taking one
or more medications that
I no longer need.

rs.094, p< .277

I would accept taking more
medications for my health
conditions.

rs.194, p< .024*

I have a good understanding of
the reasons I was
prescribed each of my
medications.
Having to pay for fewer
medications would play a role
in my willingness to stop one or
more of my medications.
I believe one or more of my
medications is giving me side
effects

rs.133, p< .123

r2 Spearman correlation

____

rs.442, p< .000*

rs -.154, p< .075

rs -.076, p< .378
rs -.069, p< .429
rs.153, p< .077
rs -.046, p< .595
rs.288, p< .001*

* Spearman’s correlation is significant at the p<0.05 level.

Interpretation of r values (Dancey and Reidy, 2007)
Strength of relationship: ±0.1 to ±0.3 weak, ±0.4 to ±0.6 moderate, ±0.7 to ± 0.9, strong, ±
1 perfect
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2.6 Responses to the All Aspects of Health Literacy Scale (AAHLS) questionnaire
The AAHLS attempts to assess multiple dimensions of health literacy including
functional, communicative and critical health literacy skills (Chinn and McCarthy,
2013) (See Older adult survey tool Appendix F). As noted in the methods chapter
(Chapter 4, section 4.2), the functional health literacy items in AAHLS measure
reading and writing skills and the ability to access support networks when reading
and/or writing skills are limited (Items 18–20). The communicative health literacy
items measure information gathering and interactive skills required to consult with
health practitioners (Items 21–23). Critical health literacy items measure respondents’
information appraisal skills in assessing the relevance, reliability, credibility and
validity of health information (Items 24–27) (Chinn, 2011, Chinn and McCarthy, 2013).
Very small numbers of respondents noted ‘rarely’ when asked about practices relating
to functional health literacy and communicative health literacy. However, when asked
about critical health literacy practices, larger numbers reported that they rarely or
only sometimes used these skills (Table 7.6).
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Table 7.6 Responses to AAHLS items (Survey questions 18–27)
AAHLS item

Often
N (%)

Sometimes
N (%)

Rarely
N (%)

Missing
N (%)

Q 18. How often do you
need someone to help you
when you are given
information to read by
your doctor, nurse or
pharmacist?
Q 19. When you need help,
can you easily get hold of
someone to assist you?
Q 20. Do you need help to
fill in official documents?
Q 21. When you talk to a
doctor or nurse, do you
give them all the
information they need to
help you?
Q 22. When you talk to a
doctor or nurse, do you ask
the questions you need to
ask?
Q 23. When you talk to a
doctor or nurse, do you
make sure they explain
anything that you do not
understand?
Q 24. Are you someone
who likes to find out lots
of different information
about your health?
Q 25. How often do you
think carefully about
whether information
makes sense in your
particular situation?
Q 26. How often do you try
to work out whether
information about your
health can be trusted?
Q 27. Are you the sort of
person who might
question your doctor or
nurse’s advice based on
your own research?

117 (85.4)

13 (9.5)

4 (2.9)

3 (2.2%)

99 (71.5)

25 (18.2)

7 (5.1)

7 (5.1)

106 (77.4)

23 (16.8)

6 (4.4)

2 (1.5)

117 (85.4)

17 (12.4)

1 (0.7)

2 (1.5)

95 (69.3)

39 (28.5)

2 (1.5)

1 (0.7)

102 (74.5)

29 (21.2)

5 (3.6)

1 (0.7)

71 (51.8)

51 (37.2)

14 (10.2)

1 (0.7)

64 (46.7)

53 (38.7)

19 (13.9)

1 (0.7)

36 (26.3)

49 (35.8)

51 (37.2)

1 (0.7)

16 (11.7)

46 (33.6)

74 (54.0)

1 (0.7)
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Most respondents demonstrated higher summed scores on both the functional (Fig
7.2a) and communicative subscales (Fig 7.2b), whereas summed critical health literacy
subscale scores (Fig 7.2c) were more variable. This patterning of scores across the
three domains is similar to that seen in a study of chronically ill patients conducted in
the Netherlands (Heijmans et al., 2015). Overall summed scores for the AAHLS (Fig
7.2d), as a whole, also indicated variability among respondents.
The high scores on the functional health literacy scale contradicted previous studies
conducted among older adults in the United States using the Short Test of Functional
Health Literacy in Adults (S-TOFLA) (Baker et al., 2000, Wolf et al., 2010) and in
England using a brief four item scale (Bostock and Steptoe, 2012). Both these studies
measured comprehension of text. Whereas the functional health literacy subscale in
the AAHLS asks how often help is required to read health information or to fill in
forms. Perhaps this difference explains the higher functional health literacy scores
seen in the current study. To our knowledge, the AAHLS has not been used in another
older adult population so further comparisons were not possible.
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Figure 7.2 Distributions of health literacy scores
Figure 7.2a Summed functional health literacy scores

Figure 7.2b Summed communicative health literacy scores
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Figure 7.2c Summed critical health literacy scores

Figure 7.2d Overall health literacy scores
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2.6.1 Relationship between PATD items and summed health literacy scores
Table 7.6 highlights the significant correlations between health literacy scores and
PATD items. Significant correlations were weak to moderate. The findings indicate
that willingness to consider stopping medication/s correlated with higher scores on
the critical health literacy subscale (P<.021) and the summed over-all score (P<.009).
A number of other positive correlations between responses were noted. There was a
positive correlation between having a good understanding of the reason medications
had been prescribed and each of the subscales of health literacy (functional,
communicative, critical) and overall health literacy score. Further positive correlations
were noted between functional health literacy score and being comfortable with the
number of medications taken and believing that all medications were necessary.
Communicative health literacy score was positively correlated with a willingness to
accept taking more medications. In addition, there was a positive correlation between
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willingness to stop one or more medications and both critical health literacy score and
overall AAHLS score. A further positive correlation was noted between overall AHHLS
score and believing that all medications were necessary. In contrast, there was a
negative correlation between both functional and communicative health literacy
scores and feeling that that one or more medication/s may no longer be needed (Table
7.7).
The current study’s findings of an association between health literacy and attitudes
toward deprescribing contradict the findings of a Danish survey (Schiotz et al. 2018).
Schiotz et al. (2018) used a different measure of health literacy: four items from the
Australian Health Literacy Questionnaire, which may have led to the different finding.
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Table 7.7 Relationship between PATD and summed health literacy scores
PATD item
I feel that I am taking
a large number of
medications.
I am comfortable with
the number of
medications that I am
taking.
I believe that all my
medications are
necessary.
If my doctor said it
was possible, I would
be willing to stop one
or more of my regular
medications.
I would like to reduce
the number of
medications that I am
taking.
I feel that I may be
taking one or more
medications that I no
longer need.
I would accept taking
more medications for
my health conditions.
I have a good
understanding of the
reasons I was
prescribed each of my
medications.
Having to pay for
fewer medications
would play a role in
my willingness to stop
one or more of my
medications.
I believe one or more
of my medications is
giving me side effects

Spearman Correlation.

Functional
rs =-.064,
p  .479

Summed Health Literacy Scores
Communicative
Critical
rs =-.030, p  .735 rs = .083, p  .345

Overall
rs = .020,
p  .830

rs = .206,

rs = .037,

rs = -.010,

rs = .095,

p  .019*

p  .671

p  .904

p  .286

rs = .268,

rs = .152,

rs = .036,

rs = .182,

p  .002*

p  .078

p  .679

p  .039*

rs = .038,

rs = .164,

rs = .198,

rs = .229.

p  .673

p  .057

p  .021*

p  .009*

rs = -.059,

rs = -.009,

rs = .145,

rs = .093,

p  .508

p  .916

p  .094

p  .294

rs =-.244,

rs = -.266,

rs = -.003,

rs = -.156,

p  .005*

p .002*

p  .970

p  .078

rs = .120,

rs = .316,

rs = -.156,

rs =-.007,

p  .176

p  .000*

p  .070

p  .936

rs = .336,

rs = .203,

rs = .170,

rs = .324,

p  .000, *

p  .019*

p  .048*

p  .000*

rs = -.118,

rs = -.146,

rs =- .003,

rs = -.069,

p  .186

p  .094

p  .973

p  .443

rs = -.031,

rs = -.130,

rs =-.050,

rs = -.071,

p  .731,

p  .134

p  .561

p  .426

*Correlation is significant at the p< 0.05 level.

Interpretation of r values (Dancey and Reidy, 2007)
Strength of relationship: ±0.1 to ±0.3 weak, ±0.4 to ±0.6 moderate, ±0.7 to ± 0.9, strong, ±
1 perfect
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Functional health literacy is fundamental to being able to access and understand
written medication information, such as prescription labels or Patient Information
Leaflets (Wali et al., 2016). This was reflected in the current study with a higher
functional health literacy score positively correlating with reporting a good
understanding of the reasons for each medication and being less likely to report taking
a medication that was perceived to be no longer needed. These findings highlight that
written medicines information, given as a part of any prescribing/deprescribing
process, should keep in mind the functional literacy needs of older adults (Mullen et
al., 2018).
Most health literacy research assesses patients’ interactions with written material,
even though verbal communication regarding medication information is the preferred
option for many (Hamrosi et al., 2014). A Higher communicative health literacy score
among the respondents was associated with having a good understanding of
prescribed medications and being willing to accept more medications to manage
health problems. In contrast, a lower score on this subscale was associated with taking
a medication that was perceived to be no longer needed. These results support the
evidence that actively involving patients in verbal communications about their
medications is important to facilitate a patient centred approach (Street, 2017) and is
key to understanding patients’ preferences and expectations regarding the ongoing
appropriateness of their medications (Reeve et al., 2014).
It is notable that higher overall AAHLS scores were positively correlated with
understanding the reasons for medications being prescribed, participating in the
decision making process and recalling a medication review. All of these factors are
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likely to be supportive of older adults’ engaging with their healthcare provider to
discuss deprescribing as a possible medication management strategy. Earlier
qualitative studies conducted with GP participants suggested that older adults had a
poor understanding of their medications due to old age or a lack of education (Linsky
et al., 2015b, Schuling et al., 2012). However, the current study results indicate that
older adults hold a different opinion of their capacity to understand their medications.
This has implications for practice, demonstrating older adults’ capacity to engage in
shared decision making and supporting the current emphasis on incorporating shared
decision making into deprescribing processes (Jansen et al., 2016, Reeve et al., 2014).
The critical health literacy results found in the present study are difficult to interpret,
which may in part be due to problems in defining and measuring the concept of
critical health literacy (Chinn, 2011, Chinn and McCarthy, 2013). Nutbeam (2000) and
Ishikawa et al.(2008) define critical health literacy as a distinct skill which implies
measurability. However, others such as Rubinelli (2009) define it as a capacity which
would preclude objective measurement. The critical health literacy items in the
AAHLS tool were based on Ishikawa’s scale (Ishikawa et al., 2008) and were designed
as a screening tool (Chinn and McCarthy, 2013). As such, the results measure the
extent to which respondents engage in critical appraisal of information and do not
give any further insight into how, or indeed if, individuals apply this knowledge to
make sense of decisions about their health. How older adults might use or apply
critical health literacy skills when considering stopping medications therefore remains
unknown and will be investigated further in chapter 8.
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Relationships between the PATD questions 11–13, the additional questions and
summed overall AAHLS score were also investigated. Recalling a medication review
(U= 1083.50, p = .0031), believing there was enough time in consultations (rs =196,
p=.031) and being involved in medication decision making (rs =198, p=.027) were
associated with higher overall summed health literacy scores. There were no
significant associations found with other items (Table 7.8).
Table 7.8 Relationship between PATD questions (11–13), additional questions
(14–17) and overall health literacy score
PATD responses (questions 11–13)

Mann-Whitney a or

P value

Mantel-Haenszel b
value
Have you ever tried to stop a regular
medication
How many tablets/capsules taken each day
would you consider to be a lot?
What is the maximum number of
tablets/capsules that you would be comfortable
taking in one day?

1844.50a

.348

1.438 r= .108b

.230

0.60 r=.023b

.806

Experiences with Primary Health Care Questions
(questions 14–17)
In the past 12 months, have you delayed or not
bought one or several medications because you
needed to spend your money on other items?
In the past 12 months, has your doctor taken
time during a consultation to check all the
different medications you are using, including
medication prescribed by other medical
doctors?

171.00a

.326

1083.00a

.001*

In the past 12 months, how often did your
doctor involve you in decisions related to your
medications?

4.549 r=.194b

.033*

Does your doctor allow you enough time to
discuss your feelings, fears or concerns about
new medicines or medicines you may have
been taking for some time?

5.138 r=.204b

.023*

*Correlations significant at  0.05 level a Mann-Whitney statistics B Mantel-Haenszel statistics
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2.6.2 Individual characteristics and overall summed health literacy score.
Summed overall AAHLS scores were investigated to identify if there were any
associations between health literacy capabilities and individual respondent
demographic characteristics. Respondents with lower overall AAHLS scores were
significantly more likely to be in the group using 10 or more medications (U= 921.50, p
= .003) and were significantly more likely to self-report a poorer quality of life (X2 (2)
= 7.241, p  .027) and a poorer health status (X2 (2) = 6.698, p  .035). No other
significant associations were found between overall AAHLS scores and characteristics,
including gender, location of residence, SEIFA decile, country of birth and completed
education levels.
These findings are consistent with previous research which found low health literacy
levels to be an independent indicator for low self-rated health status among older
adults (Bennett et al., 2009) and poorer quality of life (Panagioti et al., 2018). It is not
possible to determine from our results the direction of this relationship. Poorer quality
of life and lower overall health may be contributing to lower health literacy scores or
vice versa. Recent definitions regard health literacy as a dynamic skill that is
changeable through the life course so it is possible that the direction of this
relationship may also change (Squiers et al., 2012).
As no significant correlations were noted between socio-economic status and
education in the present study, these factors do not appear to influence health literacy
scores in this sample. These findings are in contrast to other studies, which found that
education status and indicators of socio-economic position were associated with
health literacy level among older adults (Bostock and Steptoe, 2012, Wolf et al., 2010).
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Use of the AAHLS scale with a larger sample is therefore recommended in order to
test this finding.

4. Conclusions
Most respondents (88%) demonstrated a positive attitude toward deprescribing and
would be willing to stop medication/s in the context of receiving this advice from their
doctor. However, it is unclear from the results if this item is accurately measuring
willingness to deprescribe. This research found that opportunities for respondents to
proactively consider deprescribing may be missed as one third could not recall a
recent review of their medications. Older adults who are using polypharmacy are
generally comfortable with their medications and experience few concerns. However,
they may express an interest in stopping one or more of their medications in order to
reduce the number they are taking, especially those who are using ten or more. Costs,
experiencing side effects, or believing that medication/s may be unnecessary may
result in a desire to reduce the number of medications taken.
The relationship between attitudes toward deprescribing and health literacy was
previously unexplored. Higher health literacy scores were associated with key aspects
such as involvement in decision making, knowledge of medications and willingness to
stop. Appropriate written and verbal communications about medications and
providing information on trusted websites are likely to be important to allow all older
adults to understand and access the information they require to participate in
medication management decisions. Involving older adults in regular reviews of the
ongoing appropriateness of current medications may allow opportunities to discuss
and plan deprescribing proactively.
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Chapter 8 Older adult qualitative study
1. Introduction
This chapter presents the results from the qualitative study arm conducted to examine
the attitudes of community living older adult polypharmacy users toward the
management of their medications, including deprescribing. The results indicate that
attitudes toward medication use vary, however, medication use in older age was
expected, shaped by stereotypical views of expected poor health in older age. Despite
some negativity participants adopted a pragmatic approach to medication use,
recognising their overall benefit. This perception was reinforced by their prescriber’s
continued use of medications in their treatment.
Participants were trusting of their prescribers’ decisions regarding their medications.
Most were content to ask few questions during consultations. This has implications for
shared decision making. Searching for and accessing medication information from a
variety of sources, including the internet was common. Most often health literacy
skills were used in practice between consultations in the work undertaken to manage
complex regimens and medication side effects but was generally not applied during
consultations.
The following research objectives were explored from the perspective of the older
adult participants:


How does the structure of the healthcare environment in primary care in
Australia facilitate or impede discussions about polypharmacy and
deprescribing between older adults and their GP?

177



What is the relationship between perceptions of ageing and the likelihood of
discussions about polypharmacy and deprescribing?



What is the role of health literacy in managing polypharmacy and making
decisions about deprescribing?



What, if any, is the relationship between attitudes to medication use, age
cohort, socio-economic status and the likelihood of discussions about
polypharmacy and deprescribing?

The use of a sequential mixed methods approach was described in chapter 4. As noted
there and in chapter 6, this approach has allowed different aspects of the research
question to be investigated and for results across the different methodologies to be
considered alongside each other. Specifically, this study arm sought to gain more
insight into why quantitative studies of older adult attitudes toward deprescribing,
including the quantitative arm included in this work, all find that a majority of older
adults would be happy to consider deprescribing if their doctor recommended it. The
exploration of the influence of health literacy on deprescribing and the management
of polypharmacy, begun in the earlier older adult quantitative arm was also explored.
Participants’ health literacy practices were examined via their descriptions of their
interactions with their GP and specialists regarding medications and of their day to
day management of medications.
These results were able to add data from the perspective of Australian community
living older adults, building on a considerable number of qualitative studies conducted
elsewhere, mostly in Europe (see literature review Chapter 2).
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2. Results
Twenty-five older adults were interviewed and their characteristics are noted in Table
8.1. Seven were aged between 65 and 75 years while the remainder (18) were aged over
75 years. They were using between 5 and 25 medications. The number of medications
used was assessed based on the self-report of the participant, supported by the
inspection of printed medication lists, dosette boxes or blister packs and sometimes a
visual inspection of medication packages and bottles in their home. All participants
managed their medications independently, without the involvement of caregivers,
either paid or family members. However, the eldest two participants did have their
medications delivered weekly from their local pharmacy. Of those residing in high
SEIFA areas, all were born in Australia. No other patterns were noted.
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Table 8.1 Older adult interview participant characteristics
Participants
Male
Female
SEIFA decile of residence
High
Low
Age range
Median age
Country of birth
Australia
UK/Ireland
Europe
Marital Status
Married
Widowed
Single
Number of medications
5–9
≥10
Self-reported health status
Poor
Fair
Good
Very good
Excellent
Self-reported quality of life
Poor
Fair
Good
Very good
Excellent

11
14
11
14
67–95 years
79 years
18
5
2
15
9
1
16
9
1
4
10
9
1
0
3
6
13
2

SEIFA: Socio-Economic Indexes for Areas
Four themes were identified: attitudes toward medication use, managing
polypharmacy in daily life, discussing and deciding about medications, and the
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influence of the healthcare environment. A number of subthemes were also identified,
as illustrated in Figure 8.1. These will be explored in the sections that follow.

Figure 8.1 Older adult results: themes and subthemes


In theme one, participants expressed a range of attitudes toward taking their
medications, sometimes within the one interview. The participants navigated a
way of reconciling their sometimes ambivalent attitudes toward their
medications, with the perceived necessity of their use, by adopting a pragmatic
approach.



The participants’ description of their management of polypharmacy is the focus
of theme two. Extensive work was required and this sometimes resulted in
negativity toward medication use. Frailty impacted the ability to manage these
tasks. In this theme health literacy practices were demonstrated.



Discussing medications varied according to the communication preferences of
the participants. Trust influenced how decision were made. This third theme
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demonstrates how communication preferences and trust intersect to influence
participation in share decision making.


The focus of the final theme is on factors within the healthcare environment
that influenced the participants’ access to medications and other non–
pharmacological alternatives. Ongoing prescribing emphasised the importance
of medications.

2.1 Attitudes to medication use (Theme 1)
Expressed attitudes toward medication use varied from very positive to quite negative.
These sometimes competing attitudes are further explored in the following sections.
2.1.1 Positive views of medication use
The participants expressed positive views about their medications that were founded
on their current perception of the general usefulness of medication. The idea of
usefulness was formed on the basis on two main views: a view of usefulness based on
their assessment of their personal benefit from their medication and a view based on
observations of how others known to them missed out on the benefits of medication
use.
Primarily, participants discussed their medications as being necessary to treat their
current conditions and to protect their future health by reducing risks, for example,
stroke. This result confirmed the findings of the earlier older adult quantitative study
where 80% agreed their medications were necessary. More detail was provided in this
arm to explain why this view was held. Participants commented that their medications
enabled them to remain independent, avoiding becoming a burden on others. Also,
medications allowed them to remain active, contributing to their family and
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community. In these ways medications enabled participants to exert some agency over
the effect of their current conditions and also avoid future illness by actively choosing
to take their medications. Thus, they perceived their use of medicines as an effective,
rational and responsible action and expressed a level of comfort with their current and
future medication use.
‘They're (medications) very important because I'm involved in community
activities and if I don’t keep healthy, I'm letting down people…. There's my
daughter as well. I have a responsibility to stay around as long as I can for her.’
Monica, 88
‘I don’t mind taking them, so long as they keep me above ground.’ Peter, 81
Some shared stories or first-hand experiences of caring for family members who they
thought had not used medications appropriately. These experiences now motivated
them to hold a positive attitude toward their own continued medication use, in order
to prevent poor health or premature death.
‘I lost one sister at 82, but it was her own fault. She wouldn’t take her medication
for diabetes. Now, I do what I’m told.’ Yvonne, 80
Participants also recalled the suffering of past relatives who had no access to
medications. Mostly, as participants reflected on this generational difference, they
talked of the benefits of medication use. This again positively framed medication use,
leading to the perception that to avoid the same fate, it was necessary and acceptable
to take medications.
‘When I think back years ago, our parents didn’t have any tablets to take and our
grandparents, oh dear…..they lived till they were old but they suffered too.’
Gwenda, 79
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2.1.1.1 The ‘normality’ of medication use in old age
Taking medication was regarded as a normal aspect of growing older. The participants’
views of growing older were generally negative and were marked by references to loss,
deterioration and limitations even if that did not appear to be their current
experience. Poor health was expected and likewise their use of medications was
expected. Medications were seen as a resource or tool to manage the effects of older
age, as described by Tom, aged 74, who compared the need to maintain old cars to the
need to use medication in old age. Because of this expectation for the use of
medication, as the body declines, there may have been a reluctance to stop
medications, believing they may always be needed.
‘I think it’s more on the downhill slide at my age. So, I can’t imagine a time when
I will get better and not need any of these things.’ Daphne, 80
2.1.2 Negative views of medication use
Despite the previously expressed positive views about medications, almost half (11/25)
of the participants also conveyed a level of general dissatisfaction with their use of
medication and a preference not to take anything. There were a number of sources of
dissatisfaction noted. Sometimes medication use was viewed as a symbol of a lack of
health or a loss of agency over being healthy, marked by the need to take medications
continually. For example Brenda, 78, always viewed herself as a fit and healthy person
and was disappointed when she needed to start using medication.
‘I’ve just always been really fit and active and healthy, so I suppose it’s a bit of a
come down to think of all these medicines now.’ Brenda, 78
Others cited fears about the safety of medicines.
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‘Well, it’s a foreign substance going into my body and I prefer just to have natural
things and not put any chemicals – and they are chemicals on the whole, I
presume. So, I’d rather not take them.’ Daphne, 80
Or for some, dissatisfaction was described in relation to specific medications, based on
stories they had heard from others who had had bad experiences after their use, or
their own bad experiences, such as ‘addiction to painkillers’ (Peter, 81). The use of
multiple medications was not something that had been anticipated in older age, as
noted by Monica, 88 ‘It never crossed my mind that I would one day be taking nine
tablets a day!’ Notably, each of these participants, despite their negative views, still
indicated that they continued to use their medications.
2.1.3 Adopting a pragmatic approach
Overall, the participants’ responses demonstrate that they adopted a pragmatic
approach to their own medication use. After weighing up positive and negative views,
relevant to their own circumstances, they decided to continue their medications,
because they perceived they continued to bring benefit. It could be argued that they
perceived the only real choice they had was to continue medication. This can be
summed up by Daphne’s (80) statement: ‘I don’t like taking medication, but I know
that I need to.’ This approach may also explain why the majority of participants (16/26)
noted they had very good or excellent quality of life, despite experiencing side effects
and the burden of daily medication management, as discussed in the following
section.
Although participants appeared to have come to this point of resolution, the
ambivalent attitudes noted above remained relevant. Their use of medicines
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continued to be associated with ageing/loss/dysfunction/illness/potential illness, a
potential or actual threat to be managed, for instance from side effects, interactions or
addiction, while also being thought of as useful, safe, effective and reliable. These
more complex and interrelated attitudes and concerns may still be important to
explore, when trying to establish patient preferences, despite their presentation of a
pragmatic acceptance of medication use. However, exploring these foundational
attitudes may take time to allow older adults to articulate their preferences in the
context of deprescribing.
2.2 Managing polypharmacy in daily life (Theme 2)
During the course of the interviews the participants described how they went about
managing their often complex regimens. Aspects of medication management and the
constancy of this work sometimes informed negative attitudes toward medication use.
Health literacy skills were described being in action in their daily life.
2.2.1 The perceived burden of medication management tasks
The participants noted the many activities which they undertook to manage their
medications on a daily basis. These activities included keeping their medications
organised, getting prescriptions, collecting supplies, setting reminders to take
medications on time, (often scheduling multiple doses per day, and often around
other activities) and attending to tests, e.g. blood tests to check therapeutic levels.
They adopted methods that best suited their individual needs and to help ensure that
they took the right medication, on time. These constant activities and workload
influenced attitudes of dissatisfaction toward their medications because of the
inconvenience caused and negative impact on quality of life.
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‘I just would be happier if I didn’t have to take any, anything, just got on with my
life, than, that I spent ten minutes every morning packing and unpacking that
much stuff.’ Ivan, 80
Another factor which contributed to medication burden was the work involved in the
safe handling and storage and access to their medications. For example, John, aged 76,
knew he needed to wash his hands after handling his Methotrexate and Norma, aged
72, knew she needed to keep her eye drops and thyroid medication cold, which was
more of a burden especially when travelling in her caravan. Plans for ongoing supplies
also had to be made if travelling. For example Ken, aged 88, had to discuss with his GP
how to access an ongoing supply of Warfarin in the USA.
Strategies around documenting information, record keeping and planning contributed
to medication burden. Most kept records of the names of their medications and the
reason for their use, especially when generic medications had been substituted for
branded medications. Some liked to record when they had taken their medications, in
order to avoid making mistakes.
‘When I was in hospital, the nurses pedantically tick off when you’ve had your
tablet…. and so, over the years, I’ve just kept my own record.’ Graham, 77
Additionally, participants actively monitored the effect of their medication use,
including observing for side effects, improvements in their symptoms or outcomes
following deprescribing, and communicated information back to their GPs. Because of
their many medications and the frequent changes to regimens this was not an
insignificant task. However this monitoring and reporting back was important as it

187

enabled their prescribers to find an acceptable balance of benefit versus side effects
from their medications and had the potential to facilitate shared decision making.
‘But she (GP) explained all of that to me – like, “I’m gonna give you this and this is
how it works,” kind of thing, and be aware that it could cause fluid problems or
fluid retention. Just keep an eye on yourself.’ Janet, 70
The extent and specific tasks of the medication management burden of older adults
using polypharmacy is rarely mentioned within the deprescribing literature. Its role as
a possible motivator for older adults to consider deprescribing has not been explored
in detail.
2.2.2 Balancing medication benefits with side effects
Medication side effects were discussed by 17 of the 25 participants. This was a larger
number than expected given that only 22% agreed they were experiencing side effects
in the earlier older adult quantitative study arm. Participants were conscious of the
effort required to monitor for and manage side effects. Again, this generated a level of
dissatisfaction with medication use. The participants indicated that they actively
weighed up the current usefulness of their medications as a resource to advance their
goals to maintain their health, independence and to help extend their lives, against
their assessment of risk in terms of current or future side effects.
‘It depends on the extent of the side effects. I mean you have to decide whether it
was better to change –… ‘cause the side effects may be just as fatal as the
medicine sort of thing.’ Monica, 88
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The balancing act of benefits and side effects was affected by an almost universal
expectation of side effects expressed by the participants. Side effects were thought of
as being inevitable especially when many medications were being used:
‘Well, when you take all these tablets all at once, you get side effects.’ Bill, 78
The participants engaged in significant and often daily work to balance the side effects
of their medications, in the hope of gaining an overall benefit from their use. They
took active steps to manage the impact of side effects, rather than stop taking
medications. For example, the oldest participant Mavis, aged 95 noted: ‘I’m very
careful. That’s why I have my walker because even around the house, I feel a little bit
unsteady since I’ve been on all of this.’ Ivan, aged 80 was experiencing drowsiness,
weight gain and poor renal function as a result of his medication regimen. He spoke at
length in his interview about the side effects of his medications. As a result he need to
manage his weight gain, monitor drowsiness, especially while driving and attend to
weekly blood tests to monitor his renal function. He was aware that he could not stop
or reduce his medications because he understood them to be necessary, despite their
impact on his quality of life.
‘If I could drop some of them off, I would reduce some of that. If I sit… still, I can
go to sleep in two minutes…..It annoys me…..Uh, and there are other side effects…
this is part of it (patting stomach). – I can’t reduce the insulin anymore….and
even these fluid tablets….are putting a strain on my kidneys….That’s why at the
moment, I’m getting probably weekly blood tests.’ Ivan, 80
An awareness of side effects allowed participants to exercise some level of agency over
their use of individual medications. For example, they managed side effects by altering
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the frequency of taking their medications, when they knew that side effects would
adversely affect their activities for the day. When they thought it was possible, they
missed medications that they knew made them sleepy or ‘fluid tablets’ to avoid the
need to go to the toilet frequently. For others, the process of assessing and balancing
benefit against potential side effects allowed them to share their own preference with
their GP, as demonstrated by Fred, 78:
‘He wanted to increase my Simvastatin to reduce my cholesterol -- from 40 to 80.
And we came home and looked at the potential side effects and I said I’m not
willing to go there.’
2.2.3 Sourcing medication information
Finding information about medications was also another significant task undertaken
by participants. They sought medication information from a range of sources
including their GP, specialists, pharmacists, practice nurses, patient information
leaflets, the internet and medication information available from health magazines and
books, as well as from family and friends. This demonstrates that the participants were
drawing on the health literacy capabilities and knowledge of many others within their
community, both professional and non-professional to build their own knowledge.
This reflects the concept of distributive health literacy and emphasises the
development of health literacy over time, rather than being a static skill as noted in
Chapter 3 section 2.5. The participants used their knowledge to inform their own
understanding of their medications which shaped their attitudes and decisions about
their use.
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‘Oh, the Nexium I take…. I’ve tried different times to take it and then somebody
told me on the net, they took it an hour before breakfast and that works for me.’
Margaret, 82
2.2.3.1 The internet as an information source
Apart from their GP, the internet was the most common source of medication
information accessed by the participants. Despite their high median age of 79, most
participants mentioned using the internet to source information. This finding
contradicts the views of GPs in the earlier qualitative study who were not aware that
their older adult patients were accessing the internet and discredits commonly held
perceptions that older adults do not have the skills to access the internet.
‘I’m on Facebook. I’m on Twitter. I’m on Instagram. And I have an iPhone and –
yeah. Well, I can get to know – as you know, we get to know everything today
with Google. So, I can Google any of the scripts I’m on to see what they’re made
of.’ Peter, 81
Even though participants were aware that information found on the internet might
not always be accurate, only one participant stated that he did not access the internet
for this reason. Others continued to access information but commented on strategies
they used to avoid unreliable sites. This included looking at government or wellknown websites or being cautious about accepting the trustworthiness of information,
such as on blog sites. This suggests older adults are using critical health literacy skills
when retrieving information in order to assess its credibility, suitability and usability
in their context.
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‘Well…you pick up Google, don’t you? And you look for reliable – as far as you
know – thing and read it. But it gives me the basis for asking a question, if I
wanted a question to ask. Not believing everything they say by any means, but
giving me a bit more understanding.’ Elaine, 87
2.2.3.2 Types of medication information sought
The participants looked for a wide range of information to help manage their
medications safely and satisfy their need for further information. They noted finding
information about why each of their medications were required, how each medication
worked and its potential side effects, including interactions between their other
medications. They also accessed information about administration such as when or
how to take their medication, how best to store it and consequences associated with
missing or changing dosages or changing medications types. One of the outcomes of
this increased knowledge was a confidence that their medications were appropriate
and safe to take.
‘I always check whatever he gives me, it doesn’t clash with what other
medications I’m taking and I found that a good rule.’ Richard, 86
Another outcome was the ability to engage with their doctors, using their
understanding of their own information needs to frame further questions during
consultations
‘I'm always a sticky beak and sometimes I’ll take a list of questions to the
cardiologist. He always looks forward to it. Sometimes he said, “Oh, yeah, what
questions you got for me today?”’ Graham, 77
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Seeking information took place as and when their information needs arose, building
up their knowledge of their medications over time. Participants sought this
information when they thought it was appropriate or when they did not believe that
their GP had enough time to provide them with adequate information.
‘I think they're time-poor. They’re pushing you through, so you really don’t get
very much information. And they’re the doctor, so you – but I always do my own
checking up.’ Judith, 67
2.2.3.3 The impact of frailty on information seeking
Medication information seeking may change over time as a result of increasing frailty.
Although only two participants were frail, their declining access to medication
information is worth noting. Beryl, aged 91, was experiencing, ‘cardiac and renal
problems’, reduced mobility, chronic pain and reduced eyesight as a result of macular
degeneration. Her quality of life was declining and she remarked ‘it's a battle to keep
going’. She lived alone in her own home and was reliant on her sons, who lived in
other cities, for support. When asked what she would like to know about her
medications, her response suggested she had made an active decision to not seek out
further information choosing not to worry about understanding her medications:
‘Well, I have so many things wrong with me. I don’t sort out one medicine from
the other. I just take them.’ Beryl, 91
Similarly Mavis, 95, previously a registered nurse, noted that she was ‘curious’ about
what her medications were for. However, at a time when her need for medication
information was greatest she was no longer physically able to access the local
pharmacy or attend medical consultations without family assistance. Although she
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would have liked to search for medication information on the internet she no longer
had access and did not have the resources herself, without relying on family, to reestablish an internet connection.
‘I have a computer, but I’ve lost the internet since they put this NBN (National
Broadband Network) thing on. My poor old computer is from 2005, and I think
it’s a bit like me, it’s a bit outdated. I’m capable of doing it but the computer won’t
–My grandson…there’s some reasons why he’s having trouble. I would like a
laptop but, anyway.’ Mavis 95
2.3 Discussing and deciding about medications (Theme 3)
Variability in the confidence of participants to express their medication preferences to
their GP was noted. However, the majority of participants’ examples of
communication about medications indicated they were not empowered in their
relationship, even when they commented that they had a good, trusting relationship
with their GP. Furthermore trust worked to reduce the participants’ motivation to ask
questions or participate in decision making.
2.3.1 Communication preferences
The way participants communicated their medication preferences varied and this
influenced their level of involvement in discussions and decision making regarding
their medications. Three distinct communication styles were noted: those who
communicated their preferences, those who communicated their preferences but
easily compromised these and those who chose not to communicate their preferences.
The participants appeared comfortable with the outcome of whatever strategy they
had adopted. These results substantiate the findings from the GP quantitative paper
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where responses indicated a similar variability in perceived older adult involvement in
decision making regarding medications.
Several participants (n=9/25) talked of actively communicating their medication
preferences to their GP. They commented that they requested changes to medication
dosages or requested medications be stopped. They discussed successful outcomes,
aligned with their preferences when giving examples from their own experience of
changes in dosage or deprescribing. This group were also much more likely to express
a dislike of medications use, have stopped a medication or to be willing to consider
stopping medication. These factors appear to have been motivational to question
current medications. This suggests that underlying attitudes toward medications and
previous experiences may influence the content and ways of communicating about
medications adopted by participants. Their descriptions illustrated how their GPs took
into consideration the participant’s goals of treatment and either adjusted doses or
deprescribed.
‘I’ve sometimes asked, “Is the medication really necessary?” ….She [GP] said “I
wonder if you could take a reduced dose.” …and I thought, “Yes, I’ve been on these
for many, many years. Do I really need one every day?” Right-o, we can give it a
try.’ Elaine, 87
A smaller group (n=5/25) of participants spoke of communicating their preferences to
stop medications however, they accepted their doctors’ treatment goals when these
preferences were challenged or were not explored.
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‘I sometimes say, “Do I really have to take that?”…. I have questioned in the past
taking statins for cholesterol and I’ve questioned taking Nexium for reflux, but
he’s convinced me that I need them, so I just take them.’ Daphne, 80
The largest group (n=11/25) were not concerned about communicating their
medication preferences or asking questions about their medications. They accepted
changes to their regimens, decided for them by their GP. This group were more likely
to be cautious about stopping any medication and were comfortable taking their
medication. Jane’s response below suggests that while her GP uses language that
suggests he is including her in decisions, in reality she understood that he does not.
He drives the agenda for their consultation and she is accepting of this.
‘No, I don’t think he does involve me…. He says “I think we’ll.” “We will.” But I
just think he means him…..I very rarely ask him anything about the medication.
He usually tells me what things I need…And I just trust him so do whatever he
says I need.’ Jane, 74
Participants in the last two groups were more likely to use expressions that indicated
their obedience to their doctors’ decisions and directions even though they may not
always follow them to the letter, for example Jane 74, quoted above, skipped doses of
her diuretics to avoid the inconvenience of needing to urinate frequently. There is a
sense in which they are presenting themselves as playing the role of ‘good patients’
because they do what they are told; they do what is expected of them within the
doctor–patient relationship. This mirrors the role of the ‘good doctor’ which is
described in the following section.
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2.3.2 The role of trust in decision making.
The majority of participants trusted their GP. This result confirmed the findings of the
earlier GP quantitative study where almost all GPs responded that their older patients
trusted their prescribing decisions. This subtheme explores the basis of that trust and
its influence on older adult participation in decision making.
2.3.2.1 The importance of trust
The participants demonstrated that they each had some knowledge of their own
health conditions and their management. However, they knew their knowledge was
limited and they lacked the medical expertise of their GP and specialists. As a result
they recognised that they needed to trust their doctors to provide good medical advice
and make decisions that would be in their best interests. Trust in their doctors led to
trust in their doctors’ prescribing and trust in the medications that were prescribed.
‘I only think they're important because the doctor said I should take them. I just
do what they say because I haven't got much medical knowledge myself, so I do
what I'm told to do.’ Brenda, 78
Previous experiences of good outcomes following the diagnosis of health problems
reinforced the participants’ trust in their GP’s medical knowledge and experience as
explained by Graham, 77. He recounted the good care he had received following a
cardiac arrest and valued the training, ability and knowledge of his GP.
‘I trust them. (Because of) the good run I’ve had, I suppose. I think in eight years,
I’ve never had a – the one problem I had, they fixed up –pleural effusion –– they’re
well-trained, I think, and they know what they’re doing.’
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Many participants noted how trust developed over time suggesting the importance of
continuity. Notably, sixteen had been seeing their current GP for 10 or more years,
nine of these having been to the same GP for more than 30 years. The participants’
responses suggested that their trust was based on familiarity and having a GP who
demonstrated, by their attitudes and practices, that they were ‘a good doctor’.
Participants described the qualities that determined a ‘good doctor’. These included
empathy and respect, being a good listener, not rushing consultations and being
approachable. These qualities contributed to the participants’ perceptions that their
GP was trustworthy.
‘And I just found her very open when I first met her….as the years have gone by,
it’s become a friendship….you know that she’s perceiving you as a whole person,
not just as a physical being that’s come with an ache or a pain or so forth. She
appreciates that there’s more to you than that.’ Elaine, 87
Familiarity also allowed participants to trust their GP because they had confidence
that their health history was known and understood. This gave them confidence that
their GP would be able to make decisions that were appropriate for their needs.
‘It’s important to go the same GP if you can….Because he understands you and he
sees you and he knows whether you're well today you whether you're not.’
Tom, 74
Robert, 69, commented on how his consultations with his GP also included personal
topics, unrelated to his medical needs such as asking about his GP’s holidays. Another
participant, Fred, 78, noted the humour present in his relationship with his GP of 16
years, for instance: ‘I said to him, “Well you can’t retire yet because you’re going to look
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after me ‘til I die,” and he said, “Then hurry up and die.”’ This familiarity was important
and facilitated good doctor–patient relationships and trust.
‘It makes a big difference if you have a doctor who, well, is nice and you can joke
and you can talk.…..So I have the feeling I can trust her with my thoughts.’
Doris, 78
2.3.2.2 Trust and conformity
Because they trusted their GPs, participants generally chose to conform to their
doctors’ decisions regarding their medications. This was the case even when they
doubted that their GP had made the right decision.
‘“Well, I don’t want you to take Lisinopril anymore”…I did it and it didn’t work.
So, I didn’t say too much, but I mean, you think to yourself, “Well, I could’ve told
you that.” but I didn’t say that to her. I just said, “All right then”.’ Janet, 72
Janet’s lack of trust in her own perceptions of the suitability of the decision resulted in
her choosing not to voice her concerns and to follow her GP’s advice.
Because they trusted their prescribers, participants also appeared to ask few questions
about their medications and instead choose to continue with the advice previously
given. This may mean that questions about deprescribing are not asked.
‘I don’t know what would happen if I stopped them. So I’m sort of – I’m taking it
because professional people said, “To maintain your health, this is what you do,”
and because I trust those people, I do it mostly.’ Fred, 78
Even when significant side effects were being experienced, the advice of their
prescribers was followed. This scenario was most evident with the oldest participant
Mavis, 95. She had been hospitalised two years ago following an episode where she
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had an irregular heartbeat and had been started on a number of new medications.
Since then she had experienced a number of side effects including a persistent itchy
rash that disturbed her sleep, loss of appetite which had resulted in her losing 15 kilos
over the last two years and lethargy and weakness which now prevented her from
leaving her unit. She previously communicated her experiences of her medications’
side effects with her GP and was given this response:
‘(GP) said, “You may be a bit allergic to some of this medications, but we’ve got
everything in balance so nicely, we don’t want to upset that ‘cause that would be
another five weeks in hospital". Mavis, 95
Despite the impact of side effects on her quality of life, she still trusted her GP’s
decision to maintain her current medication regimen. The level of trust Mavis placed
in her GP appeared to leave Mavis feeling she had no other option but to continue
following her GP’s advice.
‘Well I’ve been with Dr X for goodness knows how long, about 35 years I think…..I
think I should probably (trust her)–you know -- she’s given me no reason not to
trust her.’
The participants’ discussion of trust leading to conformity is supported by the older
adult responses to the critical health literacy items in the earlier quantitative study
arm. Only just over a quarter of respondents agreed that they often queried whether
health information was to be trusted and only 12% often questioned their doctor’s
advice.
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2.3.2.3 Trust in specialists
All but two participants were currently seeing a specialist. The participants’ trust in
their GPs appeared to be bounded as they often expressed a greater level of trust in
their specialists, who they perceived had a higher status compared to their GP. GPs
sometimes reinforced that perception by refusing to make changes to medications
prescribed by specialists.
‘When I go to the specialist ….you think of them as being a little bit more
powerful that the GP. It's like the sergeant to the lieutenant to the general or
whatever…..He’s (GP) a bit reluctant to change what they’ve changed. He says,
“Oh, no, I think I'm gonna leave it for them. Talk to them.” ’ Robert 69
Most gave more weight to their specialists’ advice regarding their prescribed
medications and described their specialists as having greater prescribing power than
their GP. This influenced who they trusted most to make changes.
‘Well, in the past, the GP has made changes which the specialist didn’t
particularly like and I would imagine that a professor is just a little bit higher
than a GP. So, I’d be inclined to take his word for it.’ Bill, 78
This belief about the important prescribing role of specialists meant that some
participants were also not sure that their GP could deprescribe medications prescribed
by a specialist.
‘Hundred percent, she [GP] is dependent on the recommendation from the
specialist….. I would prefer to talk to the specialist.’ Ken, aged 88
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2.3.2.4 An example of distrust
Judith, 67, expressed a deep distrust in doctors, medications and the health system in
general. She blamed her mother’s use of many medications for her early death and
spoke of the influence of pharmaceutical company marketing on the prescribing
patterns of doctors.
‘Doctors are paid by drug companies, go out to lunches, and do all these sort of
things to prescribe these new wonder drugs…this is marketing bullshit, half this
stuff….No, don’t trust them at all, because money and power is what it’s all
about….I believe that there’s a lot of illnesses that are probably drug induced .’
Judith, 67
Judith’s views were not representative of the others. Interestingly she was the youngest
participant and there is growing discussion in the literature of the loss of trust in
doctors among younger generations (Brown et al., 2015, Calnan and Sanford, 2004). It
is possible that her response reflects this. Judith was also Indigenous. Her mistrust of
medical services may also reflect the lack of culturally appropriate health services
available for the first peoples of Australia. Despite her level of distrust, she still
regularly accessed care and took her medications.
2.4 The influence of the healthcare environment (Theme 4)
Aspects of the healthcare environment worked to produce a culture of ongoing
prescribing and reliance on pharmaceutical treatments.
2.4.1 Normality of prescribing
Ongoing prescribing was the norm experienced by the participants. Their views about
the importance of their medications were shaped by their GP’s continued prescribing
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of medications to manage their diagnoses. They described their GPs’ prescribing work
using a variety of synonyms noting incremental adjustments to their regimens:
‘evolution’, ‘tweaking’, ‘trialling’, ‘adjusting’, ‘altering’ or ‘changing’. These adjustments
were mostly made as a result of test results. Sometimes they were also based on
feedback from the participant regarding the effectiveness of their medications or the
experience of side effects.
‘Well, the side effects of the Karvezide….If I take more, the blood pressure goes
down. If I take less, the blood pressure goes up. And the doctor and I have tried all
this –I think we’ve reached a nice happy medium where I’m happy that I’m not
going to fall over and I can put up with it just a little bit of slight dizziness every
now and again.’ Bill, 78
The perceived ongoing importance of the participants’ medications was further
illustrated by comments regarding stopping medications. Examples were given where
this had not been successful because medications had to be restarted or a different
medication prescribed. This reinforced the importance of their medications,
influencing a positive stance toward ongoing medication use.
‘But I can’t – he tried me to go off Warfarin once and he found I got a blood clot.
So, third time, he took me off them and I had it, that’s it – have to stay on it.’
Yvonne, 80
2.4.2 The role of medication reviews
In the older adult quantitative arm two thirds of respondents agreed that, in the past
12 months, their doctor had taken time during a consultation to check all their
medications. The responses in the qualitative arm add further detail regarding the
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nature of reviews. The participants’ descriptions of medication reviews varied. Only six
described how their GP conducted regular, complete medication reviews, either
during a consultation, with the practice nurse or via a home medicines review. Some
participants noted that these were useful to gain more information about their
medications or to pick up if there were problems such as ‘conflicts’, ‘doubling-up’ or
medications that were ‘nullifying’ others. This type of information was useful to
prompt a discussion between the GP and the participant regarding any necessary
regimen changes.
Others were less certain that their GP ever reviewed their medications, described ad
hoc reviews and did not mention an external review. Opportunities to express
concerns or medication preferences appeared to be limited.
‘We talk about the medications….. she sort of runs through them all, but she
doesn’t necessarily talk about them all, you know what I mean? I think she just
sort of seems to accept that if things are going okay that we’ll stick with that.’
Monica, 88
This reported variability in how medications are reviewed confirms the different
approaches to medication reviews described by participants in the GP qualitative arm.
2.4.3 Non–pharmaceutical alternatives
The perceived availability of non–pharmaceutical alternatives was limited. There was
little talk of the participants’ GPs recommending or discussing non–pharmaceutical
treatment alternatives, either as replacement therapies or in support of
pharmaceutical measures. Any comments that were made were mainly restricted to
general discussions about diet to reduce weight in the case of those who already had a
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diagnosis of diabetes or to manage high cholesterol. Even when the participants
sought further information, for example about exercise or diet, their GP appeared to
provide little guidance as illustrated by Richard’s comment:
‘I’m always interested in things that will assist your wellbeing, I exercise when I
can and – I always keep in touch with the doctor…. I’m not capable of vigorous
exercises now because I’ve lost a lot of my strength…..He hasn’t put me on a diet
as such….but I’ve made up my mind, I eat fruit and…..vegetables. I eat more
vegetables than meat now.’ Richard, 86.
Sometimes when GPs did recommend specific additional treatments these were not
easy to access in a timely way. Robert, 69, had poorly controlled pain and had been
referred to hydrotherapy and a pain management clinic. He commented about the
long wait to access services. Without good accessibility to non–pharmacological
alternatives or supplementary treatments, he had no choice but to remain on heavy
doses of his pain medications which were causing considerable side effects.
‘I like to know…is there an alternate rather than the medication…..I take a lot of
painkillers and we've been working on that to try and minimise the number of
painkillers that I am taking and the strength of those painkillers…. and I'm on the
list to do the water physiotherapy at the Port Kembla Hospital. I don't know how
long it takes to get a vacancy there, but I should imagine it takes a while and
hopefully I’ll be able to go and do that as well, to try and help.’ Robert, 69
2.4.4 Medication costs
As noted in the earlier older adult quantitative chapter, the cost of medications was
not a concern for many respondents. In this qualitative arm there were no participants
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who stated that they could not afford to access their medications. Only two
participants stated they were not eligible for the Australian government’s concessional
rate of $6.60 per prescription. However, cost was still a concern for four participants
because they were using large numbers of medications, or needed medications that
required a patient cost contribution. This was not however, a motivation for them to
consider deprescribing.
‘I wouldn’t go without them, even though the cost ….“Oh God, it’s going to cost
me $40. I’ve got to go and get my pills,” but I’d still get them, because they have
to be got, as far as I’m concerned, because I think I’m scared not to take them.’
Jane, 74

3. Conclusion
For most participants the idea of deprescribing was a non-issue as they had adopted a
pragmatic approach toward their need to use polypharmacy. They decided to continue
their medications because of their perceived benefits, despite the drawbacks
associated with their use. This finding confirms earlier research which identified the
way older adults manage competing priorities when making medication management
decisions (Fried et al., 2008).
However, the findings indicate that there are multiple reasons why the majority of
older adults would accept their doctor’s recommendation to deprescribe. Primarily
this appears to be motivated by trust in their GP’s (and/or specialist’s) advice. Trust
was informed by the older adult’s recognition of their own limited medical knowledge
and experience, compared to their GPs. Other motivational factors include a general
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preference to take less medication, a desire to reduce the daily burden of medication
management and a desire to avoid or reduce side effects.
In the previous older adult quantitative arm, health literacy was measured across three
domains based on Nutbeam’s (2000) broad model of health literacy which defined
functional, communicative and critical health literacy skills. In this qualitative arm,
participants demonstrated that they practiced skills across each of these domains as
health literacy capabilities were employed in the daily management of their
medications. Functional health literacy practices were demonstrated in the way
participants followed directions, planned schedules and kept records. Communicative
health literacy was shown in their communication of medication effects, including
side effects to their GP and specialists, and when asking questions. Critical health
literacy skills were seen in action as the participants discussed their use of research
skills to access multiple sources of medication information and applied this to their
own context, developing their health literacy over time. The management of side
effects also demonstrated the use of critical health literacy skills. When health literacy
skills were not practiced, such as when questions were not asked, or preferences not
communicated this had the potential to prevent deprescribing conversations.
Similarly, trust appeared to disrupt the application of critical health literacy skills.
The results also increase our understanding of the role and nature of shared decision
making, regarding medications, in this context. Communication, which is key to
shared decision making, varied, with almost half the group not concerned about
communicating their medication preferences. Trust also undermined shared decision
resulting in a lack of concern about their GPs’ medication management decisions.
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Chapter 9 Discussion
1. Introduction
This thesis investigated the research question: What factors affect the process of
deprescribing of medications from the perspective of both Australian GPs and older
community living adults and what influence, if any, health literacy plays in
deprescribing decision making. In this chapter, the four research objectives and
research question are discussed by integrating the findings from the four study arms
previously documented (Chapters 5,6,7,8). The integrated findings incorporate the
views of both older adults and GPs and each of the study components of the mixed
methods explanatory sequential design. Finally, the key findings are used to refine the
initial conceptual framework which had been developed to guide the research process.
This work began with a narrow focus on deprescribing medications in order to reduce
polypharmacy. From an initial reading of the literature this appeared to be a
worthwhile research topic. However, this research has led to the conclusion that it is
much more efficacious to talk about deprescribing and/or polypharmacy as aspects of
the complex actions of medication management, rather than discussing them as
separate issues. Medication management is the context in which deprescribing and
polypharmacy occur. By exploring this context it is possible to understand more about
the processes that influence both deprescribing and polypharmacy and understand
potential opportunities for change.
In the following sections, the key findings of each objective are presented. These are
discussed, noting how the findings relate to the current literature and their relevance

208

to answering the research question. Four additional, unanticipated findings are also
discussed.
The first three research objectives explored the influence of three key areas on
discussions of deprescribing. The first objective explored the influence of the structure
of the primary care environment; the second: perspectives on ageing and the third: the
influence of health literacy on deprescribing discussions. The first objective allowed a
macro view of the factors which influence practice while objectives two and three
allowed an exploration of the influence of individual attitudes and capabilities. Finally,
the fourth objective explored the relationship between attitudes toward medication
use and age cohort or socio-economic status.

2. How does the structure of the healthcare environment in primary care in
Australia facilitate or impede discussions about polypharmacy and
deprescribing between older adults and their GP? (Research objective 1)
Key findings
1. Trust facilitated deprescribing although sometimes prevented participation in
shared-decision making about medication management.
2. The GP’s generalist role in medication management was undermined by
inadequate communication, confused lines of authority and responsibility, and
time constraints.
3. Frail community living older adults found access to GP services difficult at a
time when deprescribing may be most appropriate.
4. Access to and availability of non–pharmacologic alternatives were limited.
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2.1 Trust
The results of the current study further explored the complex role of trust between GP
and older adults. The association between trust and older adult willingness to
deprescribe has been investigated previously in both quantitative (Linsky et al., 2017,
Ng et al., 2017, Reeve et al., 2019, Reeve et al., 2013c) and qualitative studies (Clyne et
al., 2017, Linsky et al., 2015a, Reeve et al., 2016b, Ross and Gillett, 2020b, Schöpf et al.,
2017, Weir et al., 2017). These studies have produced mixed results with some
suggesting trust is supportive of deprescribing, others finding no relationship or
others suggesting trust is associated with less likelihood of successful deprescribing.
These mixed results are explained by the qualitative findings of the current study
which found trust had three main roles.


Trust facilitated open discussions about medications, including deprescribing.



Trust was necessary when outcomes were uncertain.



Trust encouraged older adults to not raise medication concerns and defer
decision making to the trusted expertise of their GP.

These three actions of trust will be discussed in more detail below.
In the current study, both GPs and older adults saw interpersonal trust as a
fundamental facilitator of frank discussions. In the absence of trust, GPs were reticent
to discuss or suggest deprescribing for fear that their suggestion would be rejected.
This supports the findings of a qualitative study of GPs in New Zealand where GPs
were hesitant to deprescribe in ‘low trust’ environments characterised by short term
therapeutic relationships (Wallis et al., 2017). Trust enabled older adults to share
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openly about their concerns and share often very personal information including
treatment goals and/or end of life preferences.
Trust was necessary because of the complexity and uncertainty of deprescribing
decisions in the context of managing older adults with multimorbidity. Older adults’
trust in the expertise of their GP helped them to accept the uncertain outcomes
associated with deprescribing, confirming the results of an earlier qualitative study of
Irish older adults (Clyne et al., 2017). In this current study, components which
contributed to the participants’ trust in their GP included the length of time that they
had been seeing the same GP, repeated positive experiences of care, and the perceived
medical expertise of their GP compared to their own limited medical knowledge.
However, most placed greater trust in their specialists. Similarly, GPs acknowledged
that trust was necessary to alleviate concerns of potential risk. These findings are
supported by Brennan et al. (2013), who found that trust is important within doctor
patient relationships, where the outcome of decisions are uncertain, there is an
asymmetry in expertise or knowledge and/or there is a perceived risk.
However, the extent of older adults’ trust sometimes meant that they chose not to
participate in shared decision making and deferred decision making regarding their
medications to their GP. In the context of discussions about polypharmacy between
older adults and their GP, Schöpf et al. (Schöpf et al., 2017) also found that trust acted
as a two-edged sword, most often allowing patients to talk openly, but sometimes
resulting in them feeling it was unnecessary to ask important questions about their
medications. Hafenbrädl et al. (2016) argue that deferring decisions to an expert who
is trusted and is perceived to share the same goals is a practical and rational response.
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As noted in chapter 6, GPs made no comment on this effect of trust. They appeared
unaware that trust may result in patients choosing not to initiate a discussion of
deprescribing, share preferences or generally participate in shared decision making
regarding deprescribing. This lack of awareness of the potential negative impact of
trust has not been described in previous deprescribing studies and its implications for
shared decision making in the context of deprescribing have not been considered.
Trust was found to be an outcome of continuity of care. This finding emphasises the
importance of maintaining a model of GP service provision in Australia and elsewhere
that fosters continuity of care and consequently good interpersonal trust. Proactive
questioning about current medications would reduce the risk that trust may result in
less participation in shared decision making.
The findings from the current study did not support the view that initiating
discussions about deprescribing might damage trust. Surveyed GPs did not feel their
older patients would feel given up on if they discussed deprescribing. Additionally,
when interviewed, GPs did not think that deprescribing would alter trust within an
established, long-term GP–older patient relationship. This result is in contrast to other
qualitative studies which found that GPs fear deprescribing will undermine trust,
suggesting that patients feel ‘given up on’ (Schuling et al., 2012, Wallis et al., 2017).
2.2 Factors which undermined GPs generalist medication management role
This study confirmed that the GP’s role to coordinate medication regimens between
prescribers and across healthcare settings is an important facilitator of good
medication management and valued by older adults. However, poorly coordinated and
incomplete communication of medication information between healthcare providers,
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unclear authority for the GP to act within their generalist role from both other
specialists and older patients and limited time to provide comprehensive, personcentred medication reviews, undermined the effectiveness of this role.
2.3.1 Inadequate communication
GPs noted their frustrations with poor communication practices about medication
changes from hospital and specialist prescribers. Information gaps about prescribing
introduced uncertainty into their decision making sometimes resulting in deferred
action to deprescribe. Similar problems with communication of accurate and timely
medication information to GPs has been noted in many earlier studies of
deprescribing barriers suggesting this is an ongoing and consistent problem, not only
within the Australian healthcare environment (Anderson et al., 2017, Bell et al., 2015,
Clyne et al., 2016, Gerlach et al., 2020, Ie et al., 2017, Mc Namara et al., 2017, Nixon
and Vendelø, 2016, Wallis et al., 2017).
2.3.2 Unclear lines of authority or responsibility
This study documented a lack of clear lines of responsibility and of authority for
medication management and deprescribing between GPs and other prescribers. This
resulted in older adults also being unclear about who was responsible and had
authority over their medication regimen. In practice GPs also needed to manage the
sometimes competing treatment priorities of each specialist. As noted earlier with
poor communication of information, this also resulted in deferred action to
deprescribe. This result confirmed findings in earlier qualitative literature suggesting
it is a widespread problem, that again has not changed over time (Anderson et al.,
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2017, Anthierens et al., 2010, Linsky et al., 2015b, Moen et al., 2010, Schuling et al.,
2012, Wallis et al., 2017).
Reeve and Bancroft (2014) argue that GPs are best placed to undertake medication
management in the context of polypharmacy use as they operate within a generalist
frame and work alongside their patients to negotiate continuous and appropriate
individualised care. Clearly, promoting and facilitating the GP as the overall
coordinator of medication management will require attitudinal and structural change
within the heath care environment: a difficult task.
2.3.3 Time constraints
In previous studies, time constraints have been described broadly as a barrier to
deprescribing (Anderson et al., 2017, Bell et al., 2015, Kuntz et al., 2018, Linsky et al.,
2015b, Mc Namara et al., 2017, Wallis et al., 2017). Both GPs (in the qualitative study
only) and older adults confirmed this. GPs noted it was difficult to review medications
and older adults often felt unable to raise medication concerns because of a perceived
lack of time in consultations. Time constraints may have been a reason why personcentred care and shared decision making about medications appeared to be limited.
An earlier study has confirmed the effect of time constraints on GPs’ attention to
shared decision making (Braddock and Snyder, 2005).
The structural issue of limited time in consultations has been identified in many
earlier deprescribing studies again suggesting that no change has occurred to address
this in primary care settings (Anderson et al., 2017, Bell et al., 2015, Kuntz et al., 2018,
Linsky et al., 2015b, Mc Namara et al., 2017, Søndergaard et al., 2015, Wallis et al.,
2017). One practical approach to bring about change could be to proactively organise a
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separate time for a comprehensive medication review consultation or organise a Home
Medication Review. This would allow time for both GPs and older adults to review and
discuss together the ongoing suitability of the entire medication regimen. These are
widely under-used in Australia (Du et al., 2019, Jokanovic et al., 2016, Rigby, 2010).
2.3 Reduced access to GP services for frailer older adults
It is clear from both the GP and older adult studies that frailer older people have
greater medication management needs, including reasons to consider deprescribing.
GP participants were aware that their frailer older patients often had less access to
primary care services and/or were not able to access primary care as frequently as was
optimal, thereby reducing opportunities to discuss deprescribing. This novel finding in
respect of deprescribing suggests that steps are needed to remove barriers to access
Australian GP services for frail older adults. Australia’s current community aged care
services and funding models for GP services to provide complex care are limited
(Commonwealth of Australia, 2019). Previous research in high and middle-income
countries has identified that access to GP services for older adults can be improved by
removing cost barriers, locating services within communities, ensuring transport
options are available and that buildings are accessible (Loewenson, 2014) These
solutions may be applicable to the Australian context and require further evaluation.
2.4 Lack of non–pharmacological alternatives
There were limited discussions of non-pharmacological treatment alternatives by
either GPs or older adults. Participants noted that access to alternatives were limited
by either price or availability resulting in ongoing pharmacological treatments. The
supply and cost of allied health services in Australia is often prohibitive and not
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subsidised to the same extent by the Government or private health funds and so these
comments are to be expected (Van Gaans and Dent, 2018).
Access to and the availability of non–pharmacological alternatives are thought to be
key to the support of deprescribing interventions (Hilmer and Gnjidic, 2018). Social
prescribing may be a potential alternative to consider particularly where the aim is to
maintain or improve quality of life. This would involve GPs or others linking older
adults with non-medical, community-based sources of support such as art classes,
book clubs or walking groups (Zurynski et al., 2020). Although the evidence for its
effectiveness is incomplete, social prescribing has the potential to act as a preventive
measure or to promote wellbeing and improve self-care (Jani et al., 2019). It is worth
investigating its role as one alternative treatment model in order to reduce
polypharmacy, where appropriate.
2.6 Research objective 1 summary
Despite the strength and importance of continuity of care to good medication
management within a trusting relationship, other structures of the healthcare
environment discouraged action to consider deprescribing medications for older
community living patients. These findings confirm that the health system factors that
influence deprescribing identified in other countries and discussed in the literature
review are also relevant in the Australian context. The significant difference was the
finding of the influence of frailty on access to GP services at a time when deprescribing
is more likely to be considered. Opportunities exist to improve person-centred
medication management by the consistent use of comprehensive medications reviews
and non–pharmacological alternatives that are co-designed with the older adult.
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3. What is the relationship between ideas about/perceptions of ageing and
the likelihood of discussions about polypharmacy and deprescribing?
(Research objective 2)
Key findings
1. The contribution of negative stereotypes of age and ageing held by both GPs
and older adults is likely to have an impact on the practice of shared decision
making and person-centred deprescribing processes.
2. GPs’ awareness of the potential for poor outcomes from prescribing as a result
of age-related problems did influence their prescribing and deprescribing
practice.
3. Medication use was seen as normal in older age and this attitude may reduce
motivation to consider deprescribing.
3.1 Age and ageing stereotypes within the doctor patient relationship
3.1.1 GPs’ views of their older patients
GP participants described their older patients negatively. These negative descriptions
were applied with few exceptions suggesting that GPs had formed negative stereotypes
toward older patients. More nuanced descriptions that acknowledged variability
within their older patient cohort were the exception. None recognised the knowledge
older adults gathered over time in the management of their own health or discussed
the skills older adults employ between consultations to manage their complex
regimens safely. Instead, older adults’ forgetfulness, non-compliance and poor ability
to follow instructions were emphasised.
The above finding is not unexpected. Negative stereotypical characterisations of older
people, the ageing process and old age are highly prevalent within Western societies,
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resulting in ageism being ubiquitous (Ayalon and Tesch-Römer, 2017, O’Loughlin and
Kendig, 2017, Wilson et al., 2019, World Health Organization, 2021). Several recent
studies have documented ageism toward older patients within healthcare settings
(Clarke, 2013, Kane and Jacobs, 2018, Macrae, 2018, Makris et al., 2015). There is
extensive evidence of the negative impact of ageism on health outcomes, as
demonstrated in a systematic review of 422 quantitative studies conducted across 45
countries (Chang et al., 2020). Two previous studies exploring prescribers’ attitudes
toward the use of potentially inappropriate medications in older adults identified
ageism resulting in a paternalistic approach to the provision of care (Heser et al., 2018,
Spinewine et al., 2005). The current study’s findings add to this body of research,
further confirming the role of negative stereotypes leading to ageist perceptions of
older patients and paternalistic conduct.
3.1.2 Older adults’ views of ageing.
The older adult participants demonstrated that they held their own negative views
toward the ageing process and their progression into old age. The ageing process was
universally depicted by participants as being characterised by deterioration, loss of
functionality and of becoming a burden on others. The result was a feeling of growing
disempowerment and loss of choice. This was uniformly expressed. When older adults
described their interactions with GPs within consultations, they emphasised their lack
of empowerment and their lack of choice regarding medications decisions. However,
when discussing medication management in daily life, between consultations, the
majority of participants, besides those who were frail, did not present a picture of
being disempowered. They did not discuss the impact of their age on their ability to
manage their medications. They presented a favourable description of their
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capabilities and behaviours, especially in relation to their own understanding and
management of their medications, compared to that given by GP participants. As
noted above, GPs did not identify these positive capabilities when asked about their
older patients.
3.1.3 The impact of negative age stereotypes on deprescribing
The finding of the role of negative stereotypes and perceptions of ageing within the
doctor patient relationship in this study suggests that shared decision making and
person-centred deprescribing practices may not be easily implemented in clinical
practice. Ageist attitudes held by both GPs and their older patients appeared to remain
unexamined and unaddressed. A recent study demonstrated that healthcare
professionals are less likely to involve older people in decision making because of their
own ageist views (Wyman et al., 2018). Additionally, older adults who hold negative
self-perceptions of ageing are more likely to adopt expected behaviours, for example
becoming dependent and compliant (Ayalon and Tesch-Römer, 2017).
These mechanisms may explain the findings in the current study regarding older
adults’ limited participation in medication decisions. Importantly, the GPs’
perceptions of their patients’ willingness (or not) to be involved may not reflect their
patients’ real preference, but may be shaped by the GPs own negative stereotypes and
assumptions (Weir et al., 2021b). At the same time, the older adult’s own experience of
disempowerment, as they take on their own ageist views or conform to the behaviour
they believe is expected, may shape their willingness to participate in discussions
during consultations.
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Unexamined ageist assumptions were found to influence attitudes toward older
patients leading to paternalistic approaches to shared decision making. This finding
has important ramifications for the current emphasis on patient centred deprescribing
processes (Reeve et al., 2014) and shared decision making within deprescribing
processes (Jansen et al., 2016). It supports the finding of the importance of the
influence of prescriber assumptions found in Mangin’s qualitative study of shared
decision making in the context of older adult medication management (Mangin et al.,
2019).
GPs, as trusted healthcare providers are well positioned to influence older patients’
negative views of their own ageing. Older adults’ perceptions of ageing may change if
GPs’ explored and affirmed their medication management capabilities and the extent
of their health literacy skills. This could result in a greater empowerment of older
adults and a likelihood of their participation in deprescribing decision making.
3.2 GPs’ awareness of age-related problems associated with prescribing
The influence of patients’ age on prescribing has been studied previously noting that
decisions based on chronological age alone continue to be made in clinical practice
(Singh and Bajorek, 2015). This finding was contradicted in the current study by the
accounts of GPs who worked to provide individualised medication regimens,
recognising the variability of their older patients’ treatment needs. GPs took into
consideration cognition, functional capacity, social support, the number of other
medications currently prescribed and other illnesses, alongside age. This suggests that,
when making prescribing decisions, the GP’s personal knowledge of the medical
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histories and social circumstances of individual patients operated alongside their more
generalised negative stereotypes and assumptions of older adults.
In other research, Fialová et al. (2019) present the concept of ‘age blind’ prescribing as
an outcome of ageism. They suggest that doctors prescribe for older people in the
same way as they would for younger people, ignoring the risks associated with
polypharmacy or medications with unknown efficacy in older adults. Again, this
position was not supported, based on the evidence in this study. GPs did continue to
use polypharmacy but this was a pragmatic decision based on the need to
appropriately manage the complex comorbidities presented by many older adults. This
decision was not made because they were ‘age blind’. Rather they acknowledged the
differences in medication management required for older patients. They considered
the impact of polypharmacy use on the quality of life of their older patients and there
was wide recognition of the potential for poor health outcomes associated with
polypharmacy use in their older patients. Instead of an indiscriminate application of
clinical guidelines, which they felt contributed to polypharmacy use, the GP
participants emphasised their efforts to establish individualised medication regimens
and prescribe as little as possible. This finding emphasises the challenge of prescribing
in the context of multimorbidity where competing demands and goals all need to be
considered (Hoffmann et al., 2018).
The accounts above illustrate the extensive work GPs undertook to establish the most
appropriate individualised medication regimens for their older patients. GPs may be
reluctant to adopt recommendations regarding polypharmacy and deprescribing that
are perceived to ignore the reality of managing the needs of such a diverse population.
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3.3 The normality of medication use in older age.
While medications are most often used appropriately in older age, the findings across
this study indicated a consistent view of the normality and necessity of medication use
in older age. GPs described polypharmacy as being expected or unavoidable because
old age was associated with poor health and subsequent medication use. Older adults
also expressed a view that it was rare for people to not need medication in old age. The
continued prescribing of their medications by their GP reinforced positive attitudes
toward medication use, emphasising the ongoing usefulness and need for medication.
Medication use was closely linked with the capability to age well and older adult
participants made comparisons to earlier generations who had little access to
medications and so suffered in older age. Interestingly, for a small number, their use of
medication reminded them of their loss of health. For this reason, although they
continued taking them, their use was a constant reminder that they were not ageing
well. This desire to age well is reinforced by the current rhetoric that emphasises
‘successful ageing’, placing responsibility on the individual to ensure they take action
to age well (Flores-Sandoval and Kinsella, 2020). Again, this is likely to re-enforce
positive attitudes toward continuing medications.
In the current study, medications were therefore seen as a resource that enabled the
participants to prioritise a set of health outcomes to: remain functional, avoid
becoming a burden on others and extend life for as long as possible. These reflect the
set of universal patient outcomes reported elsewhere (American Geriatrics Society.,
2012). They also reflect the values identified in society, emphasising the need to
maintain independence and avoid the weakness, fragility and decline associated with
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old age (Flores-Sandoval and Kinsella, 2020). Such attitudes toward medication are
likely to be resistant to change, undermining motivation to consider deprescribing,
even when it may be appropriate.
The idea of the bio-medicalisation of old age was introduced in the late 20th century
(Estes and Binney, 1989). Estes and Binney argue that our view of old age is now
constructed as a medical problem or ‘pathology’. Experts, such as GPs, assess ageing
bodies and take over management, supplying clinical treatments only they can provide
access to (Powell, 2019). Medical interventions in old age are therefore normalised as
necessary and appropriate (Kaufman et al., 2004). This position was well supported by
the views about the importance of medications to manage the perceived problems
associated with old age, held by both older adults and GPs, described above.
Wyman et al.(2018) argue that the bio-medicalisation of old age results in the neglect
of other useful aspects of care and the provision of other support that is not related to
health or medical problems (Wyman et al., 2018). The findings from both the GP and
older adult participants confirm that there were very few comments regarding
referrals to or the use of allied health services or of preventative health measures and
use of non–pharmacological measures to support healthy ageing.
Overall, these novel findings regarding perceptions of the normality of medication use
in older age suggested that GPs and older adults are likely to be less motivated to
discuss deprescribing or raise medication related concerns (even if they both had
them). Strongly held beliefs about the need for, appropriateness and usefulness of
medication throughout the aging process, that are reinforced by societal values and
dominant theories of ageing, are likely to be difficult to change. The influence of these

223

views on attitudes toward ongoing medication use (as opposed to deprescribing) were
not acknowledged by either GPs or older adults.
3.4 Research objective 2 summary
Attitudes toward age and ageing mostly facilitate ongoing medication use rather than
encourage the consideration of deprescribing. Both older adults and GPs held negative
stereotypes about age and ageing that influenced their perception of the capability of
older adults to engage in decision making regarding deprescribing. This undermined
shared decision making and person-centred care. However, the findings of this study
do not support the view that GPs ignore age when prescribing. Strongly held but
unexamined views about the normality of medication use in older age are likely to
support ongoing medication use and reduce the likelihood of discussing
deprescribing.

4. Explain the role of health literacy in managing polypharmacy and making
decisions about deprescribing. (Research Objective 3)
Key findings
1. Older adult health literacy was co-produced, drawing on the knowledge and
experiences of others.
2. Older adults demonstrated good health literacy skills and applied their health
literacy capabilities to the daily management of their medications.
3. Frailty diminished the ability to use health literacy skills emphasising the
dynamic nature of health literacy.
4. GPs generally assumed their older patients had poor health literacy.
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5. Health literacy knowledge was used to assess risk but older adults relied on
different decision making criteria compared to that used by GPs.
6. Aspects of the healthcare environment prevented the use of health literacy
skills.
4.1 The co-production of health literacy
Older adult participants sought medication information from family, friends, online
communities, pharmacists and specialists as well as their GP as sources of influence on
their views and practices. This finding supports broader conceptions of health literacy
which acknowledge that health literacy is co-produced within social relations
(Samerski, 2019) and that health literacy is developed over time as described in the
model of distributive health literacy (Edwards et al., 2012, Edwards et al., 2015). This
novel finding is a reminder that health literacy is likely to have been formed and
influenced by multiple sources of information, not only by GPs. In decision making it
is helpful to acknowledge and explore other knowledge sources.
Foundational to the co-production of health literacy is trust. Older adults used trusted
sources of information, regardless of the source. Begoray and Kwan (2011) also found
that older adults’ trust in health information was dependent on the source of the
information. Notably, as specialists were often trusted as the most authoritative source
of information it suggests that they may need to demonstrate their support and
endorse any medication management decisions proposed by a GP. This has important
implications for who is best placed within the provision of care, to provide
deprescribing advice. It also suggests that shared decision making may need to be
inter-disciplinary to be effective.
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4.2 Older adult health literacy capabilities
As noted in chapter 7, older adults reported high levels of functional and
communicative health literacy while less reported high levels of critical health literacy
capability. This was the first time the AAHLS measure had been used with an older
adult sample. It indicates the variation, in this group, of perceived health literacy skills
across the three domains: functional, communicative and critical health literacy.
Higher summed health literacy scores across the three domains were associated with
being involved in medication decision making, understanding the reasons for the use
of medications and recalling a medication review. All of these factors are likely to be
supportive of older adult participation in shared decision making regarding
deprescribing.
The participants demonstrated how they used functional, communicative and critical
health literacy skills when making decisions about their medications, including when
considering the ongoing appropriateness of their medications (see chapter 8).
Rowlands et al. (2017) conducted a qualitative study with 27 adults in the UK and
found similar positive results of their sample’s ability to access, understand, evaluate
and apply health information relevant to their own needs. Much of the practice of
health literacy skills remained unseen by GPs and others as it was happening outside
of the clinical setting (Rowlands et al., 2017). This was the case in the current study
with GPs showing little awareness of their older patients’ use of health literacy in the
management of their medications between consultations. As a result, GPs were less
likely to draw on the health literacy capabilities of their older adult patients when
making decisions about deprescribing.
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All except one of the frailest participants demonstrated the application of their health
literacy skills in building a knowledge base over time in order to manage their own
medications. The other participants demonstrated that their knowledge had been
developed based on information shared with them by their prescribers but also
formed on the basis of familiarity with their medications. For example, the history of
their use, their purpose, what benefits they experienced, problems or side effects and
sometimes included information shared by friends or on the internet of others who
were using the same medication/s. This knowledge was unique to them and included
different information compared to the clinical knowledge of their medications held by
their GP. A recent qualitative study of Canadian older adults and their decision
making in the context of medication use also demonstrated that that older adults have
significant expertise based on their lived experience of medication taking (Mangin et
al., 2019). The findings suggest that GPs can have greater confidence in their older
patients’ knowledge of their medications and health literacy skills and use this as the
foundation for shared decision making. It also suggests that older adults opinions of
deprescribing may be dynamic and able to be influenced by the presentation of new
and relevant information.
4.3 Frailty: a reason for change in health literacy capabilities
The accounts of the two oldest participants illustrated the decline in health literacy
capacity as a result of the impact of frailty. However, demands on health literacy skills
are likely to increase as frailty increases and treatments become more complex and
varied and the outcomes of decisions are less certain. Understanding this interplay
would require a longitudinal study design and a larger sample to investigate in detail.
Edwards et al. (2015) have previously described the dynamic nature of health literacy
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capabilities across the lifespan. This finding highlights that the application of health
literacy skills may vary and frail older adults may need support to continue to
maintain and action their skills. It is particularly relevant as deprescribing is an
appropriate medication management strategy in response to frailty as treatment goals
change, quality of life is prioritised and compliance with complex medication
regimens potentially declines (Holmes, 2009, Le Couteur et al., 2004). Further
research is required to understand how best to support frail older adults to apply their
health literacy skills and participate in a decision making process when presented with
an option to deprescribe.
4.4 GP views of older adult health literacy.
A significant number of GPs expressed negative views about the health literacy
capabilities of their older adult patients. GPs who expressed negative views were more
likely to assume decision making authority and limit explanations of decisions,
potentially further limiting their older patients’ acquisition of health literacy.
GPs were sceptical of the reliability and benefit of other sources of medication
information used by older patients such as community pharmacists, friends and the
internet. They were unaware of their older patients’ extensive use of the internet to
access medication information. The use of the internet to source health information
has been studied among older adults in Belgium concluding that there is no longer a
traditional patient–physician dyad in terms of information sourcing and exchange
(Huisman et al., 2020). Internet usage has transformed this into an information
triangle (Huisman et al., 2020). This has implications for GPs when discussing
medication, including deprescribing. It suggests GPs should assume that their older
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patients have already accessed information about their medications and that this
information will have already influenced their preferences. Therefore, GPs are no
longer working with a ‘blank slate’ and would be wise to explore their patients’
understanding of their medications and of deprescribing first. Furthermore, these
findings emphasise that GPs can do more to understand their older patient’s health
literacy status, refrain from assuming poor health literacy and explore unmet
information needs.
4.5 Using health literacy skills to assess risk
Much has been written about the inability of patients to assess risk because of poor
health literacy and numeracy skills (Miles and Davis, 1995, Vernon et al., 2007) and
the inability of doctors to be able to understand and communicate risk information
(Wegwarth and Gigerenzer, 2020). Most GPs in the quantitative arm stated they were
confident to communicate risk information to their older patients. However, in the
later qualitative arm, many described how they were not always able to convince their
older patients to change their medication/s based on the delivery of risk information
alone. Describing risk is difficult in situations where there are multiple attributes to
consider and uncertainty, such as is the case when deprescribing in the context of
multimorbidity. Further research is warranted to explore how GPs do attempt to
explain risk in practice and how older adults understand risk communication in the
context of deprescribing, characterised by uncertainty and the consideration of
multiple considerations.
This study also described a mismatch in how older adults assess risk compared to GPs
when making a decision about ongoing medication use or deprescribing. Older adult
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participants confirmed that they applied multiple sources of information and
knowledge. As mentioned, this included information from a wide range of sources but
also included reflections on their own experience and/or others who had used and/or
stopped medication. In contrast, GPs spoke of using guidelines, objective results from
biomedical tests, patient reports of medication effects and clinical experience and
judgement to guide their assessment of risk. GPs generally did not place a high value
on the sources of information used by older adults to assess risk. This attitude is
unlikely to form a strong foundation to encourage older adults to participate in shared
decision making.
Older adult participants stratified risk noting that some medications definitely should
not be stopped. GPs also sought to prioritise their older patients’ diseases in order of
greatest to lowest risk and therefore treatment priority. However, it is not clear
whether older adults stratified their medications in the same order as GPs. Exploring
these differences could be useful to inform person-centred shared decision making
and would be an interesting area of further research.
These new findings about the differences in how GPs and older adults form their view
of risk and apply it might explain why some GPs reported patient resistance to
deprescribing. Resistance may be the result of presenting information about risk and
benefit that is not relevant to their patient’s view of risk and/or their goals of
treatment.
4.6 Barriers to health literacy use
The accounts of the older adult participants suggest that there are a number of
barriers to being able to apply their health literacy skills within consultations, where
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key decisions about their medications are being made. Older adults understood their
GPs held specific medical knowledge and expertise and valued this compared to their
own limited medical knowledge. This view sometimes undermined their confidence to
employ their health literacy skills, share their own knowledge of their medications and
participate in shared decision making. They often chose to remain passive and trusting
in decision making.
Others demonstrated that their knowledge allowed them to be more empowered to
enter into discussions with their GP about their medications. Differences in critical
health literacy capabilities may explain variability in involvement however, that would
require further investigation. GPs may interpret that older adults who are passive in
consultations are lacking in health literacy skills and this, along with a general
perception that older people have deficient health literacy skills, may deter them from
entering into a person-centred deprescribing process, based on shared decision
making. These findings expand on the work of Weir and colleagues (Weir et al., 2017,
Weir, 2020, Weir et al., 2021b) who also described variation in older adult
participation in shared decision making about deprescribing.
Older adults’ ability to engage in an informed way in shared decision making about
their medications, including about deprescribing decisions was potentially limited
because other prescribers did not always explain medication changes. Additionally,
key medication information was not given to older adults using blister packaged
medication. This finding suggests that GPs should not assume that their patients have
all the relevant information about their medications to enable them to participate in
decision making. An additional step should be added to comprehensive medication
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reviews with the purpose of ensuring patients are adequately informed about their
medications. The intent would be to clarify and extend the patient’s understanding of
the indication, purpose, duration of treatment and ongoing benefits/risks of their
medication/s. Patient education materials are available to assist older adults as they
consider deprescribing however the majority have been found to be difficult for
average readers to comprehend and they do not present information in a way that
would be sufficient to inform consent (Fajardo et al., 2019).
Time constraints during consultations suggest that older adults may not always be
presented with an opportunity to use their health literacy skills when decisions are
being made about their medications. Furthermore, the findings highlight the health
literacy demands created by the prescribing of multiple medications, often by multiple
prescribers, and the burden this creates for older adults. Even the GP participants
noted that they found the complexity associated with managing multiple morbidities,
polypharmacy and multiple prescribers hard to manage at times.
DeWitt et al. (2020) studied the use of health literacy in the lives of 50 older adults
from three European countries and noted similar barriers to the use of health literacy
skills. They also found that empowerment to engage in conversations and decision
making with health practitioners varied and was dependent on a range of factors
related to the quality of interactions with health professionals, time available and
integration and communication between healthcare services.
4.7 Research objective 3 summary
The association between attitudes toward medications or deprescribing and health
literacy had received limited research attention in the past (Schiotz et al 2018).
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However, the role of health literacy in facilitating discussions of deprescribing is an
area that had not been explored. Earlier work on deprescribing had emphasised the
literacy and numeracy limitations of older adults and the potential impact on shared
decision making when deprescribing (Jansen et al., 2016). These findings suggest that
much more complex aspects of health literacy impact participation in shared decision
making. Higher summed scores across the three domains of functional,
communicative and critical health literacy were associated with being involved in
medication decision making. However, as the qualitative data showed, older adults’
health literacy skills were less likely to be used during consultations. This was the
result of a number of factors including patient preferences for decision making
involvement, a lack of awareness on the part of the GP of the health literacy levels of
older adults, the impact of frailty and the use of different decision making criteria
between GPs and older adults when assessing risk and prioritising goals of care. These
findings all advance our knowledge of this previously unexplored area and identify the
importance of health literacy to shared decision making in the context of
deprescribing. They also indicate that person-centred care is currently less likely to
occur because of the lack of participation of older adults in deprescribing decisions.

5. What, if any, is the relationship between attitudes toward medication use,
age cohort and socio-economic status and the likelihood of discussions about
polypharmacy and deprescribing? (Research objective 4)
Key findings
1. Older adults and GPs present generally positive attitudes toward medications
and ongoing polypharmacy use.
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2. Most older adults were motivated to reduce the daily burden of managing their
medications.
3. Attitudes toward medication use were not found to be associated with either
age or socio-economic status.
5.1 Older adult and GP attitudes toward medication use
There was an overall acceptance of the need for the ongoing use of polypharmacy.
Older adults spoke of the practical benefit of their ongoing medication use in terms of
their quality and quantity of life. GP participants confirmed that their older patients
held this view, noting that they were more likely to over-estimate the ongoing benefit
of their medications. Indeed, GPs’ practice of ongoing prescribing encouraged this
view.
Despite this positive attitude towards ongoing medication use, older adults and GPs
agreed with deprescribing in a notional or hypothetical sense, when surveyed.
Consistent with quantitative previous studies of older adults’ attitudes toward
deprescribing (see Summary of quantitative studies Appendix C), the majority of older
adults held positive attitudes toward the possibility of deprescribing and/or reducing
the numbers of medications they were currently taking. Similarly, when surveyed GP’s
were confident in their ability to deprescribe and also expressed a positive view of
deprescribing confirming the results of other quantitative studies (Carrier et al., 2019,
Djatche et al., 2018, Mantelli et al., 2018).
GPs’ considerations of deprescribing were mainly focused on certain medication
classes such as statins. This reflects the finding in other qualitative studies of GPs’
focus on deprescribing ‘low hanging fruit’ or medications that are relatively easy to
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stop (Anderson et al., 2017, Linsky et al., 2015b). When discussing medication
management strategies GPs emphasised ‘tweaking’ existing medication regimens to
best meet the individual patient’s clinical needs. Finding the right balance of
polypharmacy use was stressed rather than a focus on reducing polypharmacy.
GP definitions of polypharmacy varied agreeing with earlier findings (Linsky et al.,
2015b, Moen et al., 2010). A range of numerical definitions were given and varying
levels of concern about polypharmacy use were raised. GPs’ perception of the risk of
polypharmacy use influenced their medication management practice. For most,
appropriate polypharmacy was determined on an individual patient basis. Clinical
need determined the number of medications required. Most also erred on the side of
prescribing less. However, they emphasised the difficulty of trying to reduce
polypharmacy while also managing all their older patients’ needs.
Similarly, older adults expressed varying opinions on what was considered ‘a lot’ of
medications. Using a lot of medications was understood to be potentially problematic.
Concerns were noted including the potential for drug–drug interactions, side effects
and the burden of managing multiple medications. These concerns were more often
expressed in those currently using more than 10 medications. However, even some
using only five to nine medications were also concerned. Their concerns were similar
regardless of the number taken. This finding suggests that the number of medications
is only one influence behind a desire to reduce medications and that GPs should
explore the desire to reduce medications regardless of the number being taken.
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5.2 The burden of medication management
Many older adult participants, particularly those using larger numbers of medications
described the daily burden of their medication management tasks. This led some to
form negative attitudes toward medication use. This result confirms the findings of an
earlier systematic review of qualitative studies which examined medication related
burden (Mohammed et al., 2016). That review identified that patients experienced
daily medication related hassles which had an impact on their health and wellbeing
and their beliefs and behaviours toward their medicines (Mohammed et al., 2016). A
further systematic review of 11 qualitative studies of patients’ perspectives of managing
chronic conditions noted that managing treatments for long-term multiple
morbidities requires work and impacts relationships, identity, wellbeing and function.
Patients manage this burden by implementing adaptive work for example, managing
side effects, and using ‘rationalised non-adherence’ to minimise the disruption from
treatments (Demain et al., 2015). Again, the findings of Demain’s review were
observed in this study with older adults actively choosing not to take certain
medications at times when their use would cause disruption and otherwise adapted
their daily living to manage side effects.
The review of patients’ perspectives on managing chronic conditions calls for
clinicians to adopt a person-centred approach when assessing the ‘adhere-ability’ of
regimens (Demain et al., 2015). However, only one GP noted that managing complex
daily regimens might present a burden suggesting that most GPs do not consider the
burden of medication management when making deprescribing decisions. In creating
a theory of the burden of treatment, May et al. (2014) argue that little consideration is
given to either the amount of work required by patients to manage their treatments,
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their capacity to do so and how this may change over time or as symptoms and
treatments affect functional performance. Older patients want to reduce the burden of
their medication management and this may be a motivator to consider deprescribing.
5.3 The influence of age cohort or socio-economic status
The sample size of both the quantitative arms was not of sufficient size to make any
meaningful findings regarding the effects of age cohort or socio-economic advantage
on the attitudes towards medications or discussions about polypharmacy. In the GP
arm there were no significant associations between GP workplaces located in a lower
socio-economic area and any of the survey items. Similarly in the older adult survey no
significant associations were found between location of residence in rural or regional
areas, or lower socio-economic areas or completed education levels and the other
survey items. No patterning according to age of those who were aged between 65–74
compared to those 75 or above, was noted.
However, further research using larger sample sizes is warranted as previous research
in other countries have identified patterns associated with demographic factors and
polypharmacy use. For example, a longitudinal study conducted in New Zealand found
higher rates of polypharmacy and hyper-polypharmacy use in particular regional
areas, areas of lower socio-economic advantage and within particular ethnic groups
(Nishtala and Salahudeen, 2015). Higher rates of polypharmacy and hyperpolypharmacy use have also been identified in those with low wealth in the English
Longitudinal Study of Ageing (Slater et al., 2018).
The impact of the cost of medication could have been an interesting proxy measure of
the effect of socio-economic position on polypharmacy use and was explored in both
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older adult arms. However, the potential for inequitable access to medications based
on socio-economic position is mitigated in Australia because most medication costs
are heavily subsidised for older adults. While one fifth of participants in the older
adult survey indicated that reducing costs would be a factor that would encourage
them to consider deprescribing, the vast majority (93.4%) did not find paying for
medications a financial burden. This later finding was supported in the qualitative arm
where the majority of participants talked about the benefits of government subsidised
medications capping individual prescription costs and the safety net, where
medications are provided for free once an annual out of pocket medication threshold
is reached.
5.4 Research objective 4 summary
Despite being notionally interested and favourable toward deprescribing, GPs and
older adults’ positive attitudes toward the ongoing practical usefulness of medication
prevented action to deprescribe. However, the burden of the daily management of
polypharmacy may be a motivation to deprescribe that is currently given little
attention. Further research is required to explore patterns associated with age or
economic status and attitudes toward deprescribing.

6. Additional findings
Four substantive additional findings were made, beyond the four main study
objectives.
Key findings:
1. Person-centred medication management was limited because of disruptions to
shared decision making.
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2. Pragmatic decision making principles were employed. GPs and older adults were
happy to settle for a ‘good enough’ outcome from polypharmacy use.
3. Definitions of what constitutes an older adult are inconsistently used across current
deprescribing research. This is problematic when trying to compare findings.
4. Older adults are an heterogeneous group however current numerical definitions of
polypharmacy and some deprescribing guidelines do not account for the variety
within this age group. The term appropriate polypharmacy is more applicable as it
assumes an individual approach to medication management.
6.1 Person-centred medication management
6.1.1 Factors which disrupted shared decision making
Person-centred medication management was limited because many factors prevented
shared decision making. These factors have been identified earlier however it is when
they are considered together that the challenges to person-centred care are apparent.
Trust resulted in some older adults adopting a passive role in consultations, preferring
to defer decisions to their GP. Incomplete communication of medication information
limited the capacity for older adults to engage with their GP in decisions about their
medications. Sometimes GPs also received incomplete prescribing information which
also limited their capacity to work alongside their patients to form a decision. Lack of
clarity about who was responsible for medication management decisions disrupted
shared decision making. Ageist view meant both GPs and older adults themselves
doubted their ability to engage in shared decision. Finally, GPs and older adults used
different criteria to assess the risk of polypharmacy as a result of sometimes different
goals of treatment. Successful shared decision making would require differences to be
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acknowledged and to reach an agreed accommodation of each other’s goals. Many of
these factors which disrupted shared decision making have been identified in an
earlier study of older adult views of participation in medication related decisions
conducted in the US (Belcher et al., 2006).
6.1.2 Factors which supported shared decision making
There were some factors identified which worked to support person-centred care and
promoted shared decision making about medication management. If practice is to be
improved it is helpful to understand which factors were supportive. Continuity of care
resulted in trust between the GP and older adult. This allowed decisions with
uncertain outcomes, such as deprescribing, to be considered. Trust facilitated open
conversations about potentially difficult topics, such as limited life expectancy. The
use of comprehensive medication reviews allowed older adults opportunities to share
their goals and preferences. Respect for the GP’s generalist role empowered them to
act, taking into account their holistic knowledge of their older patients developed over
time.
Figure 9.1 illustrates the interactions between factors which influence person-centred
medication management. The four axis shown illustrate four continua that capture the
key areas of influence identified in the study:


Views of age and ageing,



The empowerment of older adults during consultations



The empowerment of GPs to maximise their generalist role in managing
medications



The perception of the level of risk posed by polypharmacy use in older age.
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The continua seek to represent the range of views or practices around these four key
areas highlighting the diversity of attitudes and practices of older adults and GPs.
The circle represents the primary care environment where GP and older adult
consultations occur. The circle is divided into two halves. The left hand side promotes
person-centred medication management while the right hand promotes prescriptive
medication management.

Figure 9.1 Factors which influence person-centred medication management.
6.2 Pragmatic decision making
This section discusses the medication management decision making strategies
observed throughout the study. First, the use of varying decision criteria are discussed
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followed by a discussion of the pragmatic approach to decision which acknowledge
the likelihood of a ‘good enough’ outcome.
GPs and older adults both discussed ‘practical rules of thumb’ that were used to guide
decisions. While GPs and older adults agreed that less medication was better, where
possible, other decision making criteria used by each differed. The following decision
trees shown in Figure 9.2 are based on the results of this study and outline the
differences in decision making criteria used by older adults and GPs. GPs’ decisions
were shaped by concerns about avoiding poor health outcomes, managing side effects,
adherence and negative consequences for themselves if others such as specialists or
family members disapproved of their decisions. Older adults, on the other hand, were
concerned about reducing the daily burden of taking many medications, minimising
or avoiding side effects, avoiding medication ‘clashes’ i.e. drug–drug interactions and
maintaining health, extending life and remaining independent. Differences in patient
and prescriber goals have been described previously (Gregory et al., 2011, Reeve et al.,
2014) and these differences emphasise the need for shared decision making, where
both prescriber and patient goals are made explicit, explored and taken into
consideration.
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Figure 9.2 Pragmatic decision trees
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Both GPs and older adults took a pragmatic approach to decision making regarding
medication management, including deprescribing. GPs focused on ‘tweaking’ i.e.,
experimenting with medication regimens in order to achieve their goal of finding the
best possible balance between benefit and side effects. This approach also managed
the limited certainty about the outcome of any prescribing or deprescribing decision.
Older adults traded off the negative consequences of polypharmacy use such as side
effects, cost and the daily inconvenience of medication management with the
perceived benefits of medication use.
The pragmatic approach to medication use and related decisions used by both older
adults and GPs was focused on satisficing rather than optimising medication use.
Optimisation seeks to find the optimal solution to a problem while satisficing seeks a
solution that is good enough (Brighton, 2011). Hafenbrädl et al. (2016) argue that
optimisation is not possible where there are multiple possible choices and uncertainty.
Multimorbidity presents such a scenario when prescribing (Hoffmann et al., 2018).
The complexity of managing multimorbidity means that is not likely that all goals of
care are able to be met. Satisficing, or compromising on one or more decision criteria
is the only possible way of making a decision in such circumstances.
The findings of the current study support the use of the term ‘satisficing’. Sinnott et al.
(2015) have previously used the term satisficing to describe how GPs make decisions
when prescribing for multimorbid patients. However, the term satisficing has not been
used in the context of deprescribing by GPs or to describe how older adults make
medication decisions when faced with complex decision criteria with uncertain
outcomes. Satisficing was evident when GPs sought to find the best possible regimen,
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even if that meant compromising on their goal to prescribe as little as possible, in
order to reduce the risks associated with polypharmacy. Similarly, older adults were
generally keen to take fewer medications. However, they were willing to compromise
on this decision criteria and accept advice to take more, if they thought more
medications would help them maintain their health.
The above discussion emphasises the complexities of decision making regarding
medication management in the context of managing multimorbidity. If deprescribing
is potentially appropriate, a person-centred deprescribing process must allow the
patient and GP to interact together around the compromises they are both willing to
make when satisficing. As a part of this, differences in decision criteria also need to be
acknowledged. The potential outcome of deprescribing must be ‘good enough’ from
each of their perspectives, in order to proceed.
6.3 Defining the term ‘older adult’
In this study older adults were defined chronologically as a person aged 65 years or
older. This was explained verbally and in written information given to all study
participants. As noted in chapter 6, GP participants mostly described their care of
their frail older patients. While older patients with polypharmacy are likely to have
multimorbidities, the majority of older adults with multimorbidities cannot be
characterised as being frail (Vetrano et al., 2018). In fact, the degree of disability
associated with multiple morbidity varies (Marengoni et al., 2011). This was confirmed
in the sample included in both older adult arms of this study which included a wide
range of older adults. Only a small number presented themselves in ways which would
align with the description given earlier by the GPs. The majority of older adult
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participants rated their overall health and quality of life as being good to excellent.
This creates a dilemma when considering the application of the GP findings to the
majority of community living older adults using polypharmacy. The needs of the
majority of this group have not been appropriately acknowledged.
Other studies of deprescribing do little to advance our knowledge because of the
inconsistent use of a definition of an older adult. Sometimes no definition of the term
‘older adult’ is given (Linsky et al., 2015b, Wallis et al., 2017, Weir et al., 2021b).
Others define older adults by chronological age, as those aged 65 or older (Anderson
et al., 2017). A more specific focus is found in other studies which explore GPs’
deprescribing for very elderly and/or frail older adults (Mantelli et al., 2018, Schuling
et al., 2012). The lack of use of a definition of what is meant by older age, inconsistent
use of definitions, or (as was the case of this study), misinterpretation of key
definitions by participants, means that the results of studies of GPs’ deprescribing for
older adults need to be treated with caution. They may not be relevant for the majority
of older adults who use polypharmacy. Further studies are required that clearly define
and consistently apply definitions.
6.4 Research agendas and ageing
The findings from the older adult study arms support the notion that older adults are
a heterogeneous group, confirming the view of other researchers (Boeckxstaens and
De Graaf, 2011, O’Loughlin and Kendig, 2017). Participants each gave unique accounts
of their health status and the causes of their poor health. The perceived impact of their
health also varied with some remaining active and hopeful, despite considerable
health problems, while others had adopted a pessimistic view. Although small in
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number, those who were frail voiced different medication management needs to those
who were not. Notably, there were differences even among the two frail participants,
in terms of their interest in continuing to seek medication information. These findings
demonstrate the dynamic and varied nature of the impacts of the aging processes,
especially as frailty increases. As noted above, GPs also recognised this inherent
variability in their older patients.
The finding that older adults are a heterogeneous group emphasises the need to
explore the characteristics of this group and include their views in research. The views
of older adults have not been well represented within the deprescribing research
literature (Todd et al., 2018). While this study attempts to address this gap, more work
is needed to understand the views of older adults, especially taking into account the
variability in this group.
Current assumptions underpinning research into polypharmacy use in old age are
called into question when the variability of older adults is understood. It could be
argued that the current concept of polypharmacy based on a numerical definition is
inherently ageist because it assumes poor health outcomes in old age associated with
the use of multiple medications. It promotes reducing medications when five or more
are used, regardless of individual need, discounting the variability of older people’s
health status and the progression of the ageing process.
Conversely, the term ‘appropriate polypharmacy’ use accommodates the often
dynamic needs of the individual in terms of reviewing the appropriateness of all
medications in light of their current individual context, for example age, physiology,
comorbidities, compliance and social support (Cadogan et al., 2016, Cooper et al.,
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2015, Duerden et al., 2013, Hughes et al., 2014, Smith et al., 2020). The findings of this
current study suggest is it more suitable to use the term appropriate polypharmacy
within research as this inherently recognises the variability of older adults and the
dynamic nature of the ageing process.
GPs appear to have already adopted the term ‘appropriate polypharmacy’ as most
relevant to their practice, with a focus on devising individualised medication regimens
and making frequent modifications of their older patients’ medications. The
usefulness of deprescribing guidelines may be limited where they have been developed
in academic environments that operationalise a numerical definition of polypharmacy
and do not take into account older adult variability. However, more consistent use of
comprehensive medication reviews would help ensure ongoing appropriateness of
medications.
Further, it could be argued that the practice of deprescribing, in the context of a view
of polypharmacy as being consistently problematic, is also inherently ageist. One GP
participant presented this view, suggesting that an emphasis on deprescribing creates
a mechanism which promotes rationing of care and resources to the elderly. Although
this divergent view may not represent the view of GPs more widely, it does challenge
the possible consequences of this research agenda. In a post COVID-19 era where
governments will find it increasingly difficult to adequately resource and fund medical
care for the growing numbers of their older population, deprescribing could be an
attractive policy solution. However, deprescribing decisions should never be made
based on the motivation to reduce cost alone.

248

The recently released World Health Organisation’s Global Report on Ageism notes
that current research agendas promote institutional ageism (World Health
Organization, 2021). For example, research to determine the efficacy and safety
profiles of medicines for use in older age do not conduct age-specific clinical trials.
Older adults, as the group who use the most medications, could benefit the most from
equitable inclusion in research.
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7. Refinement of the initial conceptual framework
In chapter 1, a conceptual framework was introduced. For comparison this is included
again here (Figure 9.3). This was used to guide the research design, as demonstrated in
chapter 4. A refined conceptual framework was developed based on the findings of the
completed study (Figure 9.4).

Figure 9.3 Formative conceptual framework

Figure 9.4 Refined conceptual framework
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This refined conceptual framework illustrates the importance of the influence of preexisting attitudes including those toward polypharmacy and medication use and to
age and ageing. The influence of cohort or socio-economic status were not found to be
important although a dotted line has been used around this concept, indicating that
further research is required. The circle has remained, which represents the healthcare
environment. As the earlier discussion has shown, many aspects of this environment
are influential on medication management, including deprescribing.
Within the circle agency has been enlarged. Older adult and GP agency were found to
be influenced by many factors. The agency of GPs was influenced by the ability to
carry out their generalist role, time in consultations and the applicability of clinical
guidelines which were not well suited to managing multimorbidity. Factors which
influenced agency for older adults included GP-held perceptions of their capability,
their own preference for engagement in decision making, the availability of complete
medication information and also time in consultations. When agency was disrupted,
shared decision making was difficult to achieve. Trust has been added within the circle
as it was found to be very important in the older adult–GP relationship, especially
when decisions needed to be made in the context of uncertainty. Shared decision
making has also been added as it became apparent that it is crucial to good
medication management in order to explore and accommodate the goals of both older
adults and GPs.
The availability of health literacy and the capability to use it have remained
unchanged. These were found to be important to allow shared decision making about
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medication management. The availability and acceptability of deprescribing has also
remained as an aspect of medication management.
The term ‘satisficing’ has been added in order to describe the process by which older
adults and GPs achieve the goal of person-centred medication management, including
deprescribing. The word ‘optimal’ has been removed from the outcome box as it is
argued that person-centred outcomes that are acceptable to both older adults and GPs
are more important than optimal medication management.
Finally, the arrow at the bottom which aimed to illustrate that there is a dynamic
nature to the framework has remained. There were indications from this study that
changes in frailty were an important determinant to good medication management
and health literacy use rather than age, however the sample was small. Similarly, the
majority of GPs who participated were experienced so the influence of changing levels
of experience was not clear. As such, ‘variation over time’ has been italicised indicating
that further research is required.

8. The usefulness of the research design
The research design has allowed the initial conceptual framework to be explored and
later refined. The pragmatic approach, using a mixed methods design, identified key
concepts and then explored how and why they were influential. This allowed the
production of practical knowledge and added a greater level of insight than if a
quantitative or qualitative approach was used alone.
Analysis of the results together allowed findings from both qualitative and
quantitative phases to be compared. Sometimes this resulted in the confirmation of
findings across both phases. At other times additional findings in the qualitative
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phases complemented findings from the initial quantitative phase. Or sometimes
contradictory findings were made.
This approach was particularly useful in the exploration of health literacy. Viewed in
isolation, the quantitative analysis would have suggested a much more positive view of
the association of good health literacy with aspects likely to be supportive of
deprescribing such as participation in shared decision making. However, the
qualitative analysis allowed insight into the practical application of health literacy,
revealing many barriers to its use in consultations.
Similarly, when investigating attitudes toward deprescribing the design enabled the
expressed hypothetical willingness to consider deprescribing in phase 1 to be further
explored. The subsequent qualitative phase revealed that this willingness did not often
translate into in practice.
The All Aspects of Health Literacy Scale (Chinn and McCarthy, 2013) was first used in
an older adult population in this study. The use of a scale which measured health
literacy across three domains allowed a more nuanced understanding of health
literacy levels than early measures which only accounted for function health literacy.
While older adults indicated they had very good functional and communicative health
literacy they generally reported poorer critical health literacy skills.
The comparison of results across the phases led to the refinement of the novel GP
survey, developed for this study. This process has confirmed the content validity of the
survey and given confidence that the amended survey is suitable to be validated in
future research. The question order has been changed in order to group items into
similar domains. The wording of seven items has been revised to reflect the findings of
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the later qualitative phase and three additional questions have been added. An
amended version of the tool is presented in Appendix L.
Finally, this novel way of researching this area has captured the views of both older
adults and GPs. Incorporating the views of both allowed a comprehensive
understanding of the factors which affect deprescribing, including how factors which
affect one party interact with factors that affect the other.

9. Conclusion
Structural and attitudinal factors were found to affect the process of deprescribing of
medications in the primary care context in Australia. Health literacy was found to play
a limited role in deprescribing processes as GPs were unaware of the health literacy
capabilities of the older patients and older adults generally did not use their health
literacy skills in consultations.
This discussion has shown that there are a number of supportive factors which have
the potential to encourage deprescribing as a part of individualised medication
management. Greater empowerment of GPs to act in their generalist role to provide
continuity of care and coordinate medication regimens and empowerment of older
adults to use their health literacy skills and engage in shared decision making within
consultations would be beneficial.
The study confirmed the findings of earlier work conducted elsewhere which
demonstrated the influence on deprescribing processes of health system structural
factors. Their impact was mostly negative and promoted ongoing prescribing. These
common findings suggest that there are few differences in the Australian primary
healthcare system, compared to other countries. However, specific to the Australian
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context, frailty was found to reduce access to GP services at a time when deprescribing
is most likely to be appropriate.
As noted earlier, previous studies have focused narrowly on identifying barriers and
facilitators of deprescribing. The formation of attitudes that influence the perception
of key barriers and facilitators has been overlooked. The novel finding regarding the
role of stereotypes of age and ageing demonstrated the need to consider the
precursors of attitude formation. It demonstrated how attitudes formed and interacted
between GPs and older adults, discouraging participation by older adults in shared
decision making and normalising medication use in older age.
Health literacy had not previously been studied in the context of deprescribing.
Although health literacy was found to have a limited role in deprescribing decisions
currently, attitudinal change on behalf of both GPs and older adults could facilitate its
use and allow a person-centred approach to deprescribing.
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Chapter 10 Conclusion
1. Introduction
This chapter summarises the identified challenges faced by older adults and GPs as
they interact and consider deprescribing in the context of polypharmacy management.
It outlines practical opportunities for change and highlights where more research is
needed.

2 Key findings
Deprescribing was considered, when it was thought appropriate to do so, as a part of
the work of creating and curating individualised medication regimens. However, GPs
and older adults pragmatically accepted polypharmacy as a necessary aspect of
individual regimens to manage multimorbidity. The appropriateness of polypharmacy
was assessed, relative to the medication management needs of the individual.
This finding supports the consistent use of the term ‘appropriate polypharmacy’ as a
more relevant consideration in clinical practice than using numerical definitions of
polypharmacy. Using ‘appropriate polypharmacy’ within research may also aid in
translating research into practice, as it better reflects the real world variability,
complexity and needs faced by GPs and older adults as they seek to manage and live
with multimorbidity.
Consistent use of other definitions of key terms is also needed. This study specifically
identified the need to clarify the definition of ‘older adult’. It will remain difficult to
compare the results of deprescribing studies until there is a consistent use of and clear
communication of such definitions.
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Person-centred care was limited because of a multitude of factors which disrupted
shared decision making about medication management and as a result, deprescribing
processes. Disruptive factors arose as a result of structural characteristics of the
healthcare environment. Others arose as a result of the unexamined influence of
attitudes toward age and ageing and medication use.
Other factors worked to support person-centred care and promoted shared decision
making about medication management. These included continuity of care, the use of
comprehensive medication reviews and respect for the GP’s generalist role. Work to
promote these is needed to ensure good medication management for older adults.
No previous study had explored the role of older adult health literacy as an influence
on deprescribing. Earlier evidence suggested older adults had low health literacy
(Baker et al., 2000, Bostock and Steptoe, 2012, Geboers et al., 2016, Kutner et al.,
2006, Wolf et al., 2010). This view was evident in deprescribing research involving
GPs (Linsky et al., 2015b, Schuling et al., 2012) and commentary about the likely role
of health literacy in deprescribing decision making (Jansen et al., 2016). This deficit
view of older adult health literacy was not supported by the findings of this study.
When measured, older adult health literacy was found to be generally adequate and
older adults practiced a wide range of health literacy skills between consultations in
the management of their medications. However, health literacy capability was found
to have little bearing on discussions during consultations due to GP expectations of
low older adult health literacy, older adult attitudes which discounted their own
capabilities and healthcare environment barriers such as the incomplete provision of
information about medications to older adults.
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3 Strengths of the study design
This study bought together the voices of both GPs and older adults allowing both
perspectives to be considered and to explore how they interacted to influence
deprescribing. As identified in the earlier literature review (Chapter 2), older adults
are an heterogeneous group however, they are under-represented in studies of
deprescribing (Todd et al., 2018). The inclusion of older adults in this study increased
our knowledge of the variety of perspectives held by older adults toward
deprescribing. It gave insight into the different choices older adults made regarding
participation in decision making with their GP and the different decision making
criteria they use when considering deprescribing, compared to GPs. Importantly, their
views about deprescribing were influenced by the opinion of trusted sources,
including but not limited to their GP and were dynamic rather than fixed.
This study adopted a pragmatic approach which enabled the production of findings
that are relevant to the real world practice of medication management. A refined
conceptual framework was developed that shows the factors which contribute to
person-centred medication management, including deprescribing. The framework also
demonstrated the areas where further research is required.
The sequential explanatory mixed methods approach was another strength of the
study. This allowed findings to be compared across the study to determine if they
complemented, converged or diverged from each other. This allowed greater insight
into key factors such exploring the validity of attitudes toward deprescribing and
allowed a more nuanced understanding of health literacy.
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The study design also included the development and facilitated the refinement of a
new survey to measure GP practices and attitudes toward deprescribing. This is an
important contribution toward the development of a validated tool to use to measure
attitudes of GPs.

4 Limitations of the study
The sample sizes for the two quantitative arms were limited, although comparable to
other similar studies. They were, however, representative of age and sex, when
compared to national samples. Views of participants from outer regional or remote
areas of Australia were not represented although participants were drawn from an area
with a relatively a diverse multi-cultural heritage. In the subsequent qualitative arms
the sample size was determined when no new material was presented.
Although the items for the novel GP survey were developed based on previous
literature and pilot tested no formal validation was undertaken. The use of an
unvalidated tool to assess GP attitudes toward deprescribing may have led to
measurement error. If the study had only relied on the use of the survey then any
findings would have to be considered with caution. However, the GP survey results
were also considered in light of the later findings from the qualitative arm and
situated in relation to the current deprescribing literature (Anderson et al., 2017,
Braun and Clarke, 2021, Carrier et al., 2019, Clyne et al., 2016, D’Avanzo et al., 2020,
Djatche et al., 2018, Farrell et al., 2018, Gerlach et al., 2020, Ie et al., 2017, Linsky et
al., 2015b, Schöpf et al., 2017, Schuling et al., 2012, Sinnott et al., 2015, Søndergaard et
al., 2015, Wallis et al., 2017).
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The majority of the older adult surveys were distributed to community groups which
meant that older adults who were active community members may be over
represented in the sample. The views of frailer and socially isolated older adults may
not have been captured in the responses. This may also have led to a difference in
findings between the survey and qualitative arms. It is possible that the older adults
who participated may have been more interested to join the study because they held
strong opinions about the problematic use of multiple medications. This may have
biased the findings.
The inclusion criteria for the older adult surveys included community living older
adults aged ≥65 years who were taking ≥5 medications. Survey responses that did not
meet this inclusion criteria were removed from the analysis resulting in 50 (26%) of
the responses being excluded. More detailed information during recruitment,
especially about how best to accurately report the number of medications being used,
may have reduced the number of responses that were unable to be included in the
analysis.
The majority of GP participants in the survey were very experienced and the findings
may not have captured the views of less experienced GPs and GP registrars. Initially it
was thought that this may mean the participants would find the management of their
older patients’ medications less challenging and that this may have influenced the
survey findings. However, this was not borne out in the later qualitative phase with
experienced GPs voicing the same challenges as their younger counterparts. The GPs
who chose to respond may have a special interest in medication management for older
adults and this may have affected the findings.
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5 Implications for practice
A more consistent approach to conducting medication reviews is recommended.
Current approaches taken by GPs were varied and most did not provide opportunities
or empower older adults to voice their views or concerns about their medications.
Conducting regular, comprehensive medication reviews could allow GPs to assess the
ongoing therapeutic need for each medication as well as explore the source of any
ambivalent attitudes toward current medications or potential dissatisfaction with the
burden of daily medication management tasks. The findings also suggest that not all
older adults will express concerns or goals of care unless they are specifically invited to
do so by their GP. GPs therefore, need to take the lead in providing such
opportunities, including initiating deprescribing discussions where appropriate.
It is imperative that the health literacy capacity of each older adult is supported,
recognised, and made use of within consultations. Older adults are worthy partners
alongside the expertise of their GPs in determining when deprescribing is appropriate
because of their specific health knowledge developed over time. Recognition and use
of this capability will help to shift current practice toward delivering person-centred
care, with greater opportunities for shared decision making. It would also begin to
address the identified impact of negative stereotypes of age and ageing as a
collaborative approach to decision making would help change the current narrative
projected by both older adults and GPs of the loss of capability associated with age and
ageing.
Many previous interventions to support health literacy in healthcare settings have
narrowly focused on supporting functional health literacy emphasising improvements
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to the readability of written documents. While this remains important, this study
indicates that an area of significant need is to support older adults to develop
improved critical health literacy skills. This is most important to enable older adults to
assess the quality and applicability of the medical information they are accessing via
the internet.
The dynamic nature of health literacy was also noted. Greater support for older adults
to maintain their health literacy, especially as they become frail is important to
maintain their ability to participate in shared decisions about their medications.
Specifically those using blister packaged medication may need greater support to
maintain a good understanding of their current medications.
Access to GP services for older frail community living adults was limited at a time
when their medication management needs were likely to be changing and where
deprescribing was perhaps beneficial. It is recommended that telehealth options are
used in order to remove the access barriers noted in this study and provide new
opportunities to discuss, initiate and monitor deprescribing outcomes in
circumstances where access to attend consultations in person is poor.

6 Recommendations for further research
No validated tool exists to measure the attitudes and practices of GPs towards
deprescribing. The novel GP survey developed for this study has been further refined
in light of the study findings. Further steps are required to validate this tool in order to
facilitate a consistent approach across deprescribing studies. This can be actioned
through additional expert consultation and an assessment of its psychometric
properties.
262

The burden of work associated with managing multiple medications appeared to be a
motivator for some older adults to consider deprescribing. Further research is required
to identify older adults’ goals and preferences regarding the management of this
burden and when older adults might consider deprescribing to be appropriate.
This thesis has identified that frailty rather than age appeared as a key determinant of
the use of health literacy skills. Further longitudinal research is needed to understand
the interaction between changes in frailty, the use of health literacy skills and
discussions about deprescribing. This is important as deprescribing is most likely to be
recommended in the context of increasing frailty. This area of further research is also
relevant to the current discussions in Australia about the need to reform aged care
service provision (Commonwealth of Australia, 2021).
As noted, this sample included mostly experienced GPs and was not able to capture if
changes in the level of experience over time made significant differences to
deprescribing practices. Further research is required with a broader sample, including
those with less experience, to see if level of experience or changes in experience affect
medication management practices including deprescribing.
Older adults were shown to be curious and keen to develop their own understanding
of their medications. Therefore their views on deprescribing are likely to be
changeable. Further work is needed to identify relevant information gaps that older
adults would like addressed in order for them to better understand when
deprescribing is appropriate. This may give them greater confidence to discuss
deprescribing in consultations and help to establish realistic expectations of the
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benefit of medication use. Exploration of the design and preferred delivery mechanism
and testing of appropriate patient information would be required.
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Appendix B PRISMA-ScR checklist
Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for
Scoping Reviews (PRISMA-ScR) Checklist

PRISMA-ScR CHECKLIST ITEM

REPORTED
in Section #

1

Identify the report as a scoping review.

Chapter 2

2

Provide a structured summary that includes (as
applicable): background, objectives, eligibility criteria,
sources of evidence, charting methods, results, and
conclusions that relate to the review questions and
objectives.

N/A

3

Describe the rationale for the review in the context of
what is already known. Explain why the review
questions/objectives lend themselves to a scoping
review approach.

1

4

Provide an explicit statement of the questions and
objectives being addressed with reference to their
key elements (e.g., population or participants,
concepts, and context) or other relevant key elements
used to conceptualize the review questions and/or
objectives.

1

Protocol and
registration

5

Indicate whether a review protocol exists; state if and
where it can be accessed (e.g., a Web address); and
if available, provide registration information, including
the registration number.

N/A

Eligibility criteria

6

Specify characteristics of the sources of evidence
used as eligibility criteria (e.g., years considered,
language, and publication status), and provide a

2.1

SECTION

ITEM

TITLE
Title
ABSTRACT

Structured
summary

INTRODUCTION

Rationale

Objectives

METHODS
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SECTION

ITEM

PRISMA-ScR CHECKLIST ITEM

REPORTED
in Section #

rationale.

7

Describe all information sources in the search (e.g.,
databases with dates of coverage and contact with
authors to identify additional sources), as well as the
date the most recent search was executed.

2.1

Search

8

Present the full electronic search strategy for at least
1 database, including any limits used, such that it
could be repeated.

See below

Selection of
sources of
evidence†

9

State the process for selecting sources of evidence
(i.e., screening and eligibility) included in the scoping
review.

2.2–2.3

Data charting
process‡

10

Describe the methods of charting data from the
included sources of evidence (e.g., calibrated forms
or forms that have been tested by the team before
their use, and whether data charting was done
independently or in duplicate) and any processes for
obtaining and confirming data from investigators.

2.5

Data items

11

List and define all variables for which data were
sought and any assumptions and simplifications
made.

N/A

Critical appraisal of
individual sources
of evidence§

12

If done, provide a rationale for conducting a critical
appraisal of included sources of evidence; describe
the methods used and how this information was used
in any data synthesis (if appropriate).

N/A

Synthesis of
results

13

Describe the methods of handling and summarizing
the data that were charted.

2.5

Selection of
sources of
evidence

14

Give numbers of sources of evidence screened,
assessed for eligibility, and included in the review,
with reasons for exclusions at each stage, ideally
using a flow diagram.

3

Characteristics of
sources of
evidence

15

For each source of evidence, present characteristics
for which data were charted and provide the citations.

See appendix

Critical appraisal

16

If done, present data on critical appraisal of included

N/A

Information
sources*

RESULTS
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SECTION

ITEM

PRISMA-ScR CHECKLIST ITEM

REPORTED
in Section #

within sources of
evidence

sources of evidence (see item 12).

Results of
individual sources
of evidence

17

For each included source of evidence, present the
relevant data that were charted that relate to the
review questions and objectives.

Click here to
enter text.

Synthesis of
results

18

Summarize and/or present the charting results as
they relate to the review questions and objectives.

3.1–3.2

Summary of
evidence

19

Summarize the main results (including an overview of
concepts, themes, and types of evidence available),
link to the review questions and objectives, and
consider the relevance to key groups.

3

Limitations

20

Discuss the limitations of the scoping review process.

N/A

21

Provide a general interpretation of the results with
respect to the review questions and objectives, as
well as potential implications and/or next steps.

4

22

Describe sources of funding for the included sources
of evidence, as well as sources of funding for the
scoping review. Describe the role of the funders of
the scoping review.

N/A

DISCUSSION

Conclusions

FUNDING

Funding

JBI = Joanna Briggs Institute; PRISMA-ScR = Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping
Reviews.
* Where sources of evidence (see second footnote) are compiled from, such as bibliographic databases, social media platforms, and Web
sites.
† A more inclusive/heterogeneous term used to account for the different types of evidence or data sources (e.g., quantitative and/or
qualitative research, expert opinion, and policy documents) that may be eligible in a scoping review as opposed to only studies. This is not
to be confused with information sources (see first footnote).
‡ The frameworks by Arksey and O’Malley (6) and Levac and colleagues (7) and the JBI guidance (4, 5) refer to the process of data
extraction in a scoping review as data charting.
§ The process of systematically examining research evidence to assess its validity, results, and relevance before using it to inform a
decision. This term is used for items 12 and 19 instead of "risk of bias" (which is more applicable to systematic reviews of interventions) to
include and acknowledge the various sources of evidence that may be used in a scoping review (e.g.quantitative and/or qualitative
research, expert opinion, and policy document).
From: Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist
and Explanation. Ann Intern Med. 2018;169:467–473. doi: 10.7326/M18-0850.
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Example of database search strategy
Scopus
Limiters - Full Text; Published Date: 20100101-20200914
Expanders - Apply equivalent subjects
Narrow by SubjectAge: - aged: 65+ years
Narrow by Language: - English
Search modes - Find all my search terms

1725 document results


(physician OR "family physician" OR "general practition*" OR GP OR doctor OR clinician
OR prescriber OR "health professional" OR "health care professional" OR "health
personnel" OR "health practitioner" ) AND ( "prescription drug" OR prescribing OR
medicines OR medication OR polypharmacy ) AND ( withdraw OR withdrawing OR
withdrawal OR cease OR ceasing OR cessation OR stop OR stopping OR discontinue
OR discontinuing OR discontinuation OR reduce OR reducing OR reduction OR
deprescribe OR deprescribing OR optim* ) AND ( "older adult" OR senior OR elder* )
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Appendix C Summary of cross-sectional surveys conducted in
community settings investigating deprescribing.
See Chapter 2 Literature Review
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Author/year

Country

Tool

Target group

Number

Main finding

France

Survey with case
polypharmacy vignette

GPs

1266

91.4% felt comfortable to deprescribe although
on 34.7% decided to do so often. Sometimes
GPs prioritised patient requests over the
potential for medication associated harms.

Djatche et al.
2018

Italy

9 item survey

Primary care
physicians

160

Many barriers prevent deprescribing even
though respondents were confident in their
ability to deprescribe.

Farrell et al.
2018

Canada

15 item survey delivered
x4 following
implementation of two
medication specific
deprescribing guidelines

GPs, nurse
practitioners and
pharmacists

50 (38 GPs)
participants
giving 79
responses across
4 survey rounds

Respondents demonstrated that they knew
when they needed to deprescribe but not how
to do this.

Gillespie et al.
2018

Australia

21 item survey

GPs

85

65% of GPs felt they had enough information
to confidently deprescribe. System based
barriers for example poor communication
prevent GPs acting as the over-all coordinator
of medication regimes in order to enable
deprescribing.

Gillespie et al.
2019

Australia

PATD

Adults ≥65 years 137
using ≥5
medications

Carrier et al.
2019

88% willing to consider stopping one or more
medications

Median age 76

324

Hao et al. 2018 Malaysia

PATD

Adults ≥65 years 222
using ≥5
medications

86.9% willing to consider stopping one or
more medications.

Median age 70
Ie et al.

USA

7 item survey

GPs

61

2017

Cognitive impairment was the highest ranked
trigger to consider deprescribing.
Patient’s belief that drugs might help was the
highest ranked barrier.

Kua et al. 2019 Malaysia

rPATD

Adults ≥60 years 502 Older adults
(or caregivers) ≥
52 caregivers
1 medication

67.7% older adults and
65.4% caregivers willing to consider stopping
one or more medications

Median age 67
Linsky et al.
2017

USA

PPoD

Adults using ≥5
medications

803

Higher education, doctor recommendation,
interest in deprescribing and shared decision
making were associated with having stopped a
medication.

157

84% considered deprescribing however only
30% acted on this. The reason for
deprescribing varied according to the
medication. Perceived risk and benefit of
medication, quality of life and life expectancy
were factors which most influence
deprescribing.

Mean age 67
Mantelli et al.
2018

Switzerland Survey with 2 case
vignettes (with and
without cardiovascular
disease).

GPs

325

Ng et al. 2017

Singapore

PATD

Adults aged 45–
84 years using
≥5 medications

136

93.4% willing to consider stopping one or
more medications

Median age 68
Omar et al.
2019

Malaysia

rPATD

Adults ≥65 years 182
using ≥1
medications
Median age 72

Reeve et al.
2013

Australia

PATD

Adults ≥18 years 100
≥ 1 medications

Age, number of chronic diseases and number
of medications were positively correlated with
burden score (the burden of taking
medications). There was a negative association
between age and number of medications and
appropriateness score (perception of benefits
and harms).
92% willing to consider stopping one or more
medications

Median age 72
Reeve et al.
2018

USA

Medication attitude
module of National
Health and Aging Trends
Study

Adults aged ≥65
years

1981

92% willing to consider stopping one or more
medications

Any drug
coverage.
Median age NR

Reeve et al.
2019

Australia

rPATD
rPATD Caregiver
version

Adults ≥65 years 386 older adults
≥ 1 medication
205 caregivers
Median age 74

88% older adults
84% caregivers willing to consider
deprescribing
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Schiotz et al.
2018

Denmark

PATD

Adults aged ≥65
years ≥10
medications

100

85% willing to consider stopping one or more
medications

Median age 75
Sirois et al.
2016

Canada

PATD

Adults ≥65 years 129
≥ 1 medications

71.2% willing to consider stopping one or
more medications

Median age 76
Tegegn et al.

Ethiopia

rPATD

2018

Adults ≥65 years 316
≥ 1 medications

81.6% willing to consider stopping one or
more medications

Median age 70
Turner and
Tannenbaum
2017

Canada

Turner et al.

Canada

2019

Novel tool, not
previously validated

PATD and 10 items from
BMQ specific

Adults aged ≥65
years
Mean age 75

Only 6.9% were familiar with the term
deprescribing. 41.8% had initiated a
deprescribing conversation. Female gender,
those under 80 years of age and having an
awareness of medication harms was predictive
of initiating a deprescribing conversation.

Adults ≥65 years 489

86% willing to consider deprescribing

Using
potentially
inappropriate
medications.

41% successfully discontinued at 6 month
post-intervention

2,665

Median age 75
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Vordenberg
and ZikmundFisher

USA

MMS, BMQ

Adults aged ≥65
years

942

Mean age 70

2020

Approximately half were concerned about
stopping medication. Medication taking
preferences predict concern about stopping
medications rather than medication-specific
attributes

BMQ Beliefs about Medicines Questionnaire (Horne and Weinman 1999).
MMS Medical Maximizer-Minimizer Scale (Scherer et a. 2016)
PATD Patients’ Attitude Toward Deprescribing (Reeve et al. 2013)
rPATD revised Patients’ Attitude Toward Deprescribing (Reeve et al. 2016)
PPoD Patient Perceptions of Discontinuation (Linsky et al. 2017)
No validated survey exists to measure GP attitudes toward deprescribing
NR not reported
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Appendix D Summary of qualitative and mixed method studies
included in Chapter 2 Literature Review
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Author/Year

AlRasheed et al.

Country

Saudi
Arabia

2018

Anthierens et al.

Belgium

2010

Anderson et al.

Australia

2017

Bell et al.

Norway

2015
Clyne et al.
2016

Ireland

Research Aim/s

To explore family physicians
knowledge about
deprescribing and explore
enablers that facilitate
deprescribing.
To describe GPs’ perspective
and beliefs about
polypharmacy. Identify the
role of the GP in improving
prescribing.
To explore the views of GPs
and Consultant Pharmacists
regarding inappropriate
polypharmacy and
deprescribing in primary care.
≥65
To explore the factors that
might influence prescribers to
deprescribe falls-riskincreasing drugs.≥ 65
To explore GP views on
prescribing of potentially
inappropriate medications in
older adults.

Sample Size

Data Collection

Data Analysis

Methods

Health Care
Providers

Older Adults

Family medicine
specialist/GPs

N/A

Focus Groups

Thematic content
analysis

65 GPs

N/A

Semi-structured
interviews

Content analysis

32 GPs
15 consultant
pharmacists (CPs)

N/A

Focus groups

Thematic analysis

13 GPs

N/A

Focus groups.

Systematic text
condensation

17 GPs

N/A

Interviews

Thematic analysis
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Clyne et al.

Ireland

To explore influences and the
beliefs and attitudes toward
medications of community
living, older adults’ with
polypharmacy.

N/A

196

Italy

To identify barriers to
deprescribing, to define useful
strategies to address these and
identify tools to assist
implementing deprescribing in
practice
To understand primary care
clinicians treatment decision
making processes for older
patients with multimorbidity.

25 generalists
(including 5 GPs)

40 participants:
(36 GPs
2 NP
1Physician
assistant
1 Pharmacist)

2017

D’Avanzo et al.
2020

Fried et al.
2011

USA

Multiple regression
and thematic
analysis

N/A

Secondary analysis
of cluster
randomised control
trial data
Questionnaire
and semi-structured
interviews
Focus groups

N/A

Focus groups

Content analysis

Thematic analysis
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Gerlach et al.

Germany

2020

Heser et al.

Germany

2018

Krska et al.

UK

2013

Kuntz et al. 2018

USA

Linsky et al.

USA

2015a

To explore GPs`, pharmacists`
and specialist providers`
perceptions of professional
roles in deprescribing, and to
identify interpersonal as well
as structural factors that may
impede or enable collaborative
medication optimisation
approaches.
To investigate contextual
factors that lead to chronic
PIM use in the elderly
including barriers to PIM
cessation.
To explore patients views of
using long-term medicines on
their day-to-day lives, to
facilitate developing a tool to
measure the impact and
burden of using medicines
To examine older adult and
primary care physician’s
knowledge and attitudes
regarding nonbenzodiazepine
medication use and to identify
barriers and facilitators to
deprescribing
To identify patient
perspectives on intentional
discontinuation of prescription
medications.

33 (26 GPs, 4
Community
Pharmacists, 3
Clinical
Specialists)

N/A

Focus groups

Content analysis

N/A

52 older adults
aged between 8696 years

Semi-structured
interviews

Content analysis

N/A

21

Semi-structured
interviews

Thematic analysis
using and inductive
approach.

6 GPs

10 older adults
≥64 years with
multiple
dispensing of Zdrugs

Semi-structured
interviews

Content Analysis

N/A

27

Semi-structured
interviews and
focus groups

Modified grounded
theory approach
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Linsky et al.

USA

To understand the attitudes
and beliefs of prescribers
toward polypharmacy and
medication deprescribing.

Netherlands

To explore GPs’ main aims in
the management of multiple
morbidity and what influences
management in daily practice.
The aim of the study was to
identify the barriers and
enablers encountered in reallife discussions between
patients
and their general practitioners
(GPs) considering
deprescribing
preventive cardiovascular
medication.
To understand how GPs’
decisions about
discontinuation of medication
are influenced by
their institutional context.

2015b

Luijks et al.
2012
Luymes et al.

Netherlands

2016

Nixon & Vendelo
2016

Denmark

20 prescriber
participants
11 GPs
3 NPs
6 pharmacists
25 GPs

N/A

Semi-structured
interviews

Thematic analysis
informed by
grounded theory

N/A

Focus groups

Constant
comparative
analysis

10 GPs

49 older adults

Audio taped
deprescribing
consultations

Content analysis

24 GPs

N/A

Semi-structured
interviews,
observations of
consultations and a
review of
guidelines

Thematic analysis
(both inductive and
abductive)
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McNamara et al.

Australia

2016

Moen et al.

Sweden

2010
Pickering et al.

USA

2020

Reeve et al.

Australia

2016
Riordan et al.

Ireland

2017
Ross and Gillett
2020

Canada

To explore current approaches
to multimorbidity
management, and perceived
barriers and enablers to
appropriate medications
management for communitydwelling patients with
multimorbidity and
polypharmacy, from the
perspectives of health care
professionals.
To understand GP’s
perspective of treating older
adult users of multiple
medicines.
To identify the most
significant factors
that impact the perceived
value of a medication from the
perspective of patients and
caregivers.
To explore the beliefs and
attitudes of older adults and
informal carers toward
deprescribing
To identify the determinants of
GP prescribing for older adults
and to explore their views on
intervention strategies.
To identify older adults’
perspectives on their
relationships with medications
and perceptions of
deprescribing.

5 GPs, 6 Clinical
Specialists 6 nurses
6 pharmacists, 2
dentists, 1
physiotherapist

N/A

Semi-structured
interviews

Constant
comparative
analysis

31 GPs

N/A

Focus groups

Content analysis

N/A

16 older adults
≥65 years, using
≥5 or more
medications
17 informal carers

Focus groups (3
with caregivers, 3
with older adults)

Thematic analysis

N/A

14 older adults
14 informal carers

Focus groups

16 GPs

N/A

Semi-structured
interviews.

Directed content
analysis and
conventional
content analysis.
Content analysis
using framework
approach

N/A

16 older adults
≥70 using
polypharmacy ≥5
or more
medications

Semi-structured
interviews

Thematic analysis
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Ross and Gillett

Canada

To identify the various
paradoxes that seniors
live through regarding their
medications and the narratives
that they engage to negotiate
these contradictions in the
context of polypharmacy and
deprescribing.
To identify the perceptions of
older adults and GPs regarding
communication about
polypharmacy and medication
safety.
To explore the feelings of
experienced GPs regarding
deprescribing and their
involvement of older patients
in decision making. Discussed
vignette of 83 yr old
multimorbid pt
To explore strategies GPs use
when optimising medication
regimens for older adults with
polypharmacy.

N/A

16 older adults
≥70 using
polypharmacy ≥5
or more
medications

Semi-structured
interviews

Thematic analysis

1 GP
1 GP trainee
1 medical student

6

Semi-structured
interviews

Content analysis
using framework
approach

29 GP participants

N/A

Focus groups

Thematic analysis

12 GPs

N/A

Focus groups

Content analysis

Ireland

To explore how and why GPs
make decisions when
prescribing for multi-morbid
patients.

20 GPs
Median age of
patient cases
selected: 75 years

N/A

Semi-structured
interviews

Grounded theory
approach

Ireland

To document the views and
beliefs of GPs and pharmacists
on managing multiple
morbidity in primary care.

13 GPs
7 Pharmacists

N/A

Focus groups

Content analysis

2020

Schopf et al.

Germany

2017

Schuling et al.

Netherlands

2012

Sinnige et al.

Netherlands

2016

Sinnott et al.
2015

Smith et al.
2010
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Sondergaard et al.

Nordic
Countries

2015

Stryczek et al.

USA

2020

Thompson et al.

Denmark

2020

Thompson et al.

Denmark

2020

Van Middelaar et
al.
2018

Netherlands

To explore GPs ’ views and
attitudes
toward problems and
challenges related to the
treatment of patients with
multimorbidity.
To explore
primary care providers’
experiences with prescribing
inhaled corticosteroids among
patients with mild-to-moderate
COPD to understand factors
influencing providers’
prescribing which might
inform efforts
to improve care.
To examine how GPs discuss
Proton Pump Inhibitor
deprescribing in routine
practice and compare this to
the views of older patients.
To explore
how GPs discuss statin
deprescribing in their older
patients.

180 GPs

To explore GPs’ routines and
considerations if prescribing
and deprescribing
antihypertensive medication in
older people and to clarify the
processes underlying current
(de)prescribing processes

15 GP participants

N/A

76 GPs completed
questionnaires

13 GPs, 2 NP
participants
interviewed

Recorded
workshop
discussions and
open response
questionnaire.

Framework
analysis

Semi-structured
interviews

Descriptive
analysis of survey
results.

46 completed
survey

11 GPs

Content analysis

4 adults aged ≥65
using ≥
5medications

11 GPs

N/A

Semi-structured
interviews

Systematic text
condensation

Semi-structured
interviews

Systematic text
condensation

Semi-structured
interviews

Thematic analysis
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Wallis et al.

New
Zealand

2017

Weir et al.
2017

Australia

To explore the barriers and
facilitators to deprescribing as
reported by primary care
physicians in everyday
practice
To explore the reasons behind
the variation in patient
preferences, attitudes and
experiences in the context of
deprescribing.

24 GPs

N/A

Semi-structured
interviews

Multi-stage coding
based on grounded
theory

N/A

30 older adults
15 companions

Semi-structured
interviews

Phenomenological
approach

Abbreviations: ADEs: Adverse Drug Reactions, EBM: evidence based medicine, GPs: general practitioners (this includes primary care family physicians),
N/A: not applicable, NP: nurse practitioners, CP: consultant pharmacists, QoL: quality of life, PIM: Potentially inappropriate medication
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Appendix E GP survey tool

GP survey: Investigating medication management of community living older
adults aged 65 years or older.
Thank you for taking the time to complete this confidential survey.
Completing and returning this survey is voluntary and implies your tacit consent to
participate in this research.
There are no right or wrong answers. Please answer every question based on your own
experience.
Please indicate how strongly you agree or disagree with the following statements by putting
a cross in the box that best describes you now.
Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

1. I see my GP role as the over-all
co-ordinator or manager of my older
adults’ medications
2. I feel confident that other prescribers,
such as specialists would respect my role
as the overall co-ordinator of my older
adult patients’ medications.
3. I believe my older adult patients trust
my medication prescribing decisions.
4. I regularly consider the potential
impact of polypharmacy when
considering the ongoing quality of life of
my older adult patients.
5. My older adult patients have an
expectation that there is a ‘pill for every
ill’.
6. I find it easy to prioritise medications
to adequately manage the needs of my
older adults with multiple morbidities.
338

Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

7. I believe that applying individual
clinical treatment guidelines often
results in older adults having to manage
complex medication regimes.
8. In the case of an older adult with
multiple morbidities, I feel confident to
deviate from clinical treatment
guidelines to help reduce the complexity
of their medication regime.
9. I feel there is enough time during
consultations to regularly check all the
current medications being used by my
older adult patients.
10. I feel there is enough time during
consultations to consider deprescribing
one or more regular medications taken
by my older adult patients.
11. Where multiple prescribers are
involved in the care of an older adult, it
is easy to communicate between those
prescribers about decisions to
deprescribe medications.
12. Where specialists are involved in the
care of my older adult patients I feel
confident they would respect my
decision to deprescribe a medication.
13. I have enough information about the
risks and benefits of medication use in
older adults to incorporate
deprescribing of medications where
appropriate, for my older adult patients.
14. I feel if I discuss deprescribing
medication with one of my older adult
patients they will interpret this as being
‘given up on’.
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Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

15. Overall, I believe my older adult
patients are capable of engaging in a
decision making process regarding
medication continuation or
deprescribing.
16. I find it easy to explain the risks and
benefits of discontinuing one or more
medications to guide my older adult
patients through a decision making
process.
17. I can identify when an older adult
patient is finding it difficult to
understand the appropriateness of
deprescribing one or more medications.
18. I always ask my older adult patients
what their preference is regarding
medication continuation or
deprescribing.
19. Most of my older adult patients
prefer to make decisions on their own
about their medications after seriously
considering my opinion.
20. My older adult patients prefer to
share responsibility for making
medication decisions with me.
21. My older adult patients prefer me to
make their medication decisions for
them.

Is there anything else you would like to tell us about medication management for your older
adult patients?
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
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Questions about yourself
1. What is your age? ___________________________________

2. What is your gender?

□ Female □ Male

3. What is your country of birth? _________________________
4. In what country did you complete your medical training?

□Australia □Other__________________
5. How long have you been working as a GP?

□Less than 2 years, □2-5 years, □ 6-20 years, □21 years or more.
6. What is the postcode of the practice you work in most frequently?
_______________________

□ Would you like to tell us more about your own experiences in managing the
medications of older adults with polypharmacy? If you would like to participate in a short
30-60 minute individual interview to share your views contact Robyn Gillespie, PhD
candidate University of Wollongong rjg906@uowmail.edu.au . Due to time constraints it
may not be possible to interview everyone who is willing to be involved in this second
research stage.

□If you would like to be kept informed of the results of this research please contact Robyn
Gillespie, PhD candidate University of Wollongong rjg906@uowmail.edu.au

Thank you for taking the time to complete this survey.
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Appendix F Older adult survey tool

Investigating Medication Management for community living older
adults.
Thank you for taking the time to complete this survey.
This survey will help us understand what you think about the medicines you are currently
taking.
This survey is completely confidential and you will not be asked to give information that will
personally identify you. It will only be seen by the researchers and not by any healthcare
workers looking after you.
Completing and returning this survey is voluntary and implies your tacit consent to
participate in this research.
There are no right or wrong answers. Please answer every question based on your own
views rather than what anyone else might think.
Please indicate how strongly you agree or disagree with the following statements by putting
a cross in the box that best describes what you are thinking now.

SECTION A
strongly
disagree

disagree

unsure

agree

1. I feel that I am taking a large number of
medications.
2. I am comfortable with the number of
medications that I am taking.
3. I believe that all my medications are
necessary.
4. If my doctor said it was possible, I would be
willing to stop one or more of my regular
medications.
5. I would like to reduce the number of
medicines I am taking.
6. I feel that I may be taking one or more
medications that I no longer need.
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strongly
agree

strongly
disagree

disagree

unsure

agree

7. I would accept taking more medications for
my health conditions.
8. I have a good understanding of the reasons I
was prescribed each of my medications.
9. Having to pay less for my medications
would play a role in my willingness to stop one
or more of my medications.
10. I believe one or more of my medications is
giving me side effects.
11. Have you ever tried to stop a regular medicine (with your doctor’s knowledge)?
YES

NO

If Yes: I was able to remain off the medicine

YES

NO

I had to restart the medicine

YES

NO

I had to be started on a different medicine

YES

NO

12. How many tablets/capsules taken each day would you consider to be a lot?
5-9,

10-14,

15-19,

20-24,

25 or more
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strongly
agree

13. What is the maximum number of tablets/capsules that you would be comfortable taking
in one day? Circle one of the pictures below

14. In the past 12 months have you delayed or not bought one or several medications
because you needed to spend your money on other items?
YES

NO

15. In the past 12 months has your doctor taken time during a consultation to check all the
different medications you are using, including medication prescribed by other medical
doctors?
YES

NO

16. In the past 12 months, how often did your doctor involve you in decisions related to
your medications?
rarely

sometimes

often

not applicable

17. Does your doctor allow you enough time to discuss your feelings, fears or concerns
about new medicines or medicines you may have been taking for some time?
rarely

sometimes

often

not applicable

(Questions 1-13 Patient Attitudes Toward Deprescribing Survey. Reeve et al. 2013 Used with permission)
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SECTION B
Please indicate how often the following statements would apply to you by putting a cross in the
box that best describes your experiences.

rarely

sometimes often

18. How often do you need someone to help you when you are given
information to read by your doctor, nurse or pharmacist?
19. When you need help, can you easily get hold of someone to
assist you?
20. Do you need help to fill in official documents?
21. When you talk to a doctor or a nurse, do you give them all the
information they need to help you?
22. When you talk to a doctor or a nurse, do you ask the questions you
need to ask?
23. When you talk to a doctor or a nurse, do you make sure they explain to
you anything that you do not understand?
24. Are you someone who likes to find out lots of different information
about your health?
25. How often do you think carefully about whether health information
makes sense in your particular situation?
26. How often do you try to work out whether information about your
health can be trusted?
27. Are you the sort of person who might question your doctor or nurse’s
advice based on your own research?
(Questions 18-17 All Aspects of Health Literacy Scale Chinn and McCarthy 2013)
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SECTION C

Some details about yourself
1. Today’s date:

Day

Month

2. What is your date of birth?

Day

3. What is your sex? Female

Year

Month

Year

Male

4. What is your home postcode?

5. In which country were you born? _______________________

6. Do you speak English at home?

No

Yes

6b. If you answered NO to question 6 what language do you speak?
_________________________

7. Are you an Aboriginal or Torres Strait Islander?
This question is optional. Do not tick either box if you do not wish to answer it.
No

YES, Aboriginal

Yes, Torres Strait Islander

8. What is the highest level of education you have completed (Tick one only)
Primary School or less
High School (Year 10 or below completed)
High School (Year 12 completed)
TAFE/Trade/apprenticeship
University degree or higher
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9. What is your current work status? (You can tick more than one box)
Full time paid work

Self-employed

Part time paid work

Doing volunteer work

Completely retired/pensioner

Studying

Partially retired

Caring for spouse/partner

Caring for grandchildren
Disabled/sick
Other_____________________________

10. How many family members are currently living in your household?
________________________

11. What is your usual yearly household income before tax from all sources? (Including
benefits, superannuation, pensions etc)

less than $10,000-$19,999 per year ($1-$379 per week)
$20,000-$39,999 per year ($380-$769 per week)
$40,000-$59,999 per year ($770-$1153 per week)
$60000-$79, 999 per year ($1154-$1529 per week)
$80,000-$99,999 per year ($1530-$1919 per week)
$100,000 -$149,999 per year ($1920-$2879 per week)
$150,000 or more per year ($2880 or more per week)
I prefer not to answer
I don’t know
12. How many different prescription medicines are you currently taking every day?
_____________________________________
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13. Has your doctor ever told you if have any longstanding illness or disability? Please tick all
that apply.
Arthritis

Back Pain

Heart Problems

Asthma

Cancer

Depression or anxiety

Diabetes

Stroke

Other, please specify___________________________________________
None of the above
14. In general, how would you rate your
a) Overall health?
excellent

very good

good

fair

very good

good

fair

poor

b) Quality of life?
excellent

15. Did someone help you complete this survey?

Yes

poor

No

If yes, please describe in what way you were helped______________________________

Thank you for your time
Please return your completed survey in the attached replied paid envelope or return to

Robyn Gillespie c/o Dr Judy Mullan, School of Medicine, University of Wollongong NSW
2522.

□Would you like to tell us more about your own experiences using medications? If you
would like to participate in a short 30-60 minute individual interview to share your story
contact Robyn Gillespie, PhD candidate University of Wollongong rjg906@uowmail.edu.au

□If you would like to be kept informed of the results of this research please contact:
Robyn Gillespie, PhD candidate University of Wollongong rjg906@uowmail.edu.au
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Appendix G Interview guide: GP
Thank you for taking this time out of your busy schedule.
Today I’d like to hear about your experience caring for older adults who visit your practice and are
still living independently, although using multiple medications.
1.
Could you tell me about the challenges of treating older community living patients with
multiple medications?
2.
What do you think would make it easier to manage your older patients with many
prescriptions?
3.
Could you tell me the principles that guide your prescribing practice for your community
living older patients?
-Could you describe what guides your prescribing practice?
4.

Some say that polypharmacy may increase risks for older adults while others argue that its
use is often appropriate. What is your opinion regarding polypharmacy in your older patients?
-Do you have a specific number of medications in mind when you think of polypharmacy?

5.
There has been a growing body of research conducted recently into deprescribing or
stopping medications, especially in the context of older adults taking multiple medications. What is
your opinion about deprescribing?
6.

How might your patients respond to you if you raised the idea of deprescribing?
-What questions do they typically ask?
-How does this vary between patients?
(if not mentioned: Could you comment on the influence of patients’ age, gender, length of
relationship, duration of medication use, other medications, specific types of medications?).
7.

In your current practice what would enable you to consider deprescribing?
-When might you consider deprescribing?
-What might make you cautious about considering deprescribing?
*If not mentioned: Could you comment on decision support, training, length of consultation,
certainty of outcome, patient or family/carer expectations, expectations of others e.g. specialists, or
communication between other health care professions involved in care.
8. Is there anything else you would like to mention from your experience of the management of your
older adult patients’ medications?

9. How long you have practised as a GP? Are you a GP registrar or a GP? How many fulltime
equivalent GPs work in your current practice? What is the postcode of your practice?
Thank you again for your time.

Do you have any questions for me?
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Appendix H Interview guide: older adult
Today I’d like to hear about your experiences when you visit your GP to talk about your medications.
1. Thinking about a typical visit to your regular GP, what things do you discuss with your doctor
about your medications?
*What questions do you like to ask about your medications?
*What information do you like to know about your medicines?
*How satisfied are you with what you doctor tells you about your medications?

2. If there needs to be changes to your medication, how does your doctor involve you in making a
decision about this?
*Do you think this has changed at all over time? If yes; why?

3. If your GP recommended that you stop taking one or more of your medications-what would you
think about this?
*Why would you feel this way?
*Is there anything that would make it hard or easy for you to follow this advice?
*What if the medication had been originally prescribed by a specialist? Would you perhaps
feel differently?
If yes: why?
*How much of a say would you feel you would have in whether to stop the medication or
keep going with it?

4. Has this ever happened to you? -Have you ever had one or more of your medications discontinued
by your doctor?
 If yes: Can you tell me what happened?
*Why did your doctor think this was the best option for you?
*Why did you decide to follow your doctor’s advice?
* Was there anything that made it hard or easy for you to follow this advice?
 If no: Under what circumstances might you consider asking your GP about stopping one or
more of your medications?
* Can you tell me more about that or give me an example?
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5. Would you mind me asking how many medications you are taking at the moment?
* What are your thoughts about taking (X number of) medications?

6. Just before we finish, I’m wondering if you could tell me a little about what you are planning for
yourself in the future, say in the next five or ten years?

7. Do you have any final thoughts or ideas that you would like to add about anything we have talked
about today?
Thank you for participating in the interview today.
Do you have any questions for me?
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Appendix I GP survey open responses
CAPACITY
GP CAPACITY (TIME)
There is not enough time during consultations to cover in-depth review of medications.
Time constraints can be a factor not conducive to deprescribing
It is generally very time consuming but satisfying in rationalising medication regimes for older
patients with multiple co-morbidities
Making appropriate timed tiered consultations occurs for medication management.
I find three avenues for medication reviews helpful annually on my elderly patients which allow
more time than a standard appointment.
1. HMMR (2 yearly)
2. Annual Health assessment
3. Annual GP care plans
Reason for visit/complexity of consultation affects my time to consider deprescribing (Q10. For
shorter consults I regularly review medications and consider deprescribing.
Conduct long consultations for med reviews or deprescribing
CAPACITY (RESOURCES)
MIMS isn't very good. I miss the BNF which was available in the UK where I trained.
May need a specialist opinion to know risks and benefits of deprescribing a medication.
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STRATEGIES
We should do more medication reviews!
Independent medication reviews by pharmacists are also useful when patients are on many
medications.
Generally home medication reviews and liaison with a geriatrician helps significantly.
Medication reviews by pharmacists at home / aged care facilities have been helpful in looking at
monitoring and deprescribing some medications.
There should be an exit strategy for all medications particularly statins
Often the patient doesn't request a script when it's due, and the job is to decide whether the drug is
in fact still necessary
I rarely use clinical treatment guidelines
This appears to be about deprescribing which is not a word in my medical training. APPROPRIATE
prescribing is what it’s about with each person; an individual with individual requirements.
Conduct long consultations for med reviews or deprescribing
May need a specialist opinion to know risks and benefits of deprescribing a medication.
GENERALISM (as a subset of strategy)
Specialist often organ focused rather than considering whole patient reinforcing need for welltrained generalists.
Specialists are sometimes not holistic and treat by guidelines

COORDINATION
POOR COMMUNICATION/COORDINATION
There is lack of of co-ordination between specialists and GPs in regards to medication change as
older patient may not have a regular GP as much.
(poor) Communication between specialists and GP practices is a big barrier to safe/effective
prescribing. Often patients have no letters from appointments and cannot tell me what has been
discussed at the appointment.

ROLE /COORDINATION
I stop medications, restarted in hospital.
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1. Hospitals should stop contacting pharmacy directly and change prescription without notifying GP
first.
2. Chemist should not bypass "no substitution' on prescription to avoid confusion.
3. Specialists should not prescribe prescription to patients would prefer letter to GP who then
prescribes pill to patient.
Chemists changing brands for older people is CONFUSING. 30% of 85 yr olds have cognitive issues.
This happens even when requested not to.

PATIENT FACTORS
PATIENT CAPACITY
Chemists changing brands for older people is CONFUSING. 30% of 85 yr olds have cognitive issues.
This happens even when requested not to.
It is difficult to answer these questions as patients with capacity can take responsibility but patients
with dementia/confusion/ ? comatose will come in category of 'patient's best interest'
It is difficult to assess how confident patients (older included) are with their medication, especially
when they live at home alone. This is a significant confounding factor in ensuring their wellbeing.
In some instances, preparation of medication in Webster packs is seen as unaffordable by the
patient.
I find using dosing aides helpful (e.g dosettes or Webster packs) for compliance
Pitfalls of Webster pak with shared management of medication
There is considerable variation between older patients, some just want me to tell them what to take,
some don't want to take anything I advise!

PATIENT BELIEFS
not all patients think of a pill for every ill
some believe in naturopathy
There is considerable variation between older patients, some just want me to tell them what to take,
some don't want to take anything I advise!

MOTIVATION
+ve POLYPHARMACY CONCERN
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G.P.s overall need to be more active in ceasing medication. I constantly see patients in nursing
homes still on statins for lowering cholesterol.
Often over medicated
Overall far too many medication
Polypharmacy is the single most important factor in complications for older patients.
-ve EXTERNAL FEARS
Risk of litigation still hangs over us.

CHANGING ENVIRONMENT
It is a changing environment with more combination medication and once daily dose. I think it
should be possible to simplify treatment regimens over the next 1-2 years.
I think that this issue will evolve as time passes as the new younger generation now are more
informed/skeptical about GP's authority in prescribing and thus they are likely to play a larger role in
their own health decisions when they are elderly.

Feedback on survey design:
neutral means sometimes agree/sometimes disagree in this context for me
In the responses I have marked as neutral this usually means the answer is 'sometimes', i.e. some
patients rather than as a general yes or no.
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Appendix J Example of coded script
Box 1 Examples of coded transcripts
Example of coded transcript (Doris, 78)
Transcript
Participant:

Codes
I’m feeling quite good, so – I take my – whatever

they given me, I’ll take. And if they say I should eat horse shit, I

Benefits of medication
use

eat horse shit.
Researcher:

Why would you?

Participant:

Why would I? Because, you know, I think …it's

Trust based on past good
outcomes.

trust really, a trust issue. It's a definitely trust issue, because if I
wouldn't trust these doctors, I probably would have questioned

Trust results in passive

it more often. But until now, they have done the right thing, I'm

engagement.

feeling okay, I’m feeling good, and when I feel miserable, yeah,

Trust based on GP

then I hope I don’t get some miserable things. Well, I have Dr X,

continuing to meet

she doesn’t like giving antibiotics, but this time, she had to but,

expectations

no, I do understand that.
Negative view of future.
Necessity of medication
use
Example of coded transcript GP 1 (2 years experience)
Transcript

Codes

Participant: If things are going well, that’s really hard where the

Challenge: Maintain
status quo or
deprescribe?

patient’s happy, fit, healthy, just coming in for the annual
review, for their scripts or something like that, and there’s like
one you’re thinking, “Oh, you probably don’t need to be on

Hierarchy of prescribers.

this.” But – I suppose – well, if it’s been prescribed by a
specialist and they’re only really seeing specialists for ongoing
scripts, sort of having that power play between – I think you

Confusion about
deprescribing
responsibilities
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don’t need to be on this but your specialist is saying that you
should be – who’s actually right in that instance?
Researcher: And how would you negotiate that, if you felt

Exploration of GP and
specialist treatment goals
only.

strongly about stopping?
Participant: If I knew the specialist, sometimes I communicate
with them directly, either through letter or phone if you’re
happy to chat to them. Sometimes I talk to the patient and I

Communication between
GP and specialist
facilitated by familiarity.

say, “In this letter, I’m just going to say – talk with them about
Not willing to deprescribe
meds prescribed by
don’t think I’d stop it and not talk to them. That’s a bit hard and others
this at the next appointment,” when I’m redoing the referral. I

not professional either.

Deferring deprescribing
responsibility for action
to older adult with
specialist.
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Appendix K Example of thematic mapping
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Appendix L Amended GP survey and changes log

GP survey: Investigating medication management of
community living older adults aged 65 years or older.
Thank you for taking the time to complete this confidential survey.
Completing and returning this survey is voluntary and implies your tacit consent to
participate in this research.
There are no right or wrong answers. Please answer every question based on your own
experience.
Please indicate how strongly you agree or disagree with the following statements by putting
a cross in the box that best describes you now.
X
Strongly
Disagree

Disagree

Neutral

Agree

Strongly
Agree

1. I see my GP role as the over-all
co-ordinator or manager of my older
adults’ medications
2. I feel confident that other prescribers,
such as specialists would respect my role
as the overall co-ordinator of my older
adult patients’ medications.
3. When I have deprescribed a
medication prescribed by a specialist,
the specialist has respected my decision
and agreed with my action.
4. Where multiple prescribers are
involved in the care of an older adult, it
is easy to communicate between those
prescribers about decisions to
deprescribe medications.
5. I regularly consider the potential
impact of polypharmacy when
considering the ongoing quality of life of
my older adult patients.
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6. I find it easy to know which
medications I can safely deprescribe
when managing the medications of my
older adults with multiple morbidities.
7. I believe that applying individual
clinical treatment guidelines often
results in older adults having to manage
complex medication regimes.
8. In the case of an older adult with
multiple morbidities, I feel confident to
deviate from clinical treatment
guidelines to help reduce the complexity
of their medication regime.
9. Polypharmacy should be defined as
the use of five or more medications.
10. The use of five or more medications
should lead to a review of medications
with a view to deprescribe.
11. I feel there is enough time during
consultations to regularly review all the
current medications being used by my
older adult patients.
12. I regularly delay deprescribing a
medication to another consultation
because I do not have time.
13. I have enough information about the
risks and benefits of medication use in
older adults to incorporate
deprescribing of medications where
appropriate, for my older adult patients.
14. I find it easy to explain the risks and
benefits of discontinuing one or more
medications to guide my older adult
patients through a decision making
process.
15. My older adult patients understand
my explanation of the risks and benefits
of deprescribing.
16. Overall, I believe my older adult
patients are capable of engaging in a
decision making process regarding
medication continuation or
deprescribing.
17. I always ask my older patients what
their preference is regarding medication
continuation or deprescribing.
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18. Most of my older patients prefer to
make decisions on their own about their
medications, after seriously considering
my opinion.
19. My older patients prefer to share
responsibility for making medication
decisions with me.
20. My older patients prefer me to make
their medication decisions for them.
21. It is important to gain an older
patient’s trust before recommending
deprescribing.
22. When an older adult trusts my
prescribing decisions they may not think
they need to participate in decisions
about their medications.
23. My older adult patients tend to overestimate the value of continuing some of
their medications.
24. I feel if I discuss deprescribing
medication with one of my older adult
patients they will interpret this as being
‘given up on’.

Is there anything else you would like to tell us about medication management for your older
adult patients?
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
Questions about yourself
1. What is your age? ___________________________________

2. What is your gender?

□ Female □ Male

3. What is your country of birth? _________________________
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4. In what country did you complete your medical training?

□Australia □Other__________________
5. How long have you been working as a GP?

□Less than 2 years, □2-5 years, □ 6-20 years, □21 years or more.
6. What is the postcode of the practice you work in most frequently?
_______________________

Thank you for taking the time to complete this survey.
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Survey changes log
Original survey item

Amended item and item
number
21. It is important to gain an
older patient’s trust before
recommending
deprescribing.

Additional questions

5. My older adult patients
have an expectation that
there is a ‘pill for every ill’.

23. My older adult patients
tend to over- estimate the
value of continuing some of
their medications.

10. The use of five or more
medications should lead to
a review of medications
with a view to deprescribe.

6. I find it easy to prioritise
medications to adequately
manage the needs of my older
adults with multiple
morbidities.

6. I find it easy to know
which medications I can
safely deprescribe when
managing the medications of
my older adults with multiple
morbidities.

22. When an older adult
trusts my prescribing
decisions they may not
think they need to
participate in decisions
about their medications.

9 I feel there is enough time
during consultations to
regularly check all the current
medications being used by my
older adult patients.

9. I feel there is enough time
during consultations to
regularly check review all the
current medications being
used by my older adult
patients.

10. I feel there is enough time
during consultations to
consider deprescribing one or
more regular medications
taken by my older adult
patients.

12. I regularly delay
deprescribing a medication
to another consultation
because I do not have time.

12. Where specialists are
involved in the care of my
older patients, I feel confident
they would respect my
decision to deprescribe a
medication.
13. I can identify when an
older adult patient is finding it
difficult to understand the
appropriateness of
deprescribing one or more
medications.

3. When I have deprescribed
a medication prescribed by a
specialist, the specialist has
respected my decision and
agreed with the action.

3. I believe my older adult
patients trust my medication
prescribing decisions.

9. Polypharmacy should be
defined as the use of five or
more medications.

15. My older adult patients
understand my explanation
of the risks and benefits of
deprescribing.
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Explanatory notes:
The order of the survey items has been changed. Items are now grouped on the basis of
common areas of exploration.
Item 3 from the original survey has been amended as the item failed to add value in terms
of how trust relates to deprescribing. The wording has been changed from ‘I believe my
older adult patients trust my medication prescribing decisions.’ to ‘It is important to gain an
older patient’s trust before recommending deprescribing.’ The revised wording captures the
more nuanced view of the role of trust presented in the GP and older adult qualitative data.
Item 5 from the original survey has been amended as the item generated mixed results that
were difficult to interpret. The wording has been changed from ‘My older adult patients
have an expectation that there is a ‘pill for every ill’ to ‘My older adult patients tend to overestimate the value of continuing some of their medications.’ These changes also capture
data from the GP qualitative arm.
Item 6 from the original survey has been amended as the item generated mixed results that
were difficult to interpret. The wording has been changed from ‘I find it easy to prioritise
medications to adequately manage the needs of my older adults with multiple morbidities’.
to ‘I find it easy to know which medications I can safely deprescribe when managing the
medications of my older adults with multiple morbidities.’ The revised wording has added
clarity and is more specific to deprescribing.
Item 9 The word check has been changed to review to avoid any confusion about intent.
Item 10 from the original survey has been amended as the item generated mixed results
that were difficult to interpret. The wording has been changed from ‘I feel there is enough
time during consultations to consider deprescribing one or more regular medications taken
by my older adult patients’ to ‘I regularly delay deprescribing a medication to another
consultation because I do not have time.’ The mixed results from the original item conflicted
with previous qualitative findings and the qualitative findings in this study where GPs
consistently note limited time to deprescribe. The revised wording reflects the responses
from GPs provided during the qualitative phase.
Item 12 from the original survey has been amended as the item generated mixed results
that were difficult to interpret. The wording has been changed from ‘Where specialists are
involved in the care of my older patients, I feel confident they would respect my decision to
deprescribe a medication’ to ‘When I have deprescribed a medication prescribed by a
specialist, the specialist has respected my decision and agreed with the action.’ The revised
wording now askes GPs to reflect on a previous experience rather than a hypothetical
situation.
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Item 13 from the original survey has been amended as the item generated mixed results
that were difficult to interpret. The wording has been changed from ‘I can identify when an
older adult patient is finding it difficult to understand the appropriateness of deprescribing
one or more medications.’ to ‘My older adult patients understand my explanation of the risks
and benefits of deprescribing.’
Three additional questions have been added based on the findings of the later qualitative
phase. Two seek to explore GPs’ understanding of the term polypharmacy. The third aims to
investigate GPs’ perception of the interaction between trust and older adult participation in
decision making.
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Appendix M Ethics approval

366

367

